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Welcome Address from Chairman of Organizing Committtee
Honorable Rector of Ahmad Dahlan University,
Dean Faculty of Pharmacy of Ahmad Dahlan University,
Honorable Plenary Speakers
Dear Colleague,
Distinguished Participants,
Ladies and Gentlemen
Assalamu’alaikum warahmatullahi wabarakatuh,
Good morning,
First of all, let us give thanks to Allah, the Almighty God, who has allowed us to attend this
conference. Secondly, I would like to welcome everyone to Yogyakarta.
Preparation and reconstitution of drug products are an essential function of hospital pharmacy.
The hospital pharmacist should also take notice for central intravenous additive service including
cytotoxic reconstitution services. Thus, handling cytostatic in hospital is also crusial in hospital
practises. In other words, Cytotoxic Handling should to provide protection to patients, the operator
and environment.
Ladies and gentlemen,
To celebrate the 17th aniversary faculty of Pharmacy Ahmad Dahlan University, Yogyakarta,
in collaboarting with Bethesda Hospital, Yogyakarta, Indonesia hosted The International Conference
on Safety Management of Central Cytotoxic Reconstitution in Pharmacy Practice”. The conference is
held on 25 May, 2013 at The Grand Tjokro Hotel, Yogyakarta, Indonesia. The conference facilitated
some of professional that come from world wide such as academia, researchers, hospital pharmacists,
policy maker, and health care professionals. The second agenda is Workshop on Basic Cytotoxic
Handling for hospital pharmacists and academia. It will hold on 26-27 May, 2013 in Pharmacy
Department, Bethesda Hospital.
I do hope this conference will give a new initiative for practicing sorounding cytotoxic
handling and team-work. I thank to conference sponsors and committee members for their support.
Wassalamu’alaikum warahmatullahi wabarakatuh,
Yogyakarta, 25 May 2013
Dr.rer.nat. Endang Darmawan, M.Sc., Apotheker
Chairperson of the organizing committee
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Welcome Address from Dean of Faculty of Pharmacy,
Ahmad Dahlan University
Assalamu’alaikum Wr. Wb.
Dear all participants,
Welcome to the International Conference and Workshop on Safety Management of Central
Cytotoxic Reconstitution in Pharmacy Practice. Thank you for participating in this great event.
Hopefully, you can enjoy the days of International Conference and Workshop.
The topic of this international seminar is very interesting and important for the development of
pharmacists’ skills in drug reconstitution, since we know that our new perspective of pharmacy
practice is patients’ care and patients’ safety. Dealing with cytotoxic drug is a kind of collaboration
among physician, pharmacist, nurse, psychologist, patient and patient’s family. However, as the
pharmacists, we have unique skills and knowledge related to the preparation, administration and
monitoring of cytotoxic drug administration. Therefore, in a team work, pharmacist has some
responsibilities as a leader related to the cytotoxic drug reconstitution.
This international conference and workshop are the collaboration between Faculty of
Pharmacy, University of Ahmad Dahlan Yogyakarta as academic institution with the Bethesda
Hospital of Yogyakarta as one of the central cytotoxic reconstitution. We also invited Prof A.A.
Kaptein, from Leiden University Medical Center, Leiden, The Netherlands and Harbans Kaur
Dhillon from University Malaya, Medical Centre, Malaysia as speakers, besides Dra. L. Endang
Budiarti, M.Pharm., Apt. as practitioners in Bethesda Hospital of Yogyakarta and Dr. Dyah Aryani
Perwitasari, Apt., PhD who wants to share about development of pharmacist’s skill in medical
reconciliation. After the one day seminar, we invite you to joint with us on the workshop of Central
Cytotoxic Reconstitution which will be held in Bethesda Hospital of Yogyakarta. This workshop is
useful for us, especially when we want to start the Central Cytotoxic Reconstitution in our hospital.
I hope, The International Conference and Workshop on Safety management of Central
Cytotoxic Reconstitution in Pharmacy Practice will inspire us to practice our skills and knowledge in
our fields. In the future, we can reach one the goal of pharmacy practice, which is patients’ safety.
Have a great conference.
Wassalamu’alaikum wr wb
Dean of Faculty of Pharmacy
University of Ahmad Dahlan, Yogyakarta
Dr. Dyah A Perwitasari, Apt., Ph.D
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COMPLIANCE ADHERENCE CONCORDANCE
 SELF-MANAGEMENT QUALITY OF LIFE
Prof. dr. A.A. Kaptein
Medical Psychology
Leiden University Medical Centre
Leiden, The Netherlands
a.a.kaptein@lumc.nl
Illness elicits an enormous set of behaviours in humans. Perceiving symptoms and interpreting
them as necessitating the seeking of medical care is one major step. Enduring diagnostic and
therapeutic procedures is another. In chronic illness, long-term use of medication is usually required.
Managing the illness, and incorporating the illness and its treatment into daily life, are other major
tasks. In short, achieving an acceptable quality of life is a core task in the lives of ill people all over the
world.
In this chapter I will discuss three of the topics mentioned above: ‘compliance’;
self-management; and quality of life [‘compliance’, adherence, and concordance will be discussed
together in one section]. Some theoretical background regarding the three main issues will be
provided, with empirical studies presented as illustrations. I will do this from a behavioural medicine
perspective as this integrates biomedical, behavioural, pharmacological, and societal views, as well as
expertise regarding being ill.
This chapter may serve as a guide for initiating and executing relatively modest research
projects for students of medicine, pharmacology, and psychology. Additional sources are relatively
easily accessible for this purpose (e.g., French et al., 2010; Ogden, 2012).
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DEVELOPING PHARMACISTS’SKILLS IN MEDICATION
RECONCILLIATION
Dr. Dyah A Perwitasari, Apt., Ph.D
Faculty Of Pharmacy, Ahmad Dahlan University
The role of pharmacists in Indonesia was moved into new perspective, which is patient
oriented, since the last decade. Thus the practice knowledge and skills of pharmacy was developed
into the aim of improve of patients’ care and patients’ safety. The American Society of Health System
Pharmacist defined that the effective process of medication reconciliation reduces medication errors
and support safe medication used by patient. These fact have been supported by many evidences that
the role of pharmacists in medical reconcilitiation could reduce the potential adverse drug events,
reduce the transtition medication errors and had significant impact in the medical cost. Many experts
in The Joint Comission of Accreditation of Healthcare Organization defined that medication
reconciliation is The process of comparing the medications a patient is taking (and should be taking)
with newly ordered medications in order to resolve discrepancies or potential problems. The goal of
medication reconciliation are to obtain and maintain accurate and complete medication information
for a patient and use the information within and across the continuum of care to ensure safe and
effective medication use. By understanding the definition, we know that the main point in the medical
reconciliation is the role of pharmacist as a leader in managing of drug administered to the patients.
Even though the pharmacist work in a health profesional team, however only pharmacist who has
unique knowlede and skills about drug. Thus, the competency of pharmacists as drug experts should
be applied in their work fields. To start the medication reconciliation in our fields is not easy, but we
can start these activities as the first steps, which are ; reviewing the medication therapy , collecting the
personal medical record, applying the medication related action plan and collecting intervention
and/or referral documents. In the future, our roles as the pharmacists who have expertise in
medication reconciliation, can start to be developed from now, especiallt in the fields of policy and
procedure development, implementation and performance improvement, training and competency
assurance, information system development and advocacy.
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 3
ISBN : 978-979-18458-6-1

TRAUMATIC EXPERIENCE OF ADOLESCENT FEMALE IN
FLOODS OF COLD LAVA AFTER THE ERUPTION OF MOUNT
MERAPI IN THE PERSPECTIVE OF GROWTH AND
DEVELOPMENT IN MAGELANG REGENCY SHELTER
Retna Tri Astuti
1
, Achir Yani S.Hamid
2
, Novy Helena C.D
3
University of Muhammadiyah Magelang
Abstract
Background. Cold lava flood disaster is catastrophic eruption of Mount Merapi was in
Yogyakarta. This disaster cause a traumatic experience for the community including adolescent
female.
Objective. The Objective of this study was to explore the traumatic experience of adolescent
female in floods of cold lava after the eruption of Mount Merapi in the persfective of growth and
development in Magelang regency shelter.
Methods. Methodology in qualitative research is phenomenological. Subjects in the study were
the six partisipans taken purposively with criteria had experienced traumatic.
Outcome measured. Impact of Event Scale (IES) for screening traumatic tools and in-depth
interviews.
Results. Six themes of the picture obtained traumatic for adolescent female, the psychological
response, cognitive responses, phychical responses, changes in social relationships, personal growth
and rehabilitation of daily living.
Conclusion. Research on Adolescent Girls Traumatic Experiences Cold Lava Flood Post
Mount Merapi eruption have been identified participants experienced minor trauma is trauma and
trauma of the participants were there five participants and there are six major themes, in which the
six themes are related to specific objectives.
Keyword : Traumatic experience, psychological responses, cognitive responses, physical
responses, changes in social relations, achieving personal growth and rehabilitation of
daily living
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INTRODUCTION
Problem of prolonged natural disaster in
Indonesia has its own impact to the community.
One of the biggest natural disasters in 2010 was
the eruption of Mount Merapi in Yogyakarta and
the subsequent disaster that cold lava flood. This
flood caused a variety of damage and trauma
itself for the people who experienced it,
including for girls. Adolescent girls is one of the
most vulnerable groups experiencing traumatic
events they experienced. Vulnerability of
adolescent girls is not only the physical
vulnerability but also emotional or psychological
vulnerability and social development. Based on
the above phenomenon in this study wanted to
explore the traumatic experience of adolescent
girls due to cold lava flooding after the eruption
of Mount Merapi in the perspective of growth in
temporary shelters Magelang regency. The
Objective of this study was to explore the
traumatic experience of adolescent female in
floods of cold lava after the eruption of Mount
Merapi in the persfective of growth and
development in Magelang regency shelter.
METHODS
This research is a qualitative, descriptive,
exploratory using phenomenological methods
Election participants in this study used purposive
sampling method. Study participants were
selected based on the inclusion criteria of this
study is that participants were adolescent girls
aged 15-18 years, had mild to moderate
traumatic disorder, living in temporary shelters ±
1 years, able to communicate well with the use of
the Java language as well as Indonesian and able
to express thoughts traumatic and adolescent
growth and development for our shelter.
Participant election results obtained in this study
were 6 participants in accordance with the study
inclusion criteria above.
Data collection of this research was
conducted using face-to-face and in-depth
interviews. The time in-depth interviews
conducted for approximately 45-50 minutes
using the tools of the recorder. Processing of data
that researchers are doing by using qualitative
analysis. Analysis of the data used in this study
based on the analysis phase by Colaizzi (1978, in
Polit & Hungler, 2001).
RESULTS
Theme analysis results generated by
researchers that there are 6 themes. These themes
are (1) psychological response (2) memory of the
incident, (3) physical response, (4) changes in
social relations, (5) the development of personal
growth, (6) rehabilitation of everyday life.
DISCUSSION
Specific Objective 1: Holistic Response to
Traumatic Events Teenage Girls Holistic
response is a response that includes response to
overall physical, psychological, cognitive and
social.
Theme 1: Psychological Response
This psychological response is a response
that experienced by the participants in which the
emotional disturbance that includes the absence
of fear, panic and a sense of sadness.
Psychological responses that appear on
the participants in this study is one of the
symptoms of Post Traumatic Stress Disorder in
which the traumatic experience may lead to
interference with the integrity of the individual
and that individual experiencing fear,
helplessness and trauma itself (Townsend, 2009;
Varcarolis, 2010). The fear felt by the
participants are part of the adaptive response to
stress and cognition is a response to this will
affect the physical condition of a person who can
bring many diseases (Potter and Perry, 2005;
Perry, 2003; Wade, 2007; Fuadi, 2011).
Theme 2. Memory for Events
The memory of the events that led to the
sub-themes of repetition of traumatic
experiences due to cold lava flooding after the
eruption of Mount Merapi in the presence of
flashbacks and memories shadow of cold lava
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flood event. Memory flashbacks experienced by
the participants are part of a phenomenon that
often occurs in Post Traumatic Stress Disorder
(PTSD). Cognitive changes caused by this
traumatic event will contribute to the
development of an external locus of control
(Fontaine, 2009). Negative cognition system that
will make people have a negative thought
patterns that lead to repeated belief that
individuals have a negative effect on the physical
condition then individuals and led to many
diseases (Fuadi, 2011).
Theme 3: Physical Response
Physical responses experienced by
adolescent girls are complaints that they are
natural and physical changes. Grievances felt by
teenage girls is a sleep disorder and other pain.
Changes in body weight and height was also
experienced by the participants as expressed by
the participants.Traumatic experiences can cause
physical changes in the body's process of
adaptation to stress. When there is stress,
individuals using physiological and
psychological energy to respond and adapt. The
amount of energy required and the effectiveness
of efforts to adapt depends on the intensity, scope
and duration of the stressor and the amount of
other stressors (Potter & Perry, 2005).
Theme 4: Changes in Social Relations
Changes in social relationships that are
formed from two categories: loss of social
relationships and togetherness. The existence of
strain on relationships with peers will cause
interference with the social development. The
presence of peers is very meaningful. The
presence of peers to be a forum for learning
social skills can take on roles in the group
(Soetjiningsih, 2007).
Specific Objective 2: Meaning of Traumatic
Experiences
Theme 5: Development of Personal
Growth This includes the development of
personal growth and self-discovery motivation
in life. The development of personal growth is a
good development consciously or unconsciously
within the individual that consists of the
development of the mind, physical, emotional,
relationship spirit, creativity and interpersonal
(Levine, 2006). The advent of personal growth
development self motivation self where there is a
desire to get up and change the desire for the
happiness of the parents and study harder to get
better performance.
Specific Objective 3: Teenage Girls Hope Post
Traumatic
Theme 6: Rehabilitation of Everyday Life
Themes corresponding to the four specific
objectives are the rehabilitation of everyday life.
Where the theme is composed of a physical
guard, hope in themselves and hope for the
government. Physical custody is carried out by
participants in meeting the growth and
development tasks to undertake efforts to meet
the physical needs of participants during their
stay in temporary housing. In addition to the
physical custody, rehabilitation everyday life by
having participants hope given to her include the
return to the beginning of life and the desire to
grow healthy. It is delivered by five participants.
Participants wanting to grow healthy
people eat during their stay at the shelter. The
effects of trauma can affect the development of
skills such as personality, perception of trauma
disorders, cognitive development, psychosocial
development, and spiritual development of
adolescents (Anderson, 2005). Efforts to
improve everyday life expressed by participants
in this study in accordance with the theory that
girls should have an understanding of self and
disaster preparedness and cooperation (Ministry
of Social Affairs, 2012).
CONCLUSION
Results of this study identified six themes
generated is associated with symptoms of
traumatic and change and adaptation
mechanisms that exist in the participants. The
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resulting six themes is a psychological response,
the memory of the events, physical responses,
changes in social relationships, personal self
development and rehabilitation of everyday life.
REFERENCES
Bornfriend L.,Plotkin J., McLister C. (2012).
Specialized Treatment Programming for
Adolescent Females. 21 Februari 2012.
www.fairmountbhs.com.
Depsos. (2012). Perempuan dan Bencana. 21
Februari 2012. www.depsos.go.id.
Dhamayanti, M. (2009). Overview adolescent
health problems and services.
www.idai.or.id.
Dharma K.K. (2011). Metodologi Penelitian
Keperawatan. Jakarta: Cv.Trans Info
Media.
Fadhila F. (2011). Analisis Neurosis Tokoh John
Wade dalam Novel “In The Lake of The
Woods” Karya Tim O’brien. Maret 2011.
eprints.undip.ac.id.
Fontaine K.L. (2009). Mental Health Nursing
Sixth Edition. New Jersey : Pearson
Education,Inc..
Fuadi M.A. (2011). Dinamika Psikologis
Kekerasan Seksual: Sebuah Studi
Fenomenologi. 20 Juni 2012.
ejournal.uin-malang. ac.id.
Galea S., Nandi A., & Vlahov D. (2004). The
Epidemiology of Post-Traumatic Stress
Disorder after Disaster. 17 Desember
2007. http://epirev.oupjournals.org.
Gurian A., et.all.(2006). Caring for Kids After
Trauma, Disaster and Death: A Guide For
Parents and Professionals Second Edition.
September 2006.
www.AboutOurKids.org.
Horowitz, M.J., Wilner, M. & Alverez, W.
(1979). Impact of Events Scale: A
measure of subjective stress.
Psychosomatic Medicine, 41(3), 209-218.
Kaplan. (2002). Post-Traumatic Stress Disorder
In Children and Adolescents: A Clinical
Overview. September 2002.
www.dcmsonline.org
Komnas Perempuan. (2007). Perempuan
Pengungsi: Bertahan dan Berjuang dalam
Keterbatasan. Juli 2007.
www.internal-displacement.org.
Lubis M. (2012). Perlindungan Anak dalam
Situasi Bencana. Maret 2012.
www.ccde.or.id.
Manurung (2011). Pertumbuhan dan
Perkembangan Remaja http://
repository.usu.ac.id
Maulana R. (2011). Makna Hidup Remaja yang
Mengalami Human Traffcking. 20 Juni
2012. www.papers.gunadarma.ac.id.
Najavits L.M., Gallop R.J & Weiss R.D. (2006)
Seeking Safety Therapy for Adolescent
Girls with PTSD and Substance Use
Disorder: A Randomized Controlled
Trial. www.seekingsafety.org.
Nasution I.K.(2008). Stress pada Remaja.
library.usu.ac.id
Ngadiran A., Hamid A.Y.S., Daulima, N.H.C.
(2010). Studi Fenomenologi Pengalaman
Keluarga tentang Beban dan Sumber
Dukungan Keluarga dalam Merawat
Anggota Keluarga dengan Halusinasi di
Wilayah Cimahi dan Bandung. Jakarta.
UI.
Notoatmojo S. (2007). Kesehatan Masyarakat:
Ilmu dan Seni. Jakarta. Rineka Cipta.
Nugroho S.P. (2010). Refleksi Akhir Tahun
BNPB.
http://sinarpagi.net/index.php?option=co
m_content&view=article&id=2215:reflek
si-akhir-tahun-bnpb&catid=61:nasional&
Itemid=68
Nurhalimah, Hamid A.Y.S, Permatasari H.
(2009). Pengalaman Orang Tua
Mengasuh Remaja dengan Perilaku
Kekerasan di Kota Depok. Jakarta. UI.
8 Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013
ISBN : 978-979-18458-6-1
Nurjannah I. (2001). Hubungan Terapeutik
Perawat dan Klien: Kualitas Pribadi
Sebagai Sarana. PSIK FK UGM.
Yogyakarta.
Perry B.D. (2003). Effects of Traumatic Events
on Children. 20 Juni 2012.
www.childtrauma.org.
Polit & Hungler. (2001). Essentials of Nursing
Research Methods, Appraisal and
Utilization Fifth Edition. Philadelphia
New York: Lippincott.
Potter & Perry. (2005). Buku Ajar Fundamental
Keperawatan. Jakarta: EGC.
Rochmawati D.H. (2011). Makna Kehidupan
Klien dengan Diabetes Melitus Kronik
Sebuah Studi Fenomenologi (tidak
terpublikasi)
Soetjiningsih. (2004). Buku Ajar Tumbuh
Kembang Remaja dan Permasalahannya.
Jakarta. Sagung Seto.
Streubert H.J & Carpenter D.R. (2003).
Qualitative Research in Nursing
Advancing the Humanistic Imperative
Third Edition. Philadelphia,New York:
Lippincott.
Sugiyono. (2011). Metode Penelitian
Kuantitatif, Kualitatif & R&D. Bandung:
Alfabeta Bandung.
The United Stated Departement Veterans affairs.
(2007). Epidemiological PTSD.
http://www.ptsd.va.gov/professional/pag
es/epidemiological-facts-ptsd.asp
Townsend M.C. (2009). Psychiatric Mental
Health Nursing: Concepts of Care in
Evidence-Based Practice Sixth Edition.
DavisPlus company. Philadelphia.
Valente S.M., 2010. Evaluating and Managing
Adult PTSD in Primary Care. November
2010.
http://www.nursingcenter.com/library/Jo
urnalArticle.
Varcarolis E.M.,dkk., (2010). Foundations of
Psychiatric Mental Health Nursing : A
Clinical Approach Sixth Edition.
Sounders elsivier. St.Louis.
Videbeck S.L. (2008). Buku Ajar Keperawatan
Jiwa. EGC. Jakarta
Wardhani Y.F. & Lestari W. (2011). Gangguan
Stres Pasca Trauma pada Korban
Pelecehan Seksual dan Perkosaan. http//
journal.unair.ac.id.
Weiss, D.S. (2007). The Impact of Event Scale:
Revised. In J.P. Wilson & C.S. Tang
(Eds.), Cross-cultural assessment of
psychological trauma and PTSD (pp.
219-238). New York: Springer.
Wheeler K. (2008). Psychotherapy for the
psychiatric nurse advanced
practice,p163.St.Louis,Missouri: Mosby
Elsevier.
WHO. (2009). ICN Framework of Disaster
Nursing Competencies. Geneva: WHO.
Wiebe, R.L. (2001). The Influence of Personal
Meaning on Vicarious Traumatization in
the Rapists. [Versi elektronik]. Diakses
pada 27 Maret 2007 dari
www.twu.ca/cpsy/Documents/Theses/Rh
onda%20Wiebe%20Thesis.pdf
Wong D.L., M.Wilson,D., Winkelstein, M.L. &
Schwartz. P. (2008). Buku Ajar
Keperawatan Pediatrik. Jakarta: EGC.
Ziegler M.F., Greenwald M.H., DeGuzman
M.A. & Simon, H.K (2005).
Posttraumatic Stress Responses in
Children: Awareness and Practice Among
a Sample of Pediatric Emergency Care
Providers.
http://pediatrics.aappublications.org/cont
ent/115/5/1261.full.html
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 9
ISBN : 978-979-18458-6-1

COST ANALYSIS THERAPY OF BREAST CANCER PATIENTS
IN Prof. Dr. MARGONO SOEKARJO PURWOKERTO
Rizki Khotimah
1
, Budi Raharjo
2
, Heny Ekowati
1,3
Department of Pharmacy, Faculty of Medicine and Health Sciences,
University of Jenderal Soedirman
Abstract
Background. Breast cancer is leading cause of death in Indonesia. Treatments for breast
cancer is generally in combination therapy i.e chemotherapy, radiation and surgery. Various cancer
therapies require a lot of drugs. Various side effects also occurred in cancer therapy and require
additional drugs. This leads an increasing in the overall cost of the total cost incurred by cancer
patients.
Objectives. The purpose of this study was to describe the treatment case, treatment and the
average cost of breast cancer patients in Prof Dr. Margono Soekarjo Hospital Purwokerto in 2010.
Methods. This research was a descriptive study with retrospective data and used total
sampling method to obtain the data from medical records and receipts. The breast cancer patients
data from January to December 2010 period was taken.
Outcomes measured. Medical and non medical costs are calculated. The average cost was
calculated by dividing the total cost of side effects with the total direct costs incurred in cancer
patients.
Results. The result showed that 39 patients included in the inclusive criteria. The highest
number cases was patient in stage IIIC, 23 cases (59.00%). Alkylating and antimetabolit agent
combination was the most widely used for chemotherapy, as many as 31 cases (81.57%). Analysis of
direct and non direct medical costs : stage IIa third class was Rp. 23,669,472.50. In stage IIb, second
class was Rp. 38,062,480.30, and in third class was Rp. 11,063,230.90. In stage IIIA second class was
Rp. 22,523,373.00, while for third class was Rp. 20,380,060.73. Stage IIIB for third class was Rp.
13,503,594.00. In stage IIIC second class was Rp. 37,873,859.00 and third class was Rp.
11,256,590.00. Last stage is stage IV, in third class was Rp. 14,345,890.30.
Conclusion. The results indicated that hospital need to be more attention for handling breast
cancer therapy, particularly, because it has higher therapy cost than anyother disease.
Key words : Cost Analysis, Breast Cancer, Prof. Dr. Margono Soekardjo Hospital
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INTRODUCTION
Based on the Hospital Information System
(SIRS) data, in 2007, breast cancer was first
ranks in hospitalized patients in Indonesia
(16.85%) (Anonymous, 2010). In Central Java,
according to a report of the District Health
Office, in hospitals and health centers in 2006,
there were breast cancer cases per 1,000 people
(Anonymous, 2006). According to the America
Cancer Society (2011), breast cancer is the
uncontrolled growth of cells in the breast.
Malignant tumor is a group of cancer cells that
can be grown and then invade surrounding
tissues or spread (metastasis) to distant areas of
its origin.
There are four treatment were used in
breast cancer, including surgery, radiation,
chemotherapy and biological therapy (Balmer et
al., 2005). Surgery is usually done by taking
some cancerous tissues or whole breast removal,
depending on the stage of cancer. Second breast
cancer treatment using radiation, with high-tech
tools required expertise to operate it. For
chemotherapy, the patient using more than one
drug (combination drugs). Treatment ussualy in
a cycles, depending on the severity or stage of
breast cancer patients. Radiation and
chemotherapy has side effects such as
nausea,vomiting, anemia, etc. thus requiring
additional costs to handle this side effect.
(Balmer et al., 2005). Therefore, in the treatment
of breast cancer required huge cost.
Pharmacoeconomics use to identify the
pharmaceutical products and health services
cost, which describes the health economic
relationship involving drugs, services, and prices
used by the public (Jana et al., 2005). In this
study, we carried out Pharmacoeconomics study,
using Cost Analysis method (Shancez, 2005) to
explore the overall cost in the treatment of breast
cancer in Prof. Dr. Margono Soekarjo Hospital in
January-December 2010.
METHODS
Research design. This research was a
descriptive study with retrospective data. We
used total sampling method. Data were obtained
from medical records, financial receipts and
cards in inpatient Margono Soekarjo Hospital,
January to December 2010. Research point of
view was the perspective of the hospital.
The inclusion criteria used were patients
with a primary diagnosis of breast cancer who
underwent anticancer treatment in Margono
Soekardjo Hospital Soekarjo in 2010 and
patients were classified as public health
insurance and health insurance category.
Data collection. Data were collected from
medical records include number, age, clinical
diagnosis, date of entry, date of exit, long of stay,
the patient's outcome, and medications used
during treatment. Financial receipts include
therapeutics costs, hospitalization costs,
laboratory costs, medical costs, nutrition costs,
side effect costs, and administrative costs. We
also obtained data from the drug card in
installation of pharmacy hospital included drugs
and medical equipment costs.
Data analysis. Research data in the form
of patient demographic characteristics (age),
characteristics of breast cancer cases
(characteristic diagnosis, staging, the last
condition of patients, the identification of
patterns of breast cancer therapy) and treatment
costs were analyzed descriptively. Cost analysis
is done by looking at the major components and
the cost incurred by patients during treatment.
Calculating total direct costs using the
formula:
AB = BT+BP+BG+BTn+BPEST+BOA+BRI+BA
AB : Cost Analysis - Medical and Non-Medical
costs
BT : Therapeutics Costs
BP : Laboratory Costs
BG : Nutrition Costs
BTN : Medical Costs
BPEST : Side Effect Costs
BOA : Drugs and Medical Devices Costs
BRI : Hospitalization Costs
BA : Administrative costs
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Calculate the average cost using the
formula :
X =
C
n
X = The average cost of treatment of breast
cancer (IDR) (per therapy/stadium)
C = Total direct costs (IDR) (per
therapy/stadium)
n = number of patients (per therapy/stadium)
RESULTS AND DISCUSSION
Data population were 128, five (5) cases
with incomplete medical record data, 8 cases
with no receipts, and 78 cases were not up to six
times chemotherapy treatment cycle so only 39
cases include to inclusion criteria. The
distribution of each class were 7 patients class II
and 32 patients as class III. The number of breast
cancer patients were 39 female patients (100%).
The most patient affected by breast cancer
are between the age of 44-52. The American
Cancer Society in 2011, stated that cancer was
susceptible at above 40 years. Redalli and Radice
(2003) in their review article also mentioned that
women are usually affected by breast cancer at
40-50 years. This is because of the lack of early
detection in every woman in that age, who
susceptible to breast. Patient were grouped into
two classes, class II and class III.
Treatment class will affect the direct
medical costs. In Prof. Dr. Margono Soekarjo
hospital there are three classes, class I, II and III.
However, in this study, for breast cancer patients
was in class II and III. In this study, most patients
were treated in the third grade as many as 32
patients (82%) and class II were 7 patients
(18%).
The side effects of chemotherapy are
effects arising from cytostatika drugs used in
chemotherapy in the treatment of breast cancer.
According to Balmer et al., (2005) there
are several types of side effects caused by
chemotherapy, among which bleeding while
undergoing chemotherapy, anemia, nausea,
vomiting, pain, infections, constipation and fluid
retention. The side effects of chemotherapy is the
most frequent nausea and vomiting. There were
38 patients (51.35%) with nausea and vomiting
caused by chemotherapy. The second highest is
anemia by 22 (29.72%) patients.
Treatment for breast cancer patients
depends on the. The American Joint Committee
For Cancer (AJCC, 2003), grouped the stadium
of breast cancer into eight groups. Each stadium
had a different treatment. In this study, we found
no cases for all stages, only stage IIa, IIb, IIIa,
IIIb, IIIc and IV.
The most cases are patients with
chemotherapy, 38 cases. In stadium IIIc patient
who undergoing chemotherapy are 23 patients.
The second type of treatment for breast cancer is
surgical with totally 6 cases, 3 radical
mastectomy (removal of the affected breast
cancer) and 3 incisional biopsy (taking a small
portion of solid tumor tissue). According to the
National Cancer Institute (2009), the first option
of treatment for stage IIa, IIb and IIIa is by
radiation or surgery, then chemotherapy may be
performed as an adjuvant or neo-adjuvant. Then
for stage IIIb and IIIc, first choice treatment is
chemotherapy and surgery. But for the surgery, it
must be confirmed first, the extent to which
cancer cells spread. Then for stage IV or
metastatic, the first choice for treatment is use
high-dose chemotherapy.
Balmer et al. (2005) stated that class of
drugs that are still commonly used for breast
cancer treatment are antimetabolite, alkilating
agents and topoisomerase inhibitors. There are
31 patients in class III, who used antimetabolite,
alkilating agent and topoisomerase inhibitors as
combination. It is the highest number of patient
who use drugs combination compared with other
combination. While in class II, there was 4
patients using a combination of a taxane,
alkilating agents and topoisomerase inhibitors.
Additional drugs that most commonly
used are antiemetics, because the most frequent
adverse effects from breast cancer chemotherapy
are nausea and vomiting. Drugs used for
cytostatica in this study are cyclofosfamid
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(?1,500 mg) and dacarbazin that fall into the high
risk category (> 90%) cause nausea and
vomiting. Doxorubicin and cyclofosfamid
<1,500 mg, epirubicin which includes medium
category (30-60%) cause nausea and vomiting,
5-Flurourasil, paxus and ebetaxel are in the low
category (10-30%) which causes nausea and
vomiting. Vincristine is entered in the category
of low (<10%) cause nausea and vomiting. This
is in accordance with the Hesketh (2008) and
Hawkins (2009) research.
Primasari (2009) stated, regarding the
evaluation of antiemetic use in Prof. Dr.
Margono Soekarjo Hospital Purwokerto, the
most widely used antiemetic to overcome the
side effects of chemotherapy are dopamine
antagonists and histamine antagonists.
We found in our study, the most
commonly used antiemetic are dopamine
antagonists and histamine antagonists.
According to Hesketh (2008), in a review article,
the most effective anti-nausea vomiting caused
by chemotherapy is serotonin antagonists
(5-HT3).
Serotonin antagonist clinically proven to
be effective for the treatment of nausea and
vomiting caused by chemotherapy in cancer
patients. The mechanism that probably involved
is when serotonin out of cell enterokromafin
then binds to 5-HT3 receptors located on sensory
nerve / vagal afferents in the gastrointestinal
tract, and delivers stimulation through the nerves
to the vomiting center and chemoreceptor trigger
zone (CTZ) in the brain postrema. 5-HT3
antagonist (Ondansetron) works by blocked the
receptors in the periphery and in the CTZ to
prevent vagal stimulus that ultimately prevent
nausea and vomiting (Ikawati, 2006). However,
in this study, not all patients using 5-HT3 class to
overcome the effects of nausea and vomiting due
to the price is relatively more expensive when
compared with other drugs.
Cost analysis of breast cancer therapy in
our study conducted by the hospital perspective
focused on direct medical costs and non-medical
costs. We explored the data in order to determine
what are the components of the costs and how
much it costs in breast cancer patients during
treatment at the hospital in accordance with
patients stadium.
Components of direct medical costs
consist of the treatment costs, laboratory costs,
physicians costs, side effects treatment cost and
medical equipment costs. While the cost of
non-medical components are consisting of
administrative costs, hospitalization costs and
nutrition costs.
Breast cancer treatment costs is a cost
incurred for patients undergoing breast cancer
therapy (Table I). Included the cost of surgery,
radiation and chemotherapy for six cycles every
two weeks for 3-5 months.
Table I. Averageof Treatment Cost Based on Stadium
in breast Cancer Therapy in
Prof.Dr.MargonoSoekarjo Hospital in 2010.
Stadium
Class
II (IDR) III (IDR)
0 - -
I - -
IIa - 15,000.000
IIb 32,329,590 6,957,572
IIIa 14,443,000 14.424.998
IIIb - 7,611,378
IIIc 30,784,010 5,922,540
IV - 7,260,000
Expenses are incurred for supporting the
breast cancer diagnosis. Includes laboratory
tests, examination of the thorax, and the other
assesment according to the current stage of
patient (Table II.).
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Table II. Average Laboratory Cost Based on Stadium
of Breast Cancer Therapy in Prof.Dr.Margono
Soekarjo Hospital in 2010.
Stadium
Class
II (IDR) III (IDR)
0 - -
I - -
IIa - 442,500
IIb 1,563,000 1,718,438
IIIa 2,033,000 2,024,000
IIIb - 1,563,000
IIIc 1,875,600 1,563,000
IV - 2,615,000
Expenses in a patient was vary depending
on the class and type of therapeutic treatment.
Differences in the cost of each class is due to the
difference in rates imposed in each class, include
physician costs (Table III). The more severe or
high stage and type of therapy used, cause many
treatment have to take. The longer long of stay
the greater costs have to paid.
Table III. Average Physicians Cost Based on Stadium
in Breast Cancer Therapy in Prof.Dr.Margono
Soekarjo Hospital in 2010
Stadium
Class
II (IDR) III (IDR)
0 - -
I - -
IIa - 210,000
IIb 510,000 423,750
IIIa 660,000 495,000
IIIb - 735,000
IIIc 462,000 383,055
IV - 360,000
Side effects costs is a costs incurred as a
result of the side effects of treatment (surgery,
radiation and chemotherapy) (Table IV). It is
include the cost of medicine and blood
transfusions.
Table IV. Average of Side Effects Costs Based on
Stadium in Breast Cancer Therapy in
Prof.Dr.Margono Soekarjo Hospital in 2010
Stadium
Class
II (IDR) III (IDR)
0 - -
I - -
IIa - 140,990.50
IIb 512,132.75 1,013,465.37
IIIa 1,562,935.00 1,175,304.50
IIIb - 1,388,547.50
IIIc 2,020,057.00 1,247,157.44
IV - 2,008,952.75
Medical equipment costs are costs
incurred to purchase the medical equipment and
consumables equipments during the patient
hospitalize (Table V.).
Table V. Average of Medical Equipments Costs Based
on Stadium in Breast Cancer Therapy in
Prof.Dr.Margono Soekarjo Hospital in 2010
Stadium
Class
II (IDR) III (IDR)
0 - -
I - -
IIa - 75,937.50
IIb 376,757.50 280,618.75
IIIa 253,947.50 251,300.00
IIIb - 255,668.75
IIIc 281,942.56 278,895.83
IV - 271,937.50
Non-medical costs are costs incurred for
administrative interests, the cost of
hospitalization and cost of nutrition during
patient stay in hospital (Table VI).
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Table VI. Average of administrative Costs Based on
Stadium in Breast Cancer Therapy in
Prof.Dr.Margono Soekarjo Hospital in 2010.
Stadium
Class
II (IDR) III (IDR)
0 - -
I - -
IIa - 10,000
IIb 60,000 63,750
IIIa 70,000 70,000
IIIb - 60,000
IIIc 60,000 60,000
IV - 60,000
For patients undergoing chemotherapy,
hospitalization costs can be calculated with one
cycle during therapy in a span of 3-5 months to
six cycles and then calculated the average cost
(Table VII.).
Ta ble VII. Average of Hospitalization Costs Based on
Stadium in Breast Cancer Therapy in
Prof.Dr.Margono Soekarjo Hospital in 2010
Stadium
Class
II (IDR) III (IDR)
0 - -
Ia - -
IIa 7,700,000
IIb 2,250,000 1,498,750
IIIa 3,300,000 1,815,000
IIIb - 1,760,000
IIIc 2,190,000 1,430,000
IV - 1,320,000
The lowest hospitalization cost is in stage
III patients, due on this stage, patients only
undergoing chemotherapy for six cycles, each
cycle usually takes only two to three days. The
other stages are usually needed more than one
type of therapy, causing a longer hospitalization,
so hospitalization costs become more expensive.
Nutritional costs are costs incurred for the
cost of food production and nutrition
consultations (Table VIII).
Table VIII. Average of Nutrition Costs Based on
Stadium in Breast Cancer Therapy in
Prof.Dr.Margono Soekarjo Hospital in 2010.
Stadium
Class
II (IDR) III (IDR)
0 - -
Ia - -
IIa - 70,000
IIb 204,000 141,250
IIIa 320,500 165,000
IIIb - 160,000
IIIc 229,700 215,000
IV - 120,000
Medical and non-medical costs are the
direct costs incurred by patients during treatment
in hospital (Table IX - Table XIV).
Table IX. Average of Medical and Non Medical Costs
in Stadium IIa Breast Cancer Patients in
Prof.Dr.Margono Soekarjo Hospital in 2010
Components
Class III
IDR
Precentage
(%)
Therapy Costs 15,000,000.00 63.42
Hospitalization Costs 7,700,000.00 32.55
Laboratory Costs 442,500.00 1.87
Physician Costs 210,000.00 0.88
Side Effect Costs 140,990.50 0,59
Medical Equipment
Costs 75,937.50 0.32
Nutrition Costs 70,000.00 0.29
Administrative Costs 10,000.00 0.04
Total 23,649,428.00 100.00
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Components
Class II Class III
Jumlah (Rp) Percentage (%) Jumlah (Rp) Percentage (%)
Therapy Costs 32,329,590.00 85.51 6,957,572.00 57.51
Hospitalization Costs 2,250,000.00 5.95 1,498,750.00 12.38
Laboratory Costs 1,563,000.00 4.13 1,718,438.00 14.20
Physician Costs 510,000.00 1.34 423,750.00 3.50
Side Effect Costs 512,132.75 1.35 1,013,465.37 8.37
Medical Equipment Costs 376,757.50 0.99 280,618.75 2.31
Nutrition Costs 204,000.00 0.53 141.250,00 1.16
Administrative Costs 60,000.00 0.15 63,750.00 0.52
Total 37,805,480.25 100.00 12,097,594.12 100.00
Table X. Average of Medical and Non Medical Costs in Stadium IIb Breast Cancer Patients in Prof.Dr.Margono
Soekarjo Hospital in 2010
Components
Class II Class III
IDR Percentage (%) IDR Percentage (%)
Therapy Costs 14,443,000.00 63.78 14,424,998.00 70.63
Hospitalization Costs 3,300,000.00 14.57 1,815,000.00 8.88
Laboratory Costs 2,033,000.00 8.97 2,024,000.00 9.91
Physician Costs 660,000.00 2.91 495,000.00 2.42
Side Effect Costs 1,562,935.00 6.90 1,175,304.50 5.75
Medical Equipment Costs 253,757.50 1.12 251,300.00 1.23
Nutrition Costs 320,500.00 1.41 165,000.00 0.80
Administrative Costs 70,000.00 0.30 70,000.00 0.34
Total 22,643,192.50 100.00 20,420,602.50 100.00
Table XI. Average of Medical and Non Medical Costs in Stadium IIIa Breast Cancer Patients in
Prof.Dr.Margono Soekarjo Hospital in 2010
Components
Class III
IDR Percentage (%)
Therapy Costs 7,611,378.00 56.24
Hospitalization Costs 1,760,000.00 13.00
Laboratory Costs 1,563,000.00 11.54
Physician Costs 735,000.00 5.43
Side Effect Costs 1,388,547.50 10.26
Medical Equipment Costs 255,668.75 1.88
Nutrition Costs 160,000.00 1.18
Administrative Costs 60,000.00 0.44
Total 13,533,594.25 100.00
Table XII. Average of Medical and Non Medical Costs in Stadium IIIb Breast Cancer Patients in
Prof.Dr.Margono Soekarjo Hospital in 2010
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Components
Class II Class III
IDR Percentage (%) IDR Percentage (%)
Therapy Costs 30,784,010.00 81.21 5,922,540.00 53.35
Hospitalization Costs 2,190,000.00 5.77 1,430,000.00 12.88
Laboratory Costs 1,875,600.00 4.94 1,563,000.00 14.08
Physician Costs 462,000.00 1.21 383,055.55 3.45
Side Effect Costs 2,020,057.00 5.32 1,247,157.44 11.23
Medical Equipment Costs 281,942.56 0.74 278,895.83 2.51
Nutrition Costs 229,700.00 0.60 215,000.00 1.93
Administrative Costs 60.000.00 0.15 60,000.00 0.54
Total 37,903,309.56 100.00 11,099,648.82 100.00
Table XIII. Average of Medical and Non Medical Costs in Stadium IIIc Breast Cancer Patients in
Prof.Dr.Margono Soekarjo Hospital in 2010
Components
Class III
IDR Percentage (%)
Therapy Costs 7,260,000.00 51.79
Hospitalization Costs 1,320,000.00 9.41
Laboratory Costs 2,615,000.00 18.65
Physician Costs 360,000.00 2.56
Side Effect Costs 2,008,952.75 14.33
Medical Equipment Costs 271,937.50 1.94
Nutrition Costs 120,000.00 0.85
Administrative Costs 60,000.00 0.42
Total 14,015,890.25 100.00
Table XIV. Average of Medical and Non Medical Costs in Stadium IV Breast Cancer Patients in
Prof.Dr.Margono Soekarjo Hospital in 2010
Components
Average of Medical and Non Medical Costs
Class II (IDR) Class II (IDR)
0 - -
I - -
IIa - 23,649,428.00
IIb 37,805,480.25 12,097,594.12
IIIa 22,643,192.50 20,420,602.50
IIIb - 13,543,594.25
IIIc 37,903,309.56 11,099,648.82
IV - 14,015,890.25
Table XV. Cost Analysis of Medical and Non Medical Costs in Breast Cancer Patients in Prof.Dr.Margono
Soekarjo Hospital in 2010
In our study, patients with stage IIIb taken
surgical therapy and six chemotherapy cycles.
Patients usually have to take medication to
overcome the side effects caused by
chemotherapy.
According Radelli and Radice (2003) the
most expensive cost is in the most severe stage,
ie stage IV. However, in our study, the greatest of
average direct medical costs are among stage IIa
(Table 15.). This can be due to the difference of
the individual components for treatment in breast
cancer patients. This difference can be seen from
not every patient get all kinds of tests to support
the diagnosis and treatment of breast cancer.
Then, the absence of Home Health Care (the
control exercised by the hospital for patients
undergoing breast cancer therapy). Home health
care is the second greatest costs in direct medical
cost in Redelli and Radice research.
In our study, the most expensive cost is
therapy cost. This result is in good agreement
with research by Redelliand Radice (2003). The
cost of breast cancer treatment is the cost of
chemotherapy, surgery costs, charges and
expenses, and radiation in each stage.
CONCLUSION
The results indicated that hospital need to
be more attention for handling breast cancer
therapy, particularly, because it has higher
therapy cost.
REFERENCES
Anonymous. 2011. American Cancer
Society.Breast Cancer.
Anonymous, 2006. Profil Kesehatan Provinsi
Jawa Tengah.
Anonymous, 2010, Profil RSUD Margono
Soekarjo.
Anonymous, 2003, American Joint Committee
for Cancer. Adjuvant Therapy and
Chemotherapy for Breast Cancer.
Balmer, C.M., Valley, A.W., Lannucci, A.,
2005, Cancer Treatment And
Chemotherapy, in Pharmacotherapy : A
Pathophysiologic Approach, Sixth
Edition, Section 17, Chapter 124 :
2279-2325, The McGraw-Hill
Companies, United States of America.
Hawkins, R and Steven G. 2009.
Chemotheraphy Induce
Nausea-Vomitting Opportunities For
Improved Patient Outcomes. Vol.13 No.1.
Journal Of Oncology Nursing Society.
Hesketh, P.J. 2008. Chemotheraphy Induce
Nausea-Vomitting. ol. 358:2482-2494.
New England Journal Of Medicine.
Ikawati, Z. 2006. Pengantar Farmakologi
Molekuler. Gajah Mada University Press :
Yogyakarta.
Jana, S.P.M. 2005, Pharmacoeconomics : The
need to sensitize undergraduate medical
students. Department of Pharmacology,
Calcutta National Medical College, India
Vol 37, 277-278.
Primasari, D.A, 2009, Evaluasi Penggunaan
Antiemetik Pada Pasien Kamoterapi di
RSUD Prof. Dr. Margono Soekarjo,
skripsi, Fakultas Kedokteran dan
Ilmu-Ilmu kesehatan- Jurusan Farmasi
UNSOED, Purwokerto.
Radelli, A and Radice, D, 2003, Breast Cancer
Management Quality Of Life and Cost
Consideration, Pharmacoeconomics 21
(6).
Shancez, L.A.,2005, Pharmacoeconomics:
Principle, Concepts and Application
dalam dipiro,J.T.,Talbert R.L.,Yee G.,
Matzge Z.R., Wells,B.G.,and Pryes,L.M.,
Pharmacoterapy: A Pathophysiologic
Approach Sixth Edition , 1956-1958, The
Mc-Graw-Hill Companies, Inc,USA.
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 19
ISBN : 978-979-18458-6-1

PHARMACIST COUNSELING INTERVENSION BY ORAL CAN
INCREASE THE PATIENTS ADHERENCE AND DECREASE
SYSTOLIC BLOOD PRESSURE OF AMBULATORY
HYPERTENSION PATIENTS AT INTERNAL DISEASE
POLYCLINIC PKU BANTUL HOSPITAL, INDONESIA
Riza Alfian
1
, Akrom
1
, Endang Darmawa
1,2
Post Graduate Program in Clinical Pharmacy Ahmad Dahlan University Indonesia
Abstract
Background. The hypertension prevalence in Indonesia in 2004 is 27,5%. High blood pressure
can damage arteries and blood vessels. It can also cause coronary artery disease, kidney failure and
stroke. It is expected that the appropriate counseling can improve the patients adherence and blood
pressure target.
Objective. The purpose of this study is to investigate the influence of pharmacist counseling
orally on the adherence and systolic blood pressure of ambulatory hypertension patients at internal
disease polyclinic PKU Muhammadiyah Bantul Hospital, Indonesia.
Methods. This study were conducted with quasi-experimental design. The ambulatory
hypertension patients data were collected prospectively during the period of January until April
2013. Sixty patients were divided into 2 groups, 30 (50%) patients were received counseling
(intervension group) and 30 (50%) patients were not received counseling (control group). Exclusion
criteria were a deaf and pregnant patients. Data collection were conducted by doing interview and
completion of Morisky Modification Adherence Scale (MMAS) questionnaire, while the blood
pressure data were taken from their medical record.
Outcome Measured. Adherence and systolic blood pressure of ambulatory hypertension
patients
Results. The results showed that oral counseling intervension could increased the patients
adherence in the intervension group (66,7%) in comparison to the control group (20%) (p=0,000).
Consequently, pharmacist counseling intervension could decreased the systolic blood pressure in the
intervention group (17,27 ±14,60 mmHg; p=0,000). There was no decreasing the systolic blood
pressure (1.27±19.89; p=0,730) in the control group. Based on the correlation test between MMAS
and systolic blood pressure, there were positive correlation in the patients adherence and systolic
blood pressure values (p=0,020; r=0,200).
Conclusion. Over all it can be concluded that the pharmacist counseling intervension by oral
can increase the patients adherence on antihypertension management. Furthermore, it can decrease
the systolic blood pressure (p<0,05)
Key words :Hypertension, pharmacist counseling, systolic blood pressure, adherence
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INTRODUCTION
Hypertension is as one of the major risk
factors for coronary heart disease. Besides
causing coronary heart disease, hypertension can
cause kidney failure and cerebrovasculer
disease. The prevalence of hypertension will
increase in line with the life style changes such as
smoking, obesity, physical inactivity, and
psychosocial stress in many countries.
Hypertension has been the public health problem
and will be a bigger problem if it is not restrained
earlier1. The prevalence of hypertension in
Indonesia in 2004 is 27,5 %1. (Depkes, 2004).
WHO states that non adherence to
hypertension therapy is the key factor that inhibit
blood pressure control so that it needs
intervention to improve the therapeutic
adherence. It is estimated that the poor adherence
to antihypertensive medication is approximately
30-50 %. The causes of the poor adherence is
very complex, including the complexity of
medical regiment, cost of medication, age,
lowness of social support, and cognitive
problem2. (Sagate, 2003).
Health people 2010 for hypertension
suggest the necessity of a more comprehensive
and intensive approach to achieve optimal blood
pressure control. The intervention which can be
applied by pharmacists to manage hypertension
patients is counceling. Counceling can improve
the outcome therapy by maximizing the use of
appropriate medication3 (Romtucci, 1997). One
of the counseling benefit is improve mediaction
adherence, so the mortality rate and detriment
(either cost or loss of productivity) can be
pressed down4. (Palaian et.al, 2006).
Self-report scale to evaluate the adherence
of antihypertensive therapy was already
developed by Morisky et al (2008). The study
examines the psychometric properties and tests
the concurrent and predictive validity of self
report medication adherence was test on
hypertension patients in 2007 and published in
2008. Self report medication adherence is
measured by new 8 item self report Morisky
Medication Adherence Scale (MMAS).
Over all, it is necessary to investigate the
influence of counceling orally on the adherence
and systolic blood pressure of ambulatory
hypertension patients at internal disease
polyclinic PKU Muhammadiyah Bantul
Hospital, Indonesia.
METHODS
It is a prospective study to determine
adherence to anti-hypertensive therapy and
decreasing the systolic blood pressure in
ambulatory patients at internal disease polyclinic
PKU Muhammadiyah Bantul Hospital,
Indonesia. The study group included 60 patients.
They were devided in to two groups as
intervension and control group. The intervension
group patients received counseling regarding
hypertension and hypertension therapy, while
the control group not received counseling. The
follow up patients were done from baseline to
second follow up. The inclusion criteria were
patients 18-65 years old with diagnosed to have
hypertension and got antihypertensive
medication in their prescription. The exclusion
criteria were deaf and pregnant patients.
The data were collected from January to
April 2013. Data collection was conducted by
doing interview and completion of Morisky
Medication Adherence Scale (MMAS)
questionnaire, while the blood pressure data
were taken from their medical record. Validation
questionnaire was carried out via conducting
pilot study. The pilot study was conducted with
30 patients. The reliability analysis of the
questionnaire was performed by calculating
cronbach alpha value. The Cronbach alpha value
was obtained 0,64 which indicated that the
questionnaire was reliable to be used for this
study.
The collected data were analyzed and
result were expressed as mean ± standard
deviation. P value of < 0,05 was considered
statistically significant.
RESULTS
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Sixty patients were included in the pre and
post study. At the pre-study, clinical and
sociodemographic data of patients were
collected. The characteristic data of the subject
can be seen on the table I. Based on the
characteristic patients, the subject were
dominated by male patients (66.7%) for
intervension group and female patients (70.0%)
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Characteristic Patients
Intervension Group Control Group
(n=30) % (n=30) %
Sex
Male 20 66,7 9 30,0
Female 10 33,3 21 70,0
Age (year)
40-49 4 13,3 5 16,7
50-59 18 60,0 16 53,3
60-65 8 26,7 9 30
Stage of hypertension
Stage 1 8 26,7 15 50,0
Stage 2 22 73,3 15 50,0
Habit
Smoking 4 13,3 3 10,0
Not smoking 26 86,7 27 90,0
Education
<9 year 16 53,3 20 66,7
9-12 year 4 13,3 6 20,0
>12year 10 33,3 4 13,3
Jobs
Official government 12 40,0 7 23,3
Self employed worker 12 40,0 16 53,3
Labourer 4 13,7 5 16,7
Jobless 2 6,7 2 6,7
Payment
Self payment 7 23,3 12 40,0
Health Insurance 14 46,7 9 30,0
Jamkesmas 19 30,0 8 26,7
Other Insurance 0 0 1 3,3
Hypertension History
Yes 11 36,7 9 30,0
No 19 67,3 21 70,0
Table I. Characteristic of hypertension patients
for control group. As for age, both of the
intervension and control group were dominated
by patients with the ages of 50 to 59 years. As for
stages of hypertension, both groups were
dominated by patients with hypertension stage
two. As for payment, the treatment group was
dominated by health insurance (46.7%), where
as the control group was dominated by
self-payment (40%). In this study also evaluated
the characteristic of smoking behaviour, the
history of hypertension, education, and jobs. The
subject study, either the intervension group or
the control one, both were dominated by those
who didn’t have the history of hypertension,
smoking behaviour, self employed workers and
education under 9 years.
The result on table II was the adherence of
treatment group is higher than the control group
(66.7% > 20.0%). The statistical result between
MMAS category at the intervension and control
group showed difference of the increasing
adherence scores 2.67 ± 0.48 and 1.93 ± 0.69
respectively with the significancy 0.000
(p<0.05)
The average systolic blood pressure of the
intervension and control group pre and post
study were 161.60 ± 11.78 mmHg to 144.33 ±
19.42 mmHg and 148.53 ± 20.83 mmHg to
147.27 ± 20.79 mmHg respectively. The average
of the decreasing systolic blood pressure of the
intervension group were greater than the control
group (17.27 ± 14.60 mmHg > 1.27 ± 19.89
mmHg).
The paired samples t test result on systolic
blood pressure of the intervension group was
highly significant with p value 0,000 (p<0,050),
meanwhile on the control group was not
significant with p value 0.730 (p>0.05).
The correlation test result indicates that
there was significant correlation between
MMAS category and systolic blood pressure
decreased of hypertension patients in this study
(p = 0.020; r = 0.424)
DISCUSSION
The medication adherence plays
important role in achieving target therapy,
especially for chronical disease, such as
hypertension. The poor adherence to
antihypertensive medication is as one of the
cause of poor blood pressure control. One of the
ways to evaluate the adherence of hypertension
patients in consuming medication is by using
Morisky Medication Adherence Scale (MMAS)
questionnaire.
The percentage of high adherence on
intervension group is greater than the control
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Group
(n=30)
MMAS Scores
High adherence Moderate adherence Low adherence
n % n % n %
Control 6 20,0 16 53,3 8 26,7
Intervension 20 66,7 10 33,3 0 0
Table II. MMAS scores of patients of the intervension group after done counseling and control group
in the post study
No Reason of unadherence
Group
Total (%)
Intervension Control
1 Forgotten 13 10 38,3
2 Intentionally not to take medication 2 9 18,3
3 Feeling inconvenience by the obligation to take medication. 10 12 36,7
Table III. The reasons of non adherence patients based on MMAS questionnaire
group (66.7% > 20.0%) and the significant
increase of adherence indicates that counceling
by pharmacists can contribute positive impact in
increasing the patients adherence on
hypertension therapy. Counseling give a good
knowledge about hypertension and its
medication to patients, so the patient will change
their behavioural medication from being not
adherence first to being adherence so that desired
blood pressure can be achieved. Birader et al
(2012) states the counceling intervention given
by pharmacists can increase the adherence of
hypertension patients therapy. Other study
performed by Palanisamy and Sumathy (2009)8
indicates that the rate of adherence from 0% up to
95.4% after being councelled by pharmacists.
The MMAS questionnaire provides
information on the behaviour related to the poor
adherence which is caused by unintentional
factor (ex: careless or forgetfulness to take
medication), intentionally (not to take
medication as their illness is getting more serious
on better), and the lack of knowledge about
hypertension and the purpose of its medication.
Table III indicates the non adherence of patient
to medication because of frequent forgetfulness
to take it and their misunderstanding towards
hypertension and its medication so they
intentionally not to take their medication.
Poor adherence is as challenge for
clinicians and pharmacists to determine more
effective medication. If pharmacists have ability
to identify patients with poor adherence, then
accurate and suitable intervention can be done to
improve the patients medication adherence. By
the existension of counceling by pharmacists
hopefully the understanding of patients toward
hypertension and its medication will be better.
The systolic blood pressure of the
intervension and control group were the same
undergo decrease, though, based on the average
of systolic blood pressure decrease of the
intervension group is greater than the control
group (fig. 1). Based on that, it can be concluded
that hypertension patients of the intervension
group (being councelled by pharmacists)
undergo the significant decrease of systolic
blood pressure compared with the control group.
Ramanath et al (2012) indicates that
pharmaceutical intervention can improve the
blood pressure control of hypertension. In
addition the study carried out by Vivian (2002)
show that pharmaceutical care can increase the
ability to control blood pressure so the normal
blood pressure target can be achieved.
The decrease of blood pressure patients
can be influenced by the counceling given by
pharmacists to the patients during the study so
the patients adherence increase in managing their
hypertension, either in the life style modification
or accurate use of medication.
The correlation test indicates that their is a
significant correlation between the category of
MMAS and the decrease of systolic blood
pressure of hypertension. The result is in line
with the desired outcomes, so there were a
significant correlation between the decrease of
systolic blood pressure and MMAS category,
though correlation coefficient was weak
correlation. In this case, it might be reasonable to
say that the adherence is not the most dominant
to decrease blood pressure. The others factors
which influence the decrease of blood pressure,
such as the changes of life style and the accuracy
of choosing medication. The positive
correlation, so it can be conclude that the better
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Fig 1. The Average decreased of systolic blood pressure
on the intervension and control group
improve of patients adherence will decrease
blood pressure better.
CONCLUSION
The pharmacist counseling is effective in
improving medication adherence and its
associated effect on decreasing systolic blood
pressure in patients receiving antihypertensive
therapy. Blood pressure control will reduce the
risk of coronary artery disease, kidney failure
and stroke.
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Abstract
Background. Prevalence of hypertension increased in line with changes of life style as
smoking, obesity, non physical activity, psycho-social stress in many countries. One of the pharmacist
intervention for hypertension management is counseling. This purpose to increase therapeutic
outcome and adherence in medicine. World Health Organization (WHO) has suggested that usage
text message costly more effective for increasing the adherence to improve the health quality of
patients.
Objective. This study aim to reveal the impact of pharmacist counseling and reminder
motivation via short text messages (SMS) on the adherence and decrease systolic blood pressure of
ambulatory hypertension patients in the internal disease polyclinic at PKU Muhammadiyah Bantul
Hospital, Indonesia.
Methods. Sixty patients were devided into 2 groups, 30 (50%) patients were received
pharmacist counseling and reminder motivation via SMS (intervension group) and 30 (50%) were not
received pharmacist counseling and reminder motivation via SMS (control group). The ambulatory
hypertension patients data were collected prospectively during the period of January until April
2013. Exclusion criteria were patients with pregnant, deaf, illiterate, and have not hand phone. Data
were collected by interview and take the quesioner Morisky Medication Adherence Scale (MMAS).
Blood pressure data were taken from medical records.
Outcome Measured. Adherence and systolic blood pressure of ambulatory hypertension
patientns.
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 27
2Laboratory of Pharmacology and Pharmaceutical Biology Faculty of Pharmacy Ahmad Dahlan University
Correspondence author : poet_zukhruf@yahoo.com
Result. The results showed that pharmasist counseling and reminder motivation via SMS could
improve the patients adherence in the intervension group (83.3%) in comparison to the control group
(20%) (p=0.000). Pharmacist counseling and reminder motivation via SMS could also decreased the
systolic blood pressure in the intervention group (15.37±23.69 mmHg; p=0.001). There was no
decreasing the systolic blood pressure (1.27±18.89 mmHg; p=0.730) in the control group. But, there
were no correlation between MMAS and systolic blood pressure (p=0.649; r=0.008).
Conclusion. In conclusion, the pharmacist counseling and reminder motivation via SMS can
improve adherence on antihypertension management, and decrease systolic blood pressure as well.
Keywords hypertension, pharmacist counseling, adherence, systolic blood pressure, short text
messages (SMS).
INTRODUCTION
Hypertension is one of the main factors of
coronary heart disease and stroke occurrences.
WHO has estimated that about 62% of
cerebrovascular disease and 49% of ischemic
heart disease all across the world may be caused
by blood pressure level. The high blood pressure
is estimated to have caused 7.1 million deaths per
year (WHO, 2003). Hypertension is also one of
the causes of death. Vascular complication
caused by hypertension may lead to coronary
heart disease, myocardial infarction, stroke, and
kidney failure.
The hypertension prevalence increases in
line with lifestyle changes such as smoking,
obesity, physical inactivity, and psychosocial
stress in many countries. Hypertension has
become a public health problem and will become
even into a bigger one if it is not addressed early
on.
Health People 2010 for Hypertension
suggests the need for a more comprehensive and
intensive approach in order to achieve optimal
blood pressure control. Thus, to achieve this
objective, active participation of peer
pharmacists practicing their profession is needed
in every single health care (Ministry of Health,
2007).
One of the possible interventions by
pharmacists for the hypertension patients'
handling is counseling which is intended to
improve therapy result by maximizing the
appropriate medications (Rantucci, 1997). One
of the benefits of counseling is to improve the
patients' adherence of drugs usage. Therefore,
mortality rate and losses (both cost and
productivity) can be abated (Palaian et al, 2006).
The patients' adherence affects on the
success of a treatment. The therapy result will
not reach the optimal level without the patients'
awareness, in fact, it may lead to a treatment
failure, and it may also cause complication which
is very harmful, then eventually becomes fatal
(Hussar, 1995). The safe and effective drugs
therapy will happen if the patients are given
proper information about the treatment and the
usage (Cipolle, Strand and Morley, 2004).
Based on the research result conducted by
Palanisamy and Sumathi in 2009, it explains that
the intervention by providing education and
counseling to the patients is able to improve
adherence in the treatment. Pharmacists'
intervention improves blood pressure's control in
hypertensive patients who have uncontrolled
blood pressure (Mehos et al, 2000). It is also
mentioned in the research of Faekeh et al., 2008
which shows that adherence in the treatment is
important to control blood pressure.
World Health Organization (WHO) has
also prioritized the new technology usage to help
health improvement (WHO; 2010). The potential
for benefits is recently being developed in the
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mobile phone technology usage to affect health
in developing countries (Lester and Karanja
2008). Mobile text messages which uses cheap
short message service (SMS) as well as
communications; are able be used to convey
health messages to mobile phones’ owners
(Kaplan, 2006).
Other studies on text messaging usage to
improve adherence as the primary service has
showed that SMS usage has cost effectiveness
(cost effective) than phone calls usage (Leong,
Chen et al. 2006). Dunbar, Madigan et al, have
reported high patients’ satisfaction with two
lanes SMS, this indicates that SMS application is
easier in health improvement.
The research on the effectiveness of
information delivery intervention and SMS
reminders via mobile phone reminders to
hypertensive patients in comparative,
controlled, multicenter cluster randomized study
has been conducted by Contreras, Marquez, et al,
2004. The research by messages intervention
provision (messages) and message reminders
(reminders), which are sent through mobile
phones, providing adherence level research
result of 85.1% (CI 74.9% - 95.3%) in the overall
research subjects (N = 67 ), 85.7% (CI, 70.5%
-100.9%) in the control group and 84.4% in the
intervention group (CI, 70.7% -95.3%)
(Contreras, Marquez, et al, 2004).
Self-report scale to assess adherence in
antihypertensive drugs usage has been
developed by Morisky et al., (2008). The
research to examine psychometric and validity
prediction of self-report medication adherence’s
structure was tested to hypertensive patients in
2007 and was published in January 2008.
Self-report of drugs usage adherence was
measured with new 8 item self-report Morisky
Medication Adherence Scale (MMAS).
Based on the above, it is necessary to
conduct a research to find out the effect of
motivational reminders provision via SMS and
pharmacy counseling (usual care) on adherence
of antihypertensive therapy result in internal
medication polyclinic in PKU Muhammadiyah
Bantul Hospital, Yogyakarta.
OBJECTIVE
The objective of this study was to
determine the effect of motivational reminders
provision via SMS and pharmacy counseling
(usual care) on adherence of antihypertensive
and systolic blood pressure therapy in
hypertensive patients in internal medication
polyclinic in PKU Muhammadiyah Bantul
Hospital, Yogyakarta
METHODS
The research was conducted
prospectively, with a quasi experimental design.
The research subjects were divided into two
groups, namely the group which received
pharmacists counseling (usual care) and
motivational reminders via SMS (intervention
group) and the other one which did not receive
counseling and motivational reminders via SMS
(control group). The inclusion criteria were adult
patients, both men and women; aged between 18
year-old - 65 year-old, who conducted control in
internal medication polyclinic in PKU
Muhammadiyah Bantul Hospital, Yogyakarta,
they were diagnosed by a doctor to have suffered
levels I and II hypertension with or without
dyslipidemia and diabetic mellitus ( DM), they
got more antihypertensive drugs more than or
equal to 1 antihypertensive drug, they had a
mobile communication device in the form of
hand phones and they were literate, they were
willing to join the research. The exclusion
criteria were patients with pregnancy, deaf,
illiterate and did not have mobile phones. The
data was collected by conducting interviews and
filling the adherence questionnaire of Morisky
Medication Adherence Scale (MMAS), while
blood pressure value was taken from medical
records.
Statistical analysis used normality test, if
P > 0:05 normally distributed, independent t-test
and paired t-test, whereas if p < 0.05 distribution
is not normal; Mann Whitney and Wilcoxon test
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is used. p < 0.05 significance indicates
significant different result between groups.
RESULT AND DISCUSSION
The Patients' Demography
The research was conducted during
January to April 2013 in internal medication
polyclinic in PKU Muhammadiyah Bantul
Hospital, Yogyakarta. The research was
conducted prospectively toward hypertension
outpatients. Sampling was done by cosecutive
sampling method, whereas all subjects came
sequentially and met the selection criteria were
included in the research until the number of the
subjects required fulfilled. The subjects'
selection for each group was done randomly,
whereas all subjects who met the research
criteria were divided into two groups by putting
the odd-numbered subjects into the control
group, while even-numbered subjects were
included into the treatment group.
The research subjects obtained 60 patients
who were included in the inclusion criteria. The
subjects who joined the research from the
beginning to the end of the research were 60
patients, consisting of 30 patients who received
pharmacist counseling and motivational
reminders via SMS (treatment group) and 30
patients who did not receive pharmacist
counseling and motivational reminders via SMS
(control group). The socio-demographic and
clinical data both on control and treatment
groups are on table I. In this research, the
relationship of the various subjects'
characteristics in the treatment and the control
groups obtains a non-significant relationship (P>
0.05) among the characteristics of gender, age,
education, employment, payment, history of
hypertension, smoking habits, and hypertension
level (Table I.)
In this research, based on the data
characteristics of the patients, it can be seen that
the majority of the research subjects; both
control and treatment groups are women, each
amounted to 21 (70.0%) in the control group and
22 (73.3%) in the treatment group, with the most
dominating age is in the range of 50-59 year-old;
i.e. 16 (53.3%) in the control group and 13
(43.3%) in the treatment group. The patients'
education level dominates on educational age of
0-9 years, 20 (66.7%) in the control group and 14
(46.7%) in the treatment group.
This research also conducted assessment
whether there was or there was not an existence
of cardiovascular risk factors, namely smoking
habits and hypertension history. The majority of
the patients did not have smoking habits both in
control and treatment groups (90%, 93.3%),
while for hypertension history in the treatment
group shows higher number; i.e. 66.7%
compared to the control group which dominates
the patients with no hypertension history
previously, which is 30% . Either on the control
group or the treatment group shows to have
patients with hypertension degree I, whereas 19
(63.3%) in the control group and 17 (56.7%) in
the treatment group.
Adherence Assessment
The patients' adherence affects on to the
success of a treatment. The therapy result will
not reach the optimal level without the awareness
of the patients themselves, in fact, it may lead
into a treatment failure, and it may also cause
highly harmful complication and eventually
becomes fatal (Hussar, 1995). Thus, it requires
outpatients' non adherence identification to
determine the effectiveness of the hypertension
control level improvement.
In this research, the patients' adherence
parameter was measured using the MMAS both
on the control group and the treatment group.
MMAS score assessment result is shown in
Table II, as following.
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The results shows that high MMAS score
(MMAS = 8) is bigger in the treatment group
than the control group (83.3% > 20.0%). This
suggests that pharmacists counseling and
motivational reminders provision via SMS have
a positive impact in adherence improvement in
the treatment group. It is also in accordance with
the meta-analysis of the research result on the
effect of reminder system on patients' adherence,
whereas in the research mentions that the
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Patients characteristics
Intervention group control group P
Spearman/
Pearson(n=30) % (n=30) %
sex
men 8 26.7 9 30.0 0.604
woman 22 73.3 21 70.0
Age (years old)
18-29 0.619
30-39 1 3.3
40-49 9 30.0 5 16.7
50-59 13 43.3 16 53.3
60-65 7 23.3 9 30.0
education level
0-9 years 14 46.7 20 66.7 0.423
10-12 years 8 26.7 6 20.0
>12 years 8 26.7 4 13.3
Job
Employment civil servants 7 23.3 7 23.3 0.536
enterpreneur 21 70.0 16 53.3
Labor 2 6.7 5 16.7
Not work 2 6.7
payment
General 10 33.3 12 40.0 0.833
Askes 13 43.3 9 30.0
Jamkesmas 4 13.3 8 26.7
Other insurance 3 10.0 1 3.3
History of hypertension
Yes 20 66.7 9 30.0
No 10 33.3 21 70.0 0.097
Smoking habbit
Smoking 2 6.7 3 10.0 0.053
No smoking 28 93.3 27 90.0
Degree of hypertension
Level 1 17 56.7 19 63.3 0.864
Level 2 13 43.3 11 36.7
Table I. Socio demography
Group
Skor MMAS
High Adherence Moderate adherence Low adherence
 %  %  %
Control (n=30) 6 20 16 53.3 8 26.7
Intervention (n=30) 25 83.3 3 10.0 2 6.7
P 0.000*
Table II. MMAS score assessment
reminder system may be in the form of via
telephone calls, text messages, pagers, video
telephone calls, etc. They can significantly
improve adherence in treatment group (which
received the reminders) compared to the control
group (66.61%, 54.71%) (Sarah DF, et al, 2012).
Statistical comparison between MMAS
value in the control group and the treatment
group is done by testing the normality.
Kolmogorov Smirnov normality test result
shows that the data of control group and the
treatment group are not normally distributed;
therefore, non-parametric Mann-Whitney test is
conducted. Mann-Whitney test result indicates
significance of 0.000 (P < 0.05), this shows that
there is a significant difference between MMAS
scores in the control and treatment groups.
Approach to assess treatment adherence
may use self-report, pill counts, pharmacy
records, drug levels. Measurement uses patient
self-report is more concise, quicker and easier to
use, but the drawback is more subjective (Cook
et al, 2005; Garber et al., 2004). Currently, a
more effective way in more effective
measurement has been developed to evaluate the
adherence, namely the new 8-item self-report
Morisky Medication Adherence Scale (MMAS)
(Morisky, et al., 2008; Garber, et al, 2004).
MMAS categorizes the patients'
adherence into 3 categories: high (score 8),
moderate (grades 6 - <8), and low (score < 6).
The research result also shows the patients are
included in low adherence category. This
becomes a challenge for pharmacists and
clinicians in the future to determine effective
treatments. The research result suggests many
factors that can affect lower adherence in the
patients, for example the factors of negligence,
depression, the lack of the patients' knowledge
about hypertension and its treatment, clinical
condition (TD) which is already improved makes
the patients decide stopping their treatment, the
drugs' side effect, economic factor, as well as
excessive prescribing which makes the patients
feel tired to take their medication and the
patients' life quality themselves.
Blood Pressure Assessment
Hypertension level was assessed at the
beginning when the patients entering the
research, which was measured by systolic blood
pressure and diastolic blood pressure at the first
control or disease treatment in internal
medication polyclinic in PKU Muhammadiyah
Bantul Hospital, Yogyakarta. Hypertension
degree identification after systolic and diastolic
blood pressure measurement was done on the
patients who became the research subjects based
on JNC VII classification.
In this research, the majority of the
patients were included in the hypertension level
1 and 2. The research result shows that there is no
difference in early hypertension level (pre) from
the treatment group and the control group based
on Mann Whitney analysis (blood pressure
systole P = 0.343), Table III.
The research result on systolic blood
pressure at the beginning of the research (pre)
both in the control and treatment groups shows
no significant difference in the mean of systolic
blood pressure either on the control group
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Patients
characteristics
Intervention group Control Group
P
(n=30) % (n=30) %
Adherence 30 6.45±1.77 30 5.8±1.86 0.172
Blood Pressure 30 30
Sistole 30 153.53±19.67 30 148.53±20.83 0.343
Diastole 30 89.73±10.34 30 83.76±10.26 0.029*
Table III. Adherence and blood pressure in intervention and control group pre counseling and motivational
reminders via SMS
(148.53 mmHg) and the treatment group (153.53
mmHg) (P = 0.343) Table III.
Systolic blood pressure; both before and
after treatment in the control group and the
treatment group is shown in Table IV below.
Wilcoxon analysis result shows that in the
treatment group; significant systolic blood
pressure changes happen before and after the
pharmacists' counseling (pre) and motivational
reminders provision via SMS (P = 0.001), than
in the control group (P = 0.730).
This suggests that pharmacists' counseling
and motivational reminders via SMS affect on
the patients' adherence and they give effect of
systolic blood pressure reduction in the treatment
group.
Significant blood pressure change in the
treatment group is indicated by systolic blood
pressure reduction prior to the research /
treatment (pre) until after the research / treatment
(post) which is of 15.37 points, while the control
group experiences non significant reduction of
1:27 points (Table V).
Significant systolic blood pressure
reduction in the treatment group shows the
influence of the pharmacists' counseling on
blood pressure control. This is consistent with
the previous research which states that
pharmacists' intervention can improve blood
pressure in hypertensive patients (Mehos et.al,
2000).
CONCLUSION
Based on this research, it can be
concluded that counseling provision (usual care)
and motivational SMS reminders by pharmacists
to hypertensive patients can improve the patients'
adherence in undergoing the drugs' therapy, as
shown by the reduction of the patients' systolic
blood pressure (p < 0.05).
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Patients
characteristics
Intervention group (n=30) Control group (n=30)
Pre Post
P
Pre Post
P
mean±SD mean±SD mean±SD mean±SD
Tekanan darah
Sistol 153.53±19.67 138.17±17.64 0.001 148.53±20.83 147.27±20.79 0.730
Diastol 89.73±10.34 83.00±10.22 0.018 83.77±10.26 83.33±9.31 0.786
Table IV. the different of blood pressure pre and post in intervention and control group.
Patients characteristics
Intervention group (n=30)
mean±SD
Control group (n=30)
mean±SD
P
Blood Pressure
Sistole 15.37±23.69 1.27±19.89 0.015*
Diastole 6.73±14.72 0.433±8.66 0.048*
Table V. the different of blood pressure pre and post in intervention and control group
Calman KC. 1984. Quality of life in cancer
patients an hypothesis. J Med Ethics
10:124-127
CMSA, 2006, Case Management Adherence
Guidelines, version 2.0, Case
Management Society of America, Chapter
7:39-41.
Cipolle, RJ., Strand, LM., Morley, PC. 2004.
Pharmaceutical Care Practice : The
Clinician’s Guide (2th Ed). New York:
The McGraw Hill Co.
Contreras, Marquez T, et al, 2004, Effectiveness
of an Intervention to Provide Information
to Patients With Hypertension as Short
Text Messages of Reminders Sent to Their
Mobile Phone (HTA-Alert). Aten
Primaria; 34(8):399-407
Depkes, 2007, InaSH Menyokong Penuh
Penanggulangan Hipertensi, Jakarta :
Depkes RI, , http ://www.depkes.go.id.
Dipiro, Joseph T, et al. 2008. Pharmacotherapy
A Pathophysiologic Approach. American
Pharmacists Association, Washington DC
Dunbar, P. J., D. Madigan, et al. 2003. “A
two-way messaging system to enhance
antiretroviral adherence.” Journal of the
American Medical Informatics
Association 10(1): 11-15
Fenerty D Sarah, Cameroon West, Scott A
Davis, Sebastian G Kaplan, Steven R
Feldman. The effect of reminder systems
on patients’ adherence to treatment. Dove
Press Journal: Patient preference and
adherence. February 2012.
Guidelines sub committe. World Health
Organisation- International Society of
Hypertension. Guidelines for the
mangement of hypertension-part II.
Cardiology today 2006; 6:146-64.
Haynes, R.B., Mc. Donald, H.P., Garg, A.X.,
2002, Helping Patients Follow Prescribed
Treatment : Clinical Applications, JAMA,
288:2880-83.
Haynes, R.B., Taylor, D.W., Sackett, D.L.,
Gibson, E.S., Bernholz, C.D., Mukhreje
J., 1980, Can Simple Clinical
Measurements Detect Patient
Noncomliance?, Hypertension, 2:757-64.
Hussar, DA., 1995. Patient Compliance, in
Remington: The Science and Practice of
Pharmacy (1796-1807), Volume II, USA:
The Philadelphia Collage of Pharmacy
and Science.
Jackevicius, C.A., Mamdani M, Tu, J.V., 2002,
Adherence With Statin Therapy in Elderly
Patients With and Without acute Coronary
Syndrome, JAMA, 288:462-67.
Kaplan, W. A. 2006. “Can the ubiquitous power
of mobile phones be used to improve
health outcomes in developing countries.”
Global Health 2(9).
Katzung., G., Bertram., 2010., Farmakologi
Dasar dan Klinik, Edisi 10, Jakarta :
Penerbit Buku Kedokteran EGC, hal.
161-162.
Knippenberg FC, de Haes JC. 1988. Measuring
the quality of life of cancer patients:
psychometric properties of instruments. J
Clin Epidemiol; 41:1043-1053
Koda Kimble, et all. 2005. Applied
Therapeutics: The Clinical Use Of Drugs,
9th Edition. Philadelphia, Pennsylvania
Laurence, L.B., Lazo J.R., and Parker K.L.,
2008, Goodman & Gilma’s ; Manual
Pharmacology and Therapeutics, Seventh
Edition, Mc Graw Hill, pp 546-60
Lester, R. and S. Karanja 2008. “Mobile phones:
exceptional tools for HIV/AIDS, health,
and crisis management.” The Lancet
infectious diseases 8(12): 738.
Lester, R. T., E. J. Mills, et al. 2009. “The
HAART cell phone adherence trial
(WelTel Kenya1): a randomized
controlled trial protocol.” Trials 10(1):
87.
Leong, K. C., W. S. Chen, et al. 2006. “The use
of text messaging to improve attendance
34 Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013
ISBN : 978-979-18458-6-1
in primary care: a randomized controlled
trial.” Family Practice 23(6): 699
Mehos BM, Saseen JJ and Mac Laughlin EJ
2000. Effect of pharmacist and initiation
of home blood pressure monitoring in
patients with uncontrolled hypertension.
Pharmacotherapy, 20: 1384-1389
Morisky, D.E., Ang A, Krousel-Wood, M.A.,
Ward H, 2008, Predictive Validity of A
Medication Adherence Measure in an
Outpatient Setting, J. Health-Syst. Pharm,
10:348
Mbuagbaw, L., L. Thabane, et al. 2011. “The
challenges and opportunities of
conducting a clinical trial in a low
resource setting: The case of the
Cameroon mobile phone SMS (CAMPS)
trial, an investigator initiated trial.” Trials
12(1): 145.
Mukund, B. K. C. and P. J. Murray, 2010. “Cell
phone short messaging service (SMS) for
HIV/AIDS in South Africa: a literature
review.” Studies in health technology and
informatics 160(Pt 1): 530
Palaian S, Mukhyaprana, Rafi S. 2006. Patient
Counseling by Pharmacist focus on
chronic illness, Pac.J.Pharm.sce:pp 19(1)
: 62-65
Palanisamy, S., Sumathy, A, 2009, Intervention
to improve patient adherence with
Antihypertensive Medications at a tertiary
care teaching hospital. Int.J. PharmTech
Res. Vol.1, No.2, pp 369-374
Rantucci, MJ., 2007. Komunikasi
Apoteker-Pasien (Edisi 2). Penerjemah :
A. N. Sani. Jakarta : Penerbit Kedokteran
EGC.
Sakthong P, Chabunthom R,
Charoenvisuthiwongs R, 2009,
Psychometric properties of the Thai
version of the 8-item Morisky Medication
Adherence Scale in patients with type 2
diabetes. Ann Pharmacother.
May;43(5):950-7. 80
Saseen, J.J., and Carter, B.L., 2005,
Hypertension, in : Dipiro, J.T., Talbert,
R.L., Yee, G.C., et al., (eds) :
Pharmacotherapy A Pathophysiologic
Approach, Sixth Edition, New York :
McGraw-Hill, pp 185-214
Saseen, J.J., and Carter, B.L., 2009, Essential
Hypertension, in : Koda Kimble, M.A.,
Young, L.Y., Kradjan, W.A., Guglielmo,
B.J., Alldredge, B.K., dan Corelli, R.L.,
(eds) : Applied Therapeutics : The Clinical
Use of Drugs, Eight Edition, New York :
Lippincot Williams & Wilkin, Chapter :
14.1-43.
Schipper H, Clinch 1988. J. Assessment of
treatment of cancer. In: Smith GT, ed.
Measuring Health: A Practical Approach.
New York: John Wiley & Sons ; 109-139.
Spilker B (ed.), 1996.Quality of Life and
Pharmacoeconomics in Clinical Trials,
2nd ed, Lippincot Raven, Philadelphia, p
58
Ware JE Jr. 2000. SF-36 health survey update.
Spine ; 25: 3130 – 3139.
WHO, 2003, International Society of
Hypertension Writing Group, World
Health Organization-International Society
of Hypertension statement of
Management of Hypertension. pp 108-17.
Yogiantoro, M., 2006, Hipertensi Esensial,
dalam : Sodoyo, A.W., Setiyohadi, B.,
Alwi, I., dkk, (eds) : Buku Ajar Ilmu
Penyakit Dalam, Jilid II, Edisi IV, Jakarta
: Pusat Penerbitan Departemen Ilmu
Penyakit Dalam, Fakultas Kedokteran
Universitas Indonesia, hal. 1079-1085.
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 35
ISBN : 978-979-18458-6-1

THE USE OF OTC (OVER-THE-COUNTER) DRUGS IN
SELF-MEDICATION (SWAMEDIKASI) EFFORT TO THE
SOCIETY IN SANTAN SUMBEREJO
Elmiawati Latifah
Universitas Muhammadiyah Magelang,
Bumi Prayudan Blok RK 13 Magelang,
latifa_apt@yahoo.co.id
081392212213
Abstract
Background. Self-medication (swamedikasi) means treating all self-complaints with
medicines bought from the pharmacies or drug store on individual initiative without the advice of a
doctor.
Objective. Objective of this study is to evaluate the source information that patients gotten.
Methods : This research is an observational research with cross sectional research design. The
numbers of respondents are 60; selected by non-random sampling with predetermined criteria. The
technique of data collection is done by using questionnaire and observation.
Outcome Measured. Source drug information for self medication.
Result. The result of the research shows that 83.3% of people in Santan Sumberejo District do
the swamedikasi or self-medication and 75% of people buy the medicine in the shop. 50% of people in
Santan Sumberejo buy OTC drugs because they are cheap. In selecting the medicines, they know from
their friends or relatives that is 41.7%, and matters which are noticed by the people in Santan
Sumberejo is the efficacy of the medicines (55%). 96.7 % of people in Santan Sumberejo have been
appropriate in medicines use. They know the rules of medicines use by reading the medicines package
(70%). 93.4% of people in Santan Sumberejo never made mistakes in treatment. OTC drugs which are
often bought in Santan Sumberejo are headache medicines by 46.1% respondents.
Conclusion. If they have not recovered, 71.7% of people in Santan Sumberejo choose to go to
the doctor as a solution. Level of knowledge of people in Santan Sumberejo is included in good
category in which 76.25% of respondents answer the questions correctly.
Keywords : drugs use, knowledge level of society, OTC drugs
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INTRODUCTION
The Republic of Indonesia government, in
this case the Ministry of Health, trying to
improve the quality of Health Care of the People.
Swamedikasi can be interpreted simply as a
person attempts to self-medicate. Swamedikasi
be an alternative that many people selected to
relieve or cure minor health complaints or to
increase the affordability of access to treatment.
Communities should be given the opportunity to
swamedikasi (Tan et al, 1993). Based on the
results of the National Socio-Economic Survey
(NSES) in 2009, BPS noted that there are 66% of
people ill in Indonesia doing swamedikasi. This
figure is relatively higher than the percentage of
people who went to the doctor (44%).
Swamedikasi who do people often do on free
drug classes and drug-free is limited. The
efficacy and safety of drug-free would be good
only if used properly according to the
instructions and warnings for use of the drug and
are not necessarily free to use without rules.
Improper use of OTC drugs can still be harmful
to users, at least not effective for the treatment
(Widodo, 2006).
Objectives
1. This research was conducted using a
quantitative approach to the type of
descriptive and survey methods. Survey
conducted by the method of cross-sectional
approach.
2. Technique using non-probability sampling
(non-random sampling)
3. Sample of this research is in the public
environment Sumberejo Santan village with
age limit 18-60 years. This study used 60
samples.
4. The timing of the research conducted during
March and April 2012
METHODS
Instruments used in data collection for the
study was a questionnaire. Data analysis was
conducted in research using Microsof Excel
program.
RESULTS
Dissemination of questionnaires given to
the respondent response obtained as follows:
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Answer Frequency Percentage
Going to the doctor 8 13%
Go to the healer / alternative medicine 2 4 %
Treat yourself to buy medicine 50 83%
Table I. Community Action If you experience pain
Answer Frequency Percentage
more practical 13 22%
cheap 30 50%
more effective 0 0 %
Easily obtained 17 28%
Table II. Reason for using OTC
Discussion
Can be seen as much as 76.25%. The level
of knowledge is included in the category of
"good" because according to (Arikunto, 2002),
the level of knowledge is quite good if the
respondents who answered correctly between
76% to 100%.
Factors influencing knowledge among
education, occupation, age, interests,
experiences, cultural surroundings, information,
ease of obtaining information. Most of the
respondents' answer is to do a self-medication to
cope with illness (83%). This is in accordance
with national socio-economic data (NSES) in
2009 BPS note that in Indonesia who do their
own treatment reached 66%. This happens for
several reasons, namely (Anonymous, 2012):
Socio-economic factors, lifestyle, Ease of
obtaining medicinal products, environmental
health factors And the availability of new
products.
CONCLUSION
Based on the results of research in the
Santan Environment can be concluded that:
1. Society in Santan Environment Sumberejo
who do swamedikasi or treat yourself as
much as 83% with most drugs where to buy in
the shop as much as 75%.
2. The reason most people in the neighborhood
Santan Sumberejo use OTC drugs as low as
50%
3. In the selection of drugs, people in the
neighborhood know Santan Sumberejo much
of the mass media with a percentage of 42%
and it is often considered in the use of drugs in
the community is neighborhood Santan
Sumberejo drug efficacy (55%).
4. A total of 97% of the people in the
neighborhood have been appropriate in the
Santan Sumberejo drug. They know the rules
of the use of drugs by reading the packaging
of drugs (70%).
5. A total of 93% of the people in the
neighborhood Santan Sumberejo never made
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No question Frequency percentage
1. The level of public knowledge about the definition of drug-free 56 92%
2. Level of public knowledge about the use of drug-free 37.6 63%
3. The level of public knowledge about drug safety 37.5 63%
4. The level of public knowledge about drug-free information 53 88%
53 88%
Table IV. Knowledge level survey data
Answer Frequency Percentage
Ever received a prescription 13 21%
Knowledge from the mass media 25 42 %
Buying drugs themselves because they know of friends 22 37%
Attractive drug packaging 0 0%
Table III. Information drug selection
a mistake in treatment. Drugs are often
purchased at the Santan Sumberejo
Environment is a headache medicine by as
much as 46% of respondents. If it has not
healed as much as 71.7% of the people in the
neighborhood Santan Sumberejo choose to
go to the doctor as a solution.
6. The level of knowledge society in Santan
Environment Sumberejo included in either
category with 76.25% of respondents
answered the question correctly.
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Abstract
Background. Prevalence of hypertension increased in line with changes of life style as smoking,
obesity, non physical activity, psycho-social stress in many countries. Comprehensive and intensive
antihypertension intervention could be more control of the blood pressure of patient. Counseling and
provision of appropriate information by pharmacists is expected to improve adherence of patient on drug
therapy in decreasing the blood pressure.
Objective. The aim of this study is to investigate the influence of pharmacist counseling and booklet
on the adherence and decrease systolic blood pressure of ambulatory hypertension patients at internal
disease polyclinic PKU Muhammadiyah Bantul Hospital, Indonesia.
Methods. This study was conducted with quasi-experimental design. The ambulatory hypertension
patients data were collected prospectivelly during the period of January until April 2013. Sixty patients
were divided into 2 groups, 30 (50%) patients receive a pharmacist counseling and booklet (intervention
group) and 30 (50%) without a pharmacist counseling and booklet (control group). Exclusion criteria was
pregnancy, deaf and illiterate. Data collection were conducted by interview and completion Morisky
Medication Adherence Scale (MMAS) adherence questionnaire, while values of blood pressure were
taken from medical records.
Outcome Measured. Adherence and systolic blood pressure of ambulatory hypertension patients.
Results. The results showed that pharmacist counseling and booklet could increased the patients
adherence in the intervention group (66.7%) in comparison to the control group (20%) (p=0.001).
Accordingly, pharmacist counseling and booklet intervention could decreased the systolic blood pressure
in the intervention group of (15.2 mmHg, p=0.000). There was no decreasing the systolic blood pressure
(1.27 mmHg, p=0.730) in the control group. There were positive correlation in patients adherence and
systolic blood pressure value (p=0.024, r=0.410).
Conclusion. In Summary, the pharmacist counseling and booklet intervension can increase the
patients adherence on antyihypertension management. Moreover, it can decrease systolic blood pressure
patients (p<0.05).
Keywords : hypertension, pharmacist counseling, adherence, systolic blood pressure, booklet.
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INTRODUCTION
Hypertension is one of the main factors
triggering coronary heart disease and stroke.
WHO has estimated about 62% of
cerebrovascular disease and 49% of ischemic
heart disease in the world can be caused by
blood pressure levels. High blood pressure is
estimated to cause 7.1 million deaths per year
(WHO and IPF, 2006).
In many countries, the prevalence of
hypertension increases with lifestyle changes
such as smoking, obesity, physical inactivity,
and psychosocial stress. In Indonesia, there are
no complete national data concerning the
prevalence of hypertension. The National
Household Health Survey (Survei kesehatan
Rumah Tangga (SKRT)) in 1995 found that the
prevalence in Indonesia was 83%. The
prevalence of hypertension in the ages of more
than 50 years ranged between 15% - 20% (The
Department of Health, 2007).
Hypertension attacks human body very
slowly. Patients with hypertension may have no
symptoms for years. This latency period covers
the development of the disease until significant
organ damage occurs. If any symptoms are
indicated, those signs are usually non-specific
ones such as headaches or dizziness. If
hypertension remains unknown and untreated,
this results in death due to heart failure,
myocardial infarction, stroke, or kidney failure.
However, early detection and effective
intervention of hypertension can reduce the
amount of morbidity and mortality. Thus, regular
blood pressure checks have significance in the
intervention of hypertension (Brown, 2006).
Healthy People 2010 for Hypertension
suggest a more comprehensive approach and
intensive in order to achieve optimal blood
pressure control. So to achieve that goal, it needs
the active participation of pharmacist in
implementing the practice of his profession at
every place of health care. Pharmacist can work
with doctors in providing education to patients
about hypertension, monitoring the response of
patients, adherence to drug therapy and
non-drug, detect and identity side effect early
reaction, and prevent and or solve problems
associated with providing drugs (The
Department of Health, 2007).
One of the possible interventions by
pharmacists for the hypertension patients’
handling is counselling. Counseling intended to
improve therapy result by maximizing the
appropriate medications (Rantucci, 1997). One
of the benefits of counseling is to improve the
patients’ adherence of drugs usage. Therefore,
mortality rate and losses (both cost and
productivity) can be abated (Palaian et al, 2006).
Not only held verbally, counseling can also
accompanied by written matter that serves to
increase knowledge and strengthen what is
delivered by farmasis when counseling (The
Department of Health, 2007).
Based on the findings of the research by
(Palanisamy and Sumathi in 2009), it is
explained that the intervention by providing
education and counseling to patients can
improve adherence to intervention. The
interventions of pharmacists improve blood
pressure control of the patients with
hypertension who have uncontrolled blood
pressure (Mehos et al, 2000).
The findings of the research carried out by
(Mansoor et al. 2008) suggested that written
materials accompanied by verbal consultation
can have a positive impact in improving
adherence. The research by Mulyasih, (2011)
showed that the provision of verbal counseling
and leaflets can affect adherence and lower
systolic and diastolic blood pressure until it
reaches the target. Based on the research by
Rostikarina, (2011), the provision of Home
Pharmacy Care (Booklet) contributed
significantly to increase knowledge about the use
of oral antihypertensives in patients with
hypertension.
Self-report scale to assess adherence with
the use of antihypertensive drugs have been
developed by Morisky et al, (2008). Reseach to
test the psychometric and predictive validity of
the structure of self-report medication adherence
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in hypertensive patients tested in 2007 and
published in January 2008. Adherence with the
use of drugs was measured with the new 8-item
self-report Morisky Medication Adherence
Scale (MMAS).
Based on the information above, it is
necessary to study to see the effect of the
provision of pharmacist counseling and booklets
on the adherence and the therapy result (systolic
blood pressure) of hypertension intervention in
internal disease polyclinic PKU Muhammadiyah
Bantul Hospital, Yogyakarta.
OBJECTIVE
1. To investigate the influence of pharmacist’s
counseling and booklet on the adherence and
therapy result (systolic blood pressure) in
hypertensive patients in internal disease
polyclinic in PKU Muhammadiyah Bantul
Hospital, Yogyakarta
2. To investigate the relation of adherence with
the terapy result in hypertensive patients in
internal disease polyclinic in PKU
Muhammadiyah Bantul Hospital,
Yogyakarta.
METHODOLOGY
The research belongs to a
quasi-experimental research. Subjects were all
hypertension patients in internal disease
polyclinic in PKU Muhammadiyah Bantul
Hospital, Yogyakarta period January to April
2013. They were divided in to two groups as
intervention group and control group. The
intervention group is the group of patients who
received a pharmacist counseling and booklet
and control group patients is the group of
patients who did not recieve a pharmacist
counseling and booklet. Data were collected
prospectively and research result was presented
descriptively. All patients received information
regarding the objectives of the study and gave
their written informed consent.
Data collection were conducted by
interview and completion Morisky Medication
Adherence Scale (MMAS) adherence
questionnaire, while values of blood pressure
were taken from medical records. The inclusion
criteria were adults patients, both men and
women with age 18-65 years old, who conducted
control in PKU Muhammadiyah Bantul
Hospital, Yogyakarta, they were diagnosed by a
doctor to have suffered levels I and II
hypertension with or without dyslipidemia and
diabetic mellitus (DM), they got more
antihypertensive drugs more than or equal to 1
antihypertensive drug, not illiterate and gave
their written informed consent. The exclusion
criteria were patients with pregnancy, deaf, and
illiterate. After all required data is obtained,
which is from medical record data, health
assessment, MMAS questionnaire, blood
pressure, do data processing with statistical
methods using SPSS version 16. Statistical
analysis used normality test, if P>0.05 normally
distributed, independent t-test and paired t-test,
whereas if p <0.05 distribution is not normal,
Mann Whitney and Wilcoxon test is used. p
<0.05 significance indicates significant different
result between groups.
RESULT AND DISCUSSION
The research was conducted during
January to April 2013 in internal disease
polyclinic in PKU Muhammadiyah Bantul
Hospital, Yogyakarta. The research was
conducted prospectively toward hypertension
outpatients. Sampling was done by cosecutive
sampling method, whereas all subjects came
sequentially and met the selection criteria were
included in the research until the number of the
subjects required fulfilled. The subjects selection
for each group was done randomly, whereas all
subjects who met the research criteria were
divided into two groups by putting the
odd-numbered subjects into the control group,
while even-numbered subjects were included
into the intervention group.
The subjects who joined the research from
the beginning to the end of the research were 60
patients, consisting of 30 patients who received a
pharmacist counseling and booklet from the
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researcher (intervention) and 30 patients who did
not receive a pharmacist counseling and booklet
(control).
1. The Patients’ Demography
The distribution of the variety subjects
characters of the intervention group to the
control group was shown on table I.
In this research, the relationship of the
various subjects characteristics in the
intervention and the control groups obtains a
non-significant relationship (P>0.05) among the
characteristics of gender, age, education,
employment, payment, history of hypertension,
smoking habits, and degree of hypertension..
In this research, based on the data
characteristics of the patients, it can be seen that
the majority of the research subjects; both
control and intervention groups are women, each
amounted to 21 (70.0%) in the control group and
19 (63.3%) in the intervention group, with the
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Subjects characters
Intervention Group Control Group
(N=30) % (N=30) %
Gender
Man 11 36.7 9 30
Women 19 63.3 21 70
Age (years old)
18-29 1 3.3 0 0
30-39 3 10 0 0
40-49 8 26.7 5 16.7
50-59 10 33.3 16 53.3
60-65 8 26.7 9 30
Education
0-9 years 18 60 20 66.7
10-12 years 7 23.3 6 20
>12 years 5 16.7 4 13.3
Employment
Civil Servants 3 10 7 23.3
Entrepreneur 18 60 16 53.3
Labor 8 26.7 5 16.7
Not Work 1 3.3 2 6.7
Payment
General 7 23.3 12 40
Askes 8 26.7 9 30
Jamkesmas 13 43.3 8 26.7
Other Insurance 2 6.7 1 3.3
History of Hypertension
Yes 17 56.7 9 30
No 13 43.3 21 70
Smoking Habit
Smoking 5 16.7 3 10
No smoking 25 83.3 27 90
Degree of Hypertension
Level I 11 36.7 19 63.3
Level II 19 63.3 11 36.7
Table I. Distribution of subjects characters in intervention group to control group
most dominating age is in the range of 50-59
year-old; i.e. 16 (53.3%) in the control group and
10 (33.3%) in the intervention group. The
patients’ education level dominates on
educational age of 0-9 years, 20 (66.7%) in the
control group and 18 (60%) in the intervention
group.
This research also conducted assessment
whether there was or there was not an existence
of cardiovascular risk factors, namely smoking
habits and hypertension history. The majority of
the patients did not have smoking habits both in
control and intervention groups (90%, 83.3%),
while for hypertension history in the intervention
group shows higher number; i.e. 56.7%
compared to the control group which dominates
the patients with no hypertension history
previously, which is 30%. In the control group
shows to have patients with hypertension degree
I 19 (63.3%) and patients with hypertension
degree II 19 (63.3%) in the intervention group.
2. Adherence Assessment
The patients’ adherence affects on to the
success of a intervention. The therapy result will
not reach the optimal level without the awareness
of the patients themselves, in fact, it may lead
into a intervention failure, and it may also cause
highly harmful complication and eventually
becomes fatal (Hussar, 1995). Thus, it requires
outpatients’ non adherence identification to
determine the effectiveness of the hypertension
control level improvement.
In this research, the patients’ adherence
parameter was measured using the MMAS both
on the control group and the intervention group.
MMAS score assessment result is shown in
Table II.
The MMAS questionnaire had a total
score of 8, with the category of high adherence
(MMAS value=8), moderate adherence (MMAS
score=6 <8) and low adherence (MMAS
value=<6). The assessment of adherence using
the MMAS was done until the second visit both
to the control group or the intervention group.
The results presented in Table II explain that the
high adherence category (MMAS score=8) is
greater in the intervention group that the one in
the control group (66.7% or 20 patients>20% or
6 patients). This suggests that counseling from
pharmacists and booklets contribute positively to
the adherence of the patients in the intervention
group.
Statistical comparison between MMAS
value ??in the control group and the intervention
group is done by testing the normality. The
results of Kolmogorov Smirnov normality test
showed that the data of both the control group
and the intervention group were not normally
distributed therefore a non-parametric test using
the Mann-Whitney test was conducted. Based on
the test results, the significance value of 0.001
(p<0.05) was obtained. Therefore, it can be
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 45
ISBN : 978-979-18458-6-1
Group
MMAS Scores
High Adherence Moderate Adherence Low Adherence
 %  %  %
Control
(n=30)
6 20 16 53.3 8 26.7
Intervention
(n=30)
20 66.7 10 33.3 0 0
P value 0.001*
Description :
MMAS : Morisky Medication Adherence Scale
Table II. MMASScores on HypertensionPatients in Intervention and Control Group after Get Counseling in the
Final Research.
concluded that there are significant differences
between the MMAS scores of the control group
and the MMAS scores of the intervention group.
Approach to assess intervention
adherence may use self-report, pill counts,
pharmacy records, drug levels. Measurement
uses patient self-report is more concise, quicker
and easier to use, but the drawback is more
subjective (Cook et al, 2005; Garber et al.,
2004). Currently, a more effective way in more
effective measurement has been developed to
evaluate the adherence, namely the new 8-item
self-report Morisky Medication Adherence
Scale (MMAS) (Morisky, et al., 2008; Garber, et
al, 2004).
Many factors have been reported can
affect lower adherence in the patients, for
example the factors of negligence, depression,
the lack of the patients knowledge about
hypertension and its intervention, clinical
condition (TD) which is already improved makes
the patients decide stopping their intervention,
the drugs’ side effect, economic factor, as well as
excessive prescribing which makes the patients
feel tired to take their medication and the
patients’ life quality themselves.
MMAS provides information on the habits
associated with low adherence that may be
caused by the coincidence (e.g. negligence),
accidentally (not taking medication when feel it
getting worse or improved). Table III shows
some patients not adherent to therapy caused
patients often forget to take the medication and
understanding patients are wrong about their
disease so that they deliberately not to take their
medicine. Patients who do not comply assume
that after a patient taking the drug antihipertensi
and there has been a decrease in blood pressure,
patients feel the ailment had healed and do not
need to take drugs again. Then patients will take
drugs again when the symptoms of elevated
blood pressure, for example pain in the back of
the head or feel dizzy. Non-adherence in taking
the drug also caused due to a lack of
understanding about the risks that will happen if
blood pressure patients aren't reach the target set.
The low adherence becomes a challenge
for pharmacists and clinicians in the future to
determine effective interventions. If pharmacists
s is to identify patients who have adherence low,
so pharmacists can intervene in an imprecise
manner and appropriate. With a counseling
pharmacists, the patient is given the
understanding that the disease hypertension
incurable and when his blood pressure not reach
the target applied will damage occurs on vital
organs other bodies.
3. Blood Pressure Assessment
Hypertension level was assessed at the
beginning when the patients entering the
research, which was measured by systolic blood
pressure at the first control or disease
intervention in PKU Muhammadiyah Bantul
Hospital, Yogyakarta.
The results of the normality test using the
Kolmogorov Smirnov concerning systolic blood
pressure showed that both the control group and
the intervention group at the beginning and in the
end of the study were normally distributed
(p>0.05). Thus, to examine the differences
between the initial condition and the final
condition of the study in both the intervention
group and the control group, a parametric
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No Reasons for non-adherence
Group
Total (%)
Intervention Control
1 Forgot 0 8 13.3
2 Deliberately not taking medication 1 4 8.3
3 Being distracted by having to take medication 3 8 18.3
Table III. The Reasons for non-adherence of patients based on a questionnaire MMAS.
statistical test with Paired Samples t-Test was
administered. In accordance with the results of
the test conducted in the intervention group, the p
value of 0.000 (p<0.05) was obtained, meaning
that there are significant differences in systolic
blood pressure measurements at the beginning
and in the end of the study. Whereas in the
control group, the p value of 0.730 (p>0.05) was
obtained, meaning that there is no significant
difference in systolic blood pressure
measurements during and in the end of the study.
The normality test on the mean of the SPB
changes using the Kolmogorov Smirnov for
systolic blood pressure showed that the data of
both the control group and the intervention group
were normally distributed (p>0.05), so as to
know the difference between the control group
and the intervention group, the parametric
statistical test of the Independent Samples t-Test
was conducted. The test results generated the p
value of 0.008 (p<0.05). Therefore, it can be
concluded that the patients with hypertension in
the intervention group (that were facilitated with
pharmacist counseling and booklets)
encountered more significant systolic blood
pressure decreases than the control group.
4. Assessment Correlation the result of
terapy with Adherence
The correlation test in to analyze the
correlation between the result of the terapy with
adherences. The result of therapy which is
correlated with adherence is reduction of blood
pressure systolic with MMAS category.
Statistical correlation test was Spearman test.
This test was chosen because the variables are
tested in the form of rasio with ordinal variables
and were not normally distributed.
The results of this test showed significant
correlation between decreasing systolic blood
pressure with MMAS score of pharmacist
patient with hypertension who become research
in internal disease polyclinic in PKU
Muhammadiyah Bantul Hospital, Indonesia.
This is an accordance with the condition
expected, namely a significant relationship
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Piture 1. The mean of Systolic Blood Pressure at the
Beginning and in the End of the Research of both the
Control Group and the Intervention Group
Group
The
Beginning
The
End
P Value
Control 148.53 147.27 0.730
Intervention 162.57 147.37 0.000*
Description :
* : Using Paired Samples t-Test
Picture 2. The average decrease in (Ä) Systolic Blood
Pressure of the Patients with Hypertension of both the
Control Group and the Intervention Group at the
Beginning and in the End of the Research
Group
The average decrease in
() SBP (mmHg)
P Value
Control 1.27 0.008*
Intervention 15.2
SBP : Systolic Blood Pressure
* Using Independent Sampels t-Test
between reduction results therapy with MMAS
score, although the correlation coefficient
showed a weak relationship. This matter could
probably cause counseling pharmacist is not
dominant as a factor of decreasing systolic blood
pressure. The direction of correlation is positive,
which means the greather the difference in a
person's blood pressure will be higher his
MMAS score.
CONCLUSION
1. Pharmacist counseling and booklets had a
positive and significant effect (p=0.001) on
adherence of ambulatory hypertension
patients in internal disease polyclinic in PKU
Muhammadiyah Bantul Hospital, Indonesia
2. Compliance has a positive and significant
(p=0.024, r=0.410) for systolic blood
pressure reduction so that the higher the level
of patient compliance, the greater the
decrease in blood pressure.
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Abstract
Background. Metabolism disorder means indicates a change in a normal metabolism either in
qualitative or in quantitative manner. This disorder can be identified through the changes of
metabolism productions, possibility of the increase or the decrease of the relevant enzymes activities,
or even the absence of an enzyme.
Objective. To study the disorder of purine and pyrimidine nucleotide metabolism, the arising
disease and its therapy
Method. The review is used the 4 books and 2 articles related to the disorder of purine and
pyrimidin nucleotide metabolism, the arising disease and its therapy.
Outcome Measured. Nucleotide degradation and enzyme activity.
Results. This article presents metabolism/catabolism/anabolism and the management of
purine and pyrimidine nucleotide metabolism are followed by the metabolism disorder and its
therapy. Following this, the nucleotide degradation and the disorder of purine and pyrimidine
metabolism in the form of the increasing activity of enzymes or the absence of certain enzymes along
with the mechanism of its therapy are presented.
Conclusion. The nucleotide degradation and the disorder of purine and pyrimidine
metabolism in the form of the increasing activity of enzymes or the absence of certain enzymes along
with the mechanism of its therapy are presented
Keywords : metabolism disorder, purine nucleotide, pyrimidine, and nucleotide degradation
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INTRODUCTION
Metabolism disorder refers to the change
in a normal metabolism and occurs in a
qualitative or in a quantitative manner. The
PRPP synthetase enzyme experiences an
increasing activity due to a quantitative change.
Hypoxanthine-guanine phosphoribosyl
transferase (HGPRT) enzyme that plays a role in
non-Inosinate-guanilate salvage pathway
biosynthesis shows a qualitative change.
This study is aimed to discuss the purine
and pyrimidine metabolism disorder. Nucleotide
consists of base N binding sugar (ribose) in C1
and phosphate in C5’. Purine Base N includes
adenine and guanine. Meanwhile, pyrimidine is
included in cytosine, uracil, and thymine.
Purine and pyrimidine nucleotide has a
number of important roles and functions. It is
including (a) as a universal energy such as
adenosin trifosfat (ATP); (b) as monomer from
nucleic acid both as ribonucleic acid (RNA) and
as deoxyribonucleic acid (DNA); (c) active
intermediate (zantara) in many biosynthesis
processes such as diacylglycerol -diphosphatase
(CDP-diacylglycerol) intermediate in phosphor
glycerol biosynthesis; (d) component of
coenzyme such as oxidized Nicotinamide
adenine dinucleotide (NAD+), flavin adenine
dinucleotide (FAD) and (e) metabolic regulator
such as cyclic adenosine mono phosphate
(cAMP).
Purine nucleotide biosynthesis (Cory,
2006; Elliot and Elliot, 1997; Berg, Tymoczko
and Stryer, 2002; Smith and Clark, 2011).
de novo pathway, It is initiated from
Phosphoribosyl pyrophosphate (PRPP) to be
Inosinate acid (IMP) and then to be Adenosine
monophosphate (also known as 5’-adenylic
acid), and guanosine monophosphate (GMP):
Purine nucleotide biosynthesis (Cory,
2006; Elliot and Elliot, 1997; Berg, Tymoczko
and Stryer, 2002; Smith and Clark, 2011).
de novo pathway, It is initiated from
Phosphoribosyl pyrophosphate (PRPP) to be
Inosinate acid (IMP) and then to be Adenosine
monophosphate (also known as 5’-adenylic
acid), and guanosine monophosphate (GMP):
PRPP a (+Glutamine – Glutamate/Amino
phosphoribosyltransferase)
5-phosphoribosyl-1-amine b (+Glycine
+ATP-ADP-Pi) Glycinamide Ribonucleotide
c (+N10-Formil THF-THF) Ribonucleotide
formiglicynamide d
(+Gln+ATP-Glu-ADP-Pi) Ribonucleo tida
formilglisinamidin e (-H2O) Ribonu
cleotide 5-aminoimidasol f (+CO2)
Ribonucleotide 5-aminoimidazole
4-carboxylate g (+Asp+ATP-ADP-Pi)
Ribonucleotide 5- aminoimidazole
l-4-N-succino carboxamide h i
(-Fumarate) Ribonucleotide 5-
aminoimidazole -4- carboxamides j
(N10-Formil THF –THF) Inosinate/IMP.
IMP k (+Asp+GTP –GDP-Pi)
Adenylosuccinate l (-Fumarate) Adenylate
/AMP.
IMP m (+NAD+ -NADH) xantilate n
(+Gln +ATP –Glu-AMP-PPi) Guanilate/
GMP.
The involved enzymes: (a). glutamine
PRPP amidotransferase, (b). GAR synthetase,
(c). GAR transformylase, (d). FGAM
synthetase, (e). AIR synthetase, (f). AIR
carbocslase, (g). SAICAR synthetase, (h).
adenylosuccinate liase, (i). AICAR
transformylase, (j). IMP cyclohydrolase, (k).
adenylosuccinate synthetase, (l).
Adenylosuccinate, (m). IMP dehydrogenate, and
(n). GMP synthetase.
Other pathway: Salvage Pathway
1. Adenine + PRPP a Adenylate + PPi
2. Hypoxanthine + PRPP b Inosinate + PPi
3. Guanine + PRPP b guanylate + PPi
a. Adenine Phosphoribosyl transferase
b. Hypoxanthine-guanine
phosphoribosyltransferase (HGPRTase)
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Arrangement of Purine Nucleotide
Biosynthesis (Cory, 2006; Berg, Tymoczko and
Stryer, 2002)
• Ribose 5-phosphate  PRPP 
Phosphoribosylamine  1 IMP 
Adenylosuccinate AMP
• 2. IMP Xanthylate GMP
• R 5-F PRPP is inhibited by IMP, AMP, and
GMP
• PRPP Phosphoribosylamine is inhibited by
IMP, AMP, and GMP
• IMP  Adenylosuccinate is inhibited by
AMP
• 1 MP Xanthylate is inhibited by GMP
Pyrimidine Nucleotide Synthesis (Cory,
2006; Elliot and Elliot, 1997; Berg, Tymoczko
and Stryer, 2002; Keggb, 2013)
Here, it is started from Carbamoyl
phosphate to be orotat and afterward to be
Uridylic acid (UMP).
Carbamoyl phosphate + aspartate a
(-Pi) N- Carbamoyl aspartate b (+H+ -H2O)
Dihydroorotate c (+NAD+ -NADH2) Orotat
d (+PRPP –PPi) orotidylate e (+H+ -CO2)
uridylate /UMP.
• The involved enzymes:
a. aspartate transcarbamoylase, b.
Dihydroorotase, c. Dihydroorotate dehydro
genase, d. Orotate phosphoribosyltransferase,
e. orotate Decarboxylase
Interconversion:
UMP + ATP UDP + ADP (UMP kinase)
AMP + ATP 2 ADP (Adenylate kinase)
XDP + YTP XTP + YDP
UDP + UTP UTP + ADP
CTP Synthesis with amination of UTP:
UTP  (+Glutamine +ATP + H2O
–Glutamate –ADP –Pi -2H+) CTP
Arrangement of Purine Nucleotide
Biosynthesis is done by inhibiting the
feedback: CTP inhibits aspartate
transcarbamoylase (ATCase); UMP inhibits
aspartate transcarbamoylase.
Degradation of purine and pyrimidine
nucleotide (Cory, 2006; Berg, Tymczko and
Stryer, 2002, Kegga, 2013, Keggb, 2013).
Nucleic acid a Nucleotide Guanine b
Guanosine c Guanine d Xanthine e Uric
Acid.
• The involved enzymes:
a. nuclease, b. nucleotidase, c. purine
nucleoside phosphorylase, d. guanase
(-NH4+), e. Xanthine oxidase.
Nucleic acid a Adenine nucleotide b
Adenosine c Inosine d Hypoxanthine e
Xanthine f Uric acid.
Adenine nucleotide g IMP h Inosine
• The involved enzyme:
a. nuclease, b. nucleotidase, c. Adenosine
deaminase, d. purine nucleoside
phosphorylase, e. Xanthine oxidase, f.
Xanthine oxidase, g. AMP deaminase, h.
nucleotidase.
Metabolism Disorder (Cory, 2006)
Disorder indicates the existence of a
change either in quantitative or in qualitative
manner. In this part, a number of qualitative
disorders and quantitative disorders will be
discussed.
1. The increasing activity of synthetase PRPP
can cause the increase of the concentration of
intracellular PRPP.
2. The activities of HGPRTase are influenced
in the pathway for de novo synthesis of
purine nucleotides. A. The decrease of
salvage pathway for hypoxanthine and
guanine, B. The decrease of salvage pathway
for hypoxanthine, IMP, and GMP
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3. Deficiency of glucose 6-phosphate can
cause the increase of PRPP concentration
(related to the PRPP amidotransferase).
With the three disorders above, Gout disease
can be emerged. It is remarked through the
high concentrate of uric acid (either in blood
or in urine). The increasing rate of purine
nucleotide synthesis (de novo synthesis)
causes the increase of synthesis followed by
its degradation into uric acid. The medical
treatment through some medicines includes
colchicines, antihyperuricemic agents, and
allopurinol. Allopurinol and the result of its
metabolism, alloxanthine is an effective
xanthine oxidase inhibitor causing the
decrease of uric acid level. Meanwhile, the
medical treatment with Allopurinol can cause
the decrease of the level of uric acid and the
decrease of purine nucleotide synthesis.
4. The absence of HGPRTase protein means
the absence of HGPRTase activities.
This disorder can bring an effect of the
emergence of Lesch-Nyhan syndromes that
include
• Remarked by hyperuricemia
• Causing the neurological problems, one of
which is mental disorder
• The role of HGPRTase has an effect on the
reaction of nucleotide synthesis from
hypoxanthine and guanine.
• The absence of HGPRTase of
Hypoxanthine and guanine has resulted in
the absence of any reaction.
• Salvage causes the increase of PRPP
concentrate and the decrease of IMP or
GMP
• Both cause the increase of de novo
synthesis of purine nucleotide.
• The activity of IMP dehydrogenate in brain
is very low and the absence of HGPRTase
can cause the decrease of the number of
intracellular GTP that in turn cause the
decrease of salvage pathway of guanine.
GTP refers to the candidate of
Tetrahydrobiopterin cofactor essential in
both neurotransmitter synthesis and
protein synthesis.
• The medical treatment with Allopurinol
will decrease the number of uric acid
formation, and releases the problem that
can cause the formation of uric acid
sodium.
• Patient with Lesch-Nyhan is marked with
the decrease of HGPRTase activity, the
absence of salvage pathway of
hypoxanthine and guanine, the dysfunction
of PRPP making the de novo synthesis of
purine nucleotide unstoppable.
• Until recently, no any solution has been
found for solving the neurological
problem. Patients are dead for kidney
damage due to the deposit of uric sodium.
5. The increasing activity of cytosolic
5’-nucleotidase
• The substrates for the enzymes are 5’AMP
or 5’UMP in which the activity can
increase 6 – 10 higher
• This disorder can marked with the slower
improvement, ataxia, seizures, severe
language deficit, hyperactivity, short
attention span, and less social interaction
• The increase of 5’nucleotidase activity can
cause the deficiency of nucleotide  The
medical treatment is done by giving uridine
orally.
6. The disorder of purine nucleoside
degradation
• The disorder can cause the
immunodeficiency:
a. Adenosine deaminase deficiency, also
called ADA deficiency
b. Purine nucleoside phosphorylase
deficiency (PNP-deficiency)
• Substrate for ADA : adenosine and
deoxyadenosine
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• Substrate for PNP: Inosine, Guanosine,
Deoxyinosine, Deoxyguanosine.
• Deficiency of ADA is related to the
immunodeficiency including the function
of cell T and cell B.
• Deficiency of PNP is related to the
immunodeficiency including the function
of cell T.
• Immunodeficiency in concentration of
intracellular dATP and
S-adenosylhomocysteine is very
increasing/large
• Hypothesis:
a. Deficiency ADA  high dATP
concentration inhibits Ribonucleotide
reductase with a consequence of
inhibiting the DNA synthesis.
b. Deoxyadenosine inactivates
S-adenosylhomocysteine hydrolase
making the decrease of
S-adenosylhomocysteine used in the
methylation from base N in RNA and
DNA.
c. The increase of adenosine concentration
leads to the increase of cAMP.
• Enabling the dysfunction of immune
system
• Medical treatment on children with
deficiency of ADA is by blood transfusion,
bone marrow transplant, ADA-PEG, gene
therapy.
• Each of them has weakness
7. The increase of nucleotide degradation
• Nucleotide is from degradation of nucleate
acid originating from the death of cell.
• The medical treatment for cancer patients
with radiation therapy or with
chemotherapy will cause the concentration
of uric acid in blood increase.
• The medical treatment to decrease the
concentration of uric acid with Allopurinol
• The increase of uric acid is due to the
degradation of purine nucleotide resulting
in the increase of uric acid level due to the
degradation of purine nucleotide that
results in xanthine and is catalyzed by
xanthine oxydase resulting in uric acid.
• Allopurinol refers to a compound
inhibiting xanthine oxydase.
8. The increase of purine nucleotide synthesis
on child
• Increasing four times higher than the
normal one
• The increasing uric acid concentration in
urine
• Autism
• The condition of mental introversion is
reflected to egoism and unawareness
9. The disorder of de novo synthesis of
pyrimidine nucleotide
• Characteristic: slow growth, increasing
concentration of orotat acid in urine
• Disorder of Orotat
phosphoribosyltransferase or Orotidine
decarboxylase,
• Combined with synthetase UMP
• Therapy with uridine per oral
• Uridine  UMP  UDP furthermore 
UTP inhibits Carbamoyl phosphate
synthetaseorotat synthesis.
CONCLUSION
By studying the disorder of
metabolism/anabolism/catabolism, it is
important to explain the mechanism of the
disease in order to overcome or conduct a
therapy and its therapy mechanism.
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Abstract
Background. The study of the effect of water fraction of Sambiloto (Andrographis paniculata
Nees) ethanol extract on the number of macrophage, neutrophil, and level of TNF- in the body fluid
of male Wistar rats after Staphylococcus aureus induction.
Methods. Animals were divided into 3 groups, namely: negative control (NC), treatment (T),
and positive control (PC) group. The NC, T and PC groups were administered by 0.9% NaCl, water
fraction of Sambiloto ethanol extract of 40mg/200g BW dose, and ibuprofen of 7.2 mg/200g BW dose,
respectively. The treatment was performed for 7 consecutive days. The number of macrophages,
neutrophils, was identified using light microscope whereas the TNF- level was identified using
ELISA.
Outcome Measured. The number of macrophage, neutrophil, and level of TNF- in the body
fluid of male Wistar rats after Staphylococcus aureus induction.
Results. The number of macrophages in the KC, the T, and the PC groups were 2.33 ± 1.58;
3.80 ± 4.06; and 2.67 ± 1.55 cells, respectively. The number of neutrophils were 0.83 ± 0.33; 0.58 ±
0.32; and 1.33 ± 0.38 cells respective to the KN, T, and PC groups. The level of TNF- were 17.78 ±
11.67; 23.48 ± 15.95; and 27.90 ± 30.54 pg/ml respective to the KN, the T, and PC groups.
Conclusion. This study indicated that water fraction of Sambiloto ethanol extract able to
increase the number of macrophage and TNF- level yet decrease the number of neutrophil in the
body fluids of male Wistar rats after Staphylococcus aureus induction.
Keywords : macrophages, neutrophils, TNF-, Herba Sambiloto, ibuprofen
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INTRODUCTION
Inflammation is a local response to
infection or tissue injury. It may occur as a local,
systemic, acute, and chronic disorder that lead to
the pathologic condition. Inflammatory response
precedence by the activation of cell mediated
immune system. The cells of immune system
respond to the foreign substances that invade the
body by several mechanisms, such as
chemotaxis, in which the immune cells move to
the site of infection, followed by an increase of
vascular permeability, and subsequently changes
of blood osmotic pressure proceed. Those
mechanisms facilitate leucocytes migration to
the site of infection (Abbas et al 2007).
Development of the inflammatory
response plays an important role in initiating
pathological condition. Therapeutic approaches
to reduce the inflammatory response caused (one
of them) by the Staphylococcus aureus need to
be conducted (Baratawidjaja and Rengganis
2012). Medication choice of inflammation may
utilize synthetic drugs and/or natural ingredients.
The long term uses of synthetic drugs may
initiate unwanted effects on the human body.
Therefore, natural ingredients are now becoming
chosen alternatives as a healing therapy of
inflammatory condition. Some examples are the
leaves of Salam (Syzygium polyanthum), herbs of
Sambiloto (Andrographis paniculata Nees.),
leaves of Cassava (Manihot utilissima Pohl),
leaves of Red Betel (Piper crocatum Ruiz &
Pav), leaves of breadfruit (Artocarpus altilis),
and others.
Sambiloto (Andrographis paniculata
Nees) is a natural ingredient which is widely
studied because of its efficacy as
medicine.Sambiloto (AP) herbs have several
active compounds. One of the compounds is
known as Andrographolide which posses anti-
inflammatory activity (Tewari et al 2010).
Previously, it was identified that
Andrographolide in ethanol extract of AP herbs
inhibited inflammation in Wistar rats
(Evacuansiany and Soebiantoro, no date). Other
studies mentioned that AP herbs active as
anti-inflammation by inhibiting the production
of radical oxygen of the neutrophil. Moreover,
AP inhibited macrophage migration, and
production of TNF- and IL-12 (Lin and Chao
2010) in the animal serum that treated with AP
herbs water fraction containing 10%
Andrographolide (Raharjo et al 2009).
Among the previous studies of AP
anti-inflammatory activity, study of AP
especially on phagocytic cells including:
monocyte, macrophage, neutrophil, and
eosinophil have not yet been conducted. We,
therefore, identified the AP anti-inflammatory
activity in male Wistar rats.
The objective of this study is to conduct a
local inflammation by infecting rats with
Staphylococcus aureus and identify the response
of immune system cells that react on the infected
bacteria after an hour. The number of phagocytic
cells, namely macrophages and neutrophils were
measured as parameter. Since the cells will
release cytokines following their activation,
therefore, levels of cytokines (TNF-) also be
counted. TNF- is the main cytokine that is
released during acute inflammation against
bacteria and other microbes by phagocytic cells
(Baratawidjaja and Rengganis 2012). The level
of TNF- measured by ELISA (Enzyme Linked
Immunosorbent Assay) method. This study
identified the effect of AP herb water fraction of
ethanol extract compared to ibuprofen on
alleviating local acute inflammation after
Staphylococcus aureus infection.
METHODS
The apparatuses: distillation equipment,
percolator, rotary evaporator (Buchi Rotavapor
R-124); separating funnel, chamber, ose, tube,
centrifuge apparatus (Hettich Zentrifugen),
Eppendorf, syringe, pipette volume, light
microscope (Olympus); microplate reader
(Thermo Scientific Multiskan-Go, USA).
The materials: Andrographidis Herbs
that were collected and determined in the
Materia Medica, Batu, East Java; ibuprofen;
distilled water; ethanol 96%; ammonia; CHCl3;
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HCl 10% v / v; klorhidrik alcohol; FeCl3; gelatin
solution; Steasny reagent; Na acetate; Na
hydroxide; ether; acetic acid glacial; Mayer
reagent; Dragendorf solution, n-hexane, ethyl
acetate; methanol; butanol, acetic acid;
kuercetin; ; Staphylococcus aureus (ATCC
25923); MSA medium; BaCl2 1%; concentrated
H2SO4; 0.9% NaCl; Giemsa dye; TNF- ELISA
kit (Abcam, USA).
Animal handling
Animal used were 18 male Wistar rats 2 - 3
months of age and approximately 150-200 g of
weight with healthy as well as normal activities.
Prior to use, rats were adapted for a week to the
new environment. The inclusive criteria of
animals were: no symptoms of illness and
uniform body weight. Prior to the experiment,
rats were fasted for 18 hours (Winter in
Hadisoewignyo 2010). Rats were divided into 3
groups of 6 animals. Group I was the negative
control (NC), group II was the AP water fraction
treated (AP), and group III was treated by
ibuprofen (PC).
RESEARCH METHODS
Preparation and Fractionation of AP Crude
Extracts
The study was preceded by maceration of
crude AP powder by 96% ethanol for 24 hours at
room temperature. The obtained extract was
filtered and evaporated with a rotary evaporator.
The condensed extract was dissolved in 50 ml of
methanol:water (7:3). Subsequently, the solution
was separated by adding 100 ml of n-hexane and
shook in a separator flask for 60 minutes. The
formed second layer was separated. The
n-hexane addition was repeated for three times.
The methanol layer was further separated by
ethyl acetate. Ethyl acetate was added to the
water layers and shook in a separator flask for 60
minutes. Then, the formed second layer was
separated. This process was repeated for three
times.
Anti-inflammatory Activity
In order to conduct anti-inflammatory
activity, the rats were injected with
Staphyloccocus aureus (SA). The SA
preparation preceded with the rejuvenation of
SA in MSA medium and incubation at 37°C for
24 hours. The rejuvenated SA, was mixed to
0.9% NaCl. Subsequently, the turbidity of
SA-NaCl suspension was compared to Mc
Farland I, in which contained 3 × 108 cfu/ ml of
bacteria. Before injected to the rats, the
suspension was incubated for 2 hour at 37° C
(Wasito et al 2008).
Rats were allowed to stand for an hour
after SA injection before conducting dissection.
Subsequently, the rats were allowed to stand for
5 minutes after 0.9% NaCl injection. Rats that
were ready for dissection were anesthetized with
ether. Peritoneal fluid was taken from the
abdominal cavity. The peritoneal fluid was
subsequently smeared and fixed by absolute
methanol for 5 minutes. Finally, the fixed
peritoneal fluid was stained with Giemsa for 20
minutes, rinsed and dried. The stained peritoneal
fluid were identified under a light microscope
(400x magnification) and counted for the
number of macrophages (Kusmardi et al 2006).
To study the number of the neutrophiles,
the blood was taken from the heart, then disposed
in a tubes contained EDTA. Prior to
centrifugation, part of the blood was taken and
subjected to be smeared, and stained as the
peritoneal fluid. Subsequently, the stained blood
was identified under light microscope
(magnification of 400x) to count the number of
neutrophil cells. The remaining of the blood was
centrifugated at 2,000 rpm for 20 minutes. After
centrifugation, serum was taken to be stored at
-20° C for measuring the level of of TNF- by
ELISA method (Abcam, 2012).
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No. Parameter
Qualifications
(IHD 1979)
Test results
1 Ashes < 12% 11.13 ± 0.35
2 Water soluble extract

17.03 ± 0.38
3 Ethanol soluble extract
	

13.53 ± 0.10
IHD : Indonesian Health Departemen
Table I Standardisation of AP Herbs
Extract
UV  254 nm UV  366 nm UV visible
Rf Compounds Rf Color Compounds Rf Color Compounds
AP Exstract 0.77 Flavon 0.60 Blue Flavanon 0.56 Yellow Flavanon
0.87 Isoflavon 0.79 Blue Flavanon 0.69 Yellow Flavanon
0.87 Red Isoflavon 0.87 Brown Isoflavon
AP-water Fraction 0.62 Flavanonol 0.6 Grey Flavanonol 0.56 Brown Flavanonol
0.75
Flavon
0.81 Blue
5-deoksiisofl
avon
0.69 Brown Flavanonol
0.87 Isoflavon
Andrografolide
0.81
Andrographolide
0.25 Blue
Andrographo
lide
Table II. Rf of AP Herbs Extract and Water Fraction under UV (254 and 366 nm) and UV Visible
Groups Macropage Neutrophil TNF-
Negative control 2.33 ± 1.58 0.83 ± 0.33 17.7 ± 11.67
AP Herbs 3.80 ± 4.06 0.58 ± 0.32 23.48 ± 15.96
Positive control 2.67 ± 1.54 1.34 ± 0.38 27.90 ± 30.54
AP Herbs: AP Water fraction
Table III. The Number of Macrophage, Neutrophil, and TNF- Leve
Results
Before used, several parameter of AP
water fraction (AP WF) was standardized
including level of ashes, level of water soluble
extract, and level of ethanol soluble extracts
(Table I). The Indonesian Health Department
(1979) qualified that level of AP WF ashes,
water soluble extract, and etanol soluble extract
were less than 12%, more than 18%, and more
than 9.7%, respectively. The levels of crude AP
herbs water-soluble extract (17.03 ± 0.38) were
not reach the qualification, therefore, the study
was continuously undergone subsequent
extraction steps used ethanol as the solvent.
This study used 1 kg of dried AP herbs that
macerated by ethanol. The macerated extract
obtained was 245 g (24.5%). The extract was
subsequently undergone organoleptic test for the
color, taste, and smell parameter. The ethanol
extract of dried AP herbs was dark green in color,
bitter in taste and specific in odor which were
qualified according to the previous mentioned
data (Indonesian Health Departement 1979).
Following the organoleptic test, the
ethanol extract was fractionated extracts by
water. The fractionated extract was then
subjected to Thin Layer Chromatography (TLC)
with butanol: acetic acid: water (3: 1: 1) as
mobile phase. The TLC plate was dotted and
eluated until reacted with ammonium and so
produced a yellowish brown color which was a
specific indication of the presence of flavonoids
(Harborne 1987) (Table II).
Table II showed the results of Rf level of
AP extract and water fraction compared to
Andrographolide. When observed at  254 and
366 nm, the Rf level of AP extracts and water
fractions were different to Andrographolide. It
was predicted due to the flavonoids remained in
both of AP extracts and water fraction, thus the
Andrographolide was not clearly stained. The Rf
following observation under the UV visible
showed no Rf of andrographolide. It was due to
the ammonium vapor was reacted solely to the
flavonoids while Andrographolide is belongs to
the diterpenoid classes (Lin and Chao 2010).
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Note F F table Significancy
Macrophage 0.42 3.59 0.67
Neutrophil 4.85 4.07 0.04
TNF- 0.07 3.34 0.94
Table IV. One Way Anova Analysis (=0,05) of Macrophage, Neutrophil, and TNF- level Between Groups
Groups Compared to Sig. Note
Negative control AP Herbs 0.34 NS
Positive control 0.07 NS
AP Herbs Negative control 0.34 NS
Positive control 0.01 S
Positive control Negative control 0.07 NS
AP Herbs 0.02 S
NS: not significant S: significant AP Herbs: AP Water fraction
Table V. LSD Analysis of the Number of Neutrophil
Table III showed the number of
macrophages which was higher than the negative
and positive control group. It was probably
caused by the injected Staphylococcus aureus
(SA) were produced an exfoliative which was
able to activated macrophages, therefore
macrophages were stimulated to release TNF-,
IL-6 and pyrogenic toxin superantigens that
subsequently induce the activation of T cells and
other macrophages to move to the site of
infection (Hidayani no date). The result
indicated that AP WF treatment may reduce
nitric oxide production and increase macrophage
activity (Guan, et al. 2012). Moreover, the
increased number of macrophages was not
different statistically compared to the negative
control group that may be caused by the AP WF
bacteriostatic and bactericidal activity
(Anonymous 2005) which may encounter SA
following injection, thus prevent the movement
of macrophages to the site of infection. The
number of macrophages in the positive control
group, that contained ibuprofen, was lower than
the AP WF group. This was an indication of less
anti-inflammatory activity conducted by
ibuprofen since approximately 90% of ibuprofen
was bound to protein serum. Therefore, it would
be more difficult for ibuprofen to penetrate to the
cell membrane to produce anti-inflammatory
effects (Wilmana and Gan, 2007).
The number of neutrophil of the AP WF
group was lower compared to the negative and
positive control group which can be explained
due to the antioxidant activity of AP WF that
may suppress the synthesis of nitric oxide (NO)
and thus less NO will be produced and neutrophil
adhesion will be inhibited, consequently
(Ezeamuzie, et al. 2009). In the positive control
group, the number of neutrophil was higher than
the negative control and the AP WF group. This
was explained due to the action of ibuprofen that
affect the biosynthesis of several inflammatory
mediators such as prostaglandins and
leukotrienes (Wilmana and Gan 2007) that
stimulate the increased number of neutrophils
(Baratawidjaja and Rengganis 2012).
The levels of TNF- of the AP WF and the
positive control groups showed higher level than
the negative control group. This is may be caused
by macrophages that activated and released
TNF- into the blood circulation (Abbas, et al.
2007) since TNF- is known as the major
cytokine in the acute inflammatory response to
bacteria and microbes. In acute inflammation
condition, the TNF- and endothelial leukocytes
are working in coordination. Thus, the increased
of macrophages is accompanied by elevated
level of TNF- (Baratawidjaja and Rengganis
2012).
CONCLUSION
Conclusively, this study indicate that AP
WF may increase the number of macrophages in
the peritoneal fluid that had been infected by
Staphylococcus aureus and consequently
increase the level of TNF- in the serum of the
Wistar rats. However, decrease the number of
netrophils in the seum of the Wistar rats.
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Abstract
Background. Rambutan (Nephelium lappaceum L.) has been widely and easy to obtain, and
also recognized by people of Indonesia. As empirically, rambutan leaves used to treat diarrhea, fever,
and black hair. The preclinical studies have shown that rambutan leaf extract has activity as lowering
blood glucose levels (Kusuma, 2008). However, the scientific studies have not found rambutan leaf
safety. To be eligible in the formal health care system, it must meet the requirements of traditional
medicine quality, safety, and efficacy.
Objectives. This study aimed to test the acute toxicity of rambutan leaf extract in mice. The
study followed unidirectional random pattern.
Methods. The study use 25 Swiss Albino male of mice, which is divided into 5 dose groups. The
dose used in the acute toxicity test of rambutan leaf extract are 1, 2, 4; 8 g/kgBBmice and a negative
control group (0.5% CMC-Na) as orally. The inspection do the 24-hour by intensive inspection on the
first 3 hours.
Outcome Measured. The observations made as clinical observations that toxic symptoms
occur, the number of dead mice and biochemical examination of ALT levels, AST, and serum
creatinine. The LD50 calculations performed using the Thompson-Weil.
Results. The results showed toxic symptoms were observed in mice during acute toxicity test
include uncontrollable way, restlessness, passivity motion, no reactivity to stimuli, and sleepy. The
test compound caused a significant increase in ALT and AST levels (p <0.05) at a dose of 8 g/kgBB,
but the test compound did not cause death in test animals.
Conclusion. The test compound can be categorized as "Practice Not Toxic".
Keywords : toxicity, extract, rambutan, Nephelium
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INTRODUCTION
In recent years, due to side effects of
synthetic products, herbal medicine are gaining
popularity in the world, particularly plant drugs
for their primary healthcare. That is documented
that 80% of the words population has faith in
herbal medicine (Dubey et al., 2004). Rambutan
leaf (Nephelium lappaceum L) has been widely
recognized by Indonesia people to treat various
of diseases. As empirically, rambutan leaf has
been used to treat diarrhea, fever and black hair
(Dalimartha, 2004). The preclinical studies have
shown that rambutan leaf extract have
antimicrobial activity, antioxidant, and
antiatheroschlerosis (Mohamed et al, 1994;
Istikharah, 2007; Singhatong et al., 2010).
Another studies have been conducted by
Kusuma (2008) and Manaharan (2012) suggests
that rambutan leaf has activity as lowering blood
glucose in mice. Rambutan leaf has been
suggested as source of potential useful
antidiabetic drugs. However the toxicity of
rambutan leaf has not been extensively studied.
The numerous warnings regarding the potential
toxicity of these therapies is needed for
practitioners to keep abreast of the reported
incidence of hepatotoxicity, nephrotoxic and
cardiotoxic caused by the ingestion of herbal
medicine (Saad et al., 2006). This effort is very
important that could be used rambutan leaf as
standardized herbs that has been tested the
efficacy and the safety.
Objectives
The general objective of this study was to
determine the toxicity level of rambutan leaf
(Nephelium lappceum L) extract in mice.
Spesific objective is to determine the acute
toxicity value (LD50) of rambutan leaf
(Nephelium lappaceum L) extract in mice.
METHODS
Plant Material
Rambutan leaf were collected at Ngluwar
Muntilan, Indonesia and were authenticated at
Pharmacy Biological Laboratory, Islamic
University of Indonesia based on Flora of Java
book (Backer and Van der Brink, 1965).
Powdered leaf of Rambutan (145 g) was
macerated of ethanolic 70% at room temperature
for 1 day and continued was percolated for 3
days. The resulting extract was concentrated to
dryness to obtain a mass of ethanol extract (29.3
g) with the extraction yield of (20.21%).
Animals
The experimental animals used in this
study were 25 Swiss Albino mice of male sexes
each weighing 20-30 g and aged 8-10 weeks
(Tedong, et al., 2007). All animals were
available at Integrated Research and Testing
Laboratories, Gadjah Mada University. The
animals were randomly distributed into five
groups. All animals (mice) were maintained at
constant temperature and humidity.
Acute Toxicity
In order to study any possible toxic effect
or changes in normal behaviour, four groups of 5
mice were used in this experiment. The acute
toxicity of the plant was studied by preparing
four different concentrations of the extract (1.0,
2.0, 4.0, 8.0 g/Kg body weight) respectively was
administered orally, to the animals as a single
dose. The control group was given diluted
solution in water. The symptoms of toxicity such
as motor activity were cheked on the first 3 hours
(Tedong et al., 2007). The animals were
observed for 24 hours and the number of dead
mice was recorded and used in the calculation of
the acute toxicity value (LD50).
Statistical Analysis
Statistical analysis was carried out using
One-Way Analysis of Variance (ANOVA)
continued Kruskal-Willis test. P values of less
than 5% (P <0.05) was considered statistically
significant differences between the groups
(Tedong et al., 2007).
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RESULTS
In this study, there were no mortality
(expressed as LD50) after oral administration of
single doses of rambutan leaf up to 8 g/kg (Table
1). However, the biochemical parameter (ALT,
AST) increased progressively with increasing
dose (Table 2). The reduction of motor activity
(uncontrollable way, restlessness, passivity
motion, no reactivity to stimuli, and sleepy) were
seen since at dose of 1 g/kg up to a dose of 8 g/kg.
DISCUSSION
Acute treatment of the mice with
rambutan leaf extract at doses of 1.0, 2.0, 4.0
g/kg for 24 hours did not affect biochemical
parameters. On the other hand, administration of
rambutan leaf extract at dose of 8 g/kg for 24
hours resulted in significant changes in the levels
of transaminases (ALT, AST), and creatinine.
There were good indicators of liver and kidney
functions (Tedong et al., 2007). It is reasonable
to deduce that the rambutan leaf extract induce
damage to liver and kidneys. The changes in the
biochemical parameter has been studied by
Tedong et al. (2007) and Mohammed et al.
(2012) by histopathological examination of
selected organs showed liver infiltration and
congestion, kidneys' mesangial expansion and
nucleus pycnosis. Histopatological indicated
mild vascular degenerative changes and necroses
to liver and kidney when compared to that of
control group. The change biochemical
parameters of rambutan leaf extract may be
related to its tannin content. Importanly, so many
species which contain tannin have been shown to
display a wide spectrum of toxicological
activities. Diets tannin had deleterious effects on
liver of the rabbits and rats (Obidah et al., 2010;
Fayemi et al., 2011).
The ethanolic rambutan leaf extract (1, 2,
4, 8 g/kg) produced a reduction in spontaneous
motor activity, motor coordination, sleepy and
depressant. Preliminary qualitative chemical
studies of some plants indicated tannin in the
extract suggested that contains some active
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Number
of mice
Dose
of extract g/kg
Number
of mice dead
Percentage
of mice dead
5 0.0 0 0
5 1.0 0 0
5 2.0 0 0
5 4.0 0 0
5 8.0 0 0
Table I. Acute Toxicity of Rambutan leaf (Nephelium lappaceum L) extract in mice
Dose
of extract g/kg
SGPT
(u/l)
SGOT
(u/l)
Kreatinin
(mg/dl)
0.0 56.0 111 0.3
1.0 49.5 93.5 0.2
2.0 49.0 81 0.4
4.0 55.0 105.5 0.3
8.0 122.0 227.0 0.2
Table II. Biochemical Animal Test After 24 hours administration
principles which possess potential
CNS-depressant action, decreased loco-motor
activity, produced muscle relaxation and showed
antianxiety activity (Bhosale et al., 2011; Habib
et al., 2011; Raju et al., 2011).
In this study, there was no lethality
observed for all the tested doses throughout the
24 hours period as well as tannins at
Cinnomomum iners leaves was no lethality
(Mustaffa et al., 2010).
CONCLUSION
On the basis of present study, it can be
concluded that rambutan leaf extract appears to
be free from acute toxicity and relatively safe
within the normal doses. However it is
recommended for the next studies:
a) To determine histologically the acute toxicity
effects of rambutan leaf the internal organs of
mice
b) Acute toxicity test used more various dose
and more obeserved day .
c) Sub-acute and chronic toxicity tests is
planned in order to determine the long-term
effects of the extract.
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IN 2010 AND 2011 BY ATC/DDD METHOD
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Abstract
Background. Hypertension is the most prevalent cardiovascular disease in the world.
Hypertension is now often compelled with Diabetes Mellitus because of changing in life style.
Objectives. This study was aimed to know the description of the use of drugs that includes the
classification of drugs, the most widely used antihypertensive, compliance with the National
Essential Medicines List (DOEN) in 2008, JNC-7 and Hospital Formulary at X Hospital in Bantul
Yogyakarta during 2010 and 2011 using ATC / DDD.
Methods. The study was conducted by descriptive design using retrospective method.
Information about antihypertensive data was obtained from the Installation Inpatient Medical
Records. All the data was then processed to determine the quantity of use of antihypertensives in units
of stay and profiles DDD/100 Drug Utilization (DU 90%), compliance with Hospital Formulary, type
of appropriate to the National Essential Drugs List (DOEN) and JNC 7 Guideline.
Outcome. The purpose of the ATC/DDD system is to serve as a tool for drug utilization
research in order to improve quality of drug use
Results. The results showed that the widely used antihypertensive drugs per 100 bed days in
2010 and 2011 was amlodipin, which were 91,45 and 60,61, respectively. The utilization of
antihypertensive drugs was changed in 2010 and 2011, based on number of antihypertensive drugs
within DU 90% segment. Types of antihypertensive appropriate to the DOEN were captopril,
lisinopril, nifedipine and diuretic were furosemide and spironolacton in 2010, however in 2011 for
the diuretic were furosemide, spironolactone and hydrochlorothiazide. The utility of antihypertensive
drugs which were not appropriate with JNC-7 were valsartane, irbesartane, candesartane
(Antagonist Agiotensine II), amlodipin (CCB) and spironolactone (Antagonist Aldosterone). Some
antihypertensive not appropriate to the Hospital Formulary.
Conclusion.The widely used antihypertensive drug was amlodipin. The utilization of
antihypertensive drugs was changed in 2010 and 2011. Types of antihypertensive appropriate to the
DOEN, however not appropriate to JNC 7 Guideline and the Hospital Formulary.
Key words : antihypertensive drugs, methods of ATC / DDD, DU 90%
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INTRODUCTION
Hypertension is a disease that suffered by
many people in Indonesia and all over the world.
The increasing quality of life brings changes in
individual life pattern. Hypertension with
diabetic will increase cardiovascular disease, it
needs choosing the right medicine. Drug use
evaluation by ATC/DDD methods, which will be
done in X Hospital in Bantul Yogyakarta.The
overall goal of treating hypertension is to reduce
hypertension associated morbidity and mortality.
This study was aimed to know the
description of the use of drugs that includes the
classification of drugs, the most widely used
antihypertensive, compliance with the National
Essential Medicines List (DOEN) in 2008,
JNC-7 and Hospital Formulary at X Hospital in
Bantul Yogyakarta during 2010 and 2011 using
ATC / DDD.
METHODS
The study was conducted by descriptive
design using retrospective method. Information
about antihypertensive data was obtained from
the Installation Inpatient Medical Records. All
the data was then processed to determine the
quantity of use of antihypertensives in units of
stay and profiles DDD/100, Drug Utilization
(DU 90%), type of appropriate to the National
Essential Drugs List (DOEN), compliance with
JNC 7 Guideline and Hospital Formulary.
RESULTS AND DISCUSSION
The results of this study showed in these tables
below:
1. Appropriate to the National Essential
Drugs List (DOEN)
From Table I, there were 5 drugs included
in the DU 90%, the rank order decreased of the
utilization antihypertensive drug was
Amlodipin, Furosemide, Irbesartan, Captopril
and Valksartan, percent utility of 26,90, 21,61,
20,32, 14,15 and 5,99, respectively.
From Table II, there were 4 drugs included
in the DU 90%, the rank order decreased of the
utilization antihypertensive drug was
Amlodipin, Irbesartan, Captopril and
Furosemide, percent utility of 30.24, 23.16,
19.06, and 15.96, respectively.
Amlodipin was the highest percentage to
use because it is effecacious in improving left
ventricular function in hypertension and
ischemic heart (Alam et al., 2009; Pimenta,
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Generic name DDD/100days % of used Cumulative percentage Segment
Amlodipine 91,45 26.90 26.90 DU 90%
Furosemide 73.45 21.61 48.51
Irbesartan 69.09 20.32 68.83
Captopril 48.09 14.15 82.98
Valsartan 20.36 5.99 88.97
Ramipril 15.27 4.49 93.46 10%
Nifedipin 6.18 1.76 95.22
Candesartan 6 1.76 96.98
Bisoprolol 3.64 1.07 98.05
Diltiazem 3.51 1.03 99.08
Lisinopril 1.27 0.38 99.49
Spironolactone 1.21 0.36 99.87
Nicardipin 0.44 0,13 100
Table I. The value of DDD/100days and DU90% in 2010
2009). In JNC 7, for compelling indication
diabetes, the first choice is ACEI (Angiotensin
Coverting Enzyme Inhibitor) or ARB
(Angiotensin Receptor Blocker), because both
tend to renoprotective effect, then used diuretic
thiazide and the last BB (Beta Blocker) or CCB
(Calcium Channel Blocker) (JNC 7, 2003).
Based on this study, it can be concluded that the
utilization of antihypertensive drugs was
changed in 2010 and 2011, based on number of
antihypertensive drugs within DU 90% segment.
2. The use of antihypertensive compliance
a. Antihypertensive drugs utilization
Antihypertensive drugs utilization at X
Hospital Bantul Yogyakarta were appropriate to
the DOEN; were, captopril, lisinopril, nifedipin,
furosemide, spironolactone (Depkes, 2008) and
captopril, lisinopril, nifedipin, furosemide,
hydrochlorothiazide and spironolacton (Depkes,
2011).
b. JNC 7
From Table III, it appeared that there were
two classes of antihypertensive drugs were not
appropriate with JNC 7, namely Ca antagonist
and Antagonist aldosteron. Both
dihydropyridine and non-dihydropyridine
calcium channel blockers (CCBs) effective in
lowering blood pressure, but only
non-dihydropyridine CCBs (diltiazem and
verapamil) which may reduce over proteinuria
and improve glomerular size selectivity in
patient with nephropathy due to type 2 diabetes
(Giuseppe et al., 2002.; Burney and Bakris,
2010).
The precence of diabetic nephropathy
should influence the choice of an ACE inhibitors
versus an ARB. Amlodipin an Calcium Channel
Blocker (CCB) (dihydropyridine) are second
line to ACEI or ARB. Data are emerging for
combined therapy (Dipiro, 2008).
In cardiac disease cases, for blood
pressure management: a given lower goal than
for essential hypertension, often requires more
antihypertensive medications. Hypertension
regimen should include an ACE inhibitor or
ARB (Dipiro, 2008). Thiazide diuretics, ARB,
and ACE inhibitors may be the best first-line
although other agents are usually necessary and
goals may not be achieved even with three or
four agents. Aggressive blood pressure control
may be the most important factor in preventing
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Generic name DDD/100days % of use Cumulative percentage Segment
Amlodipin 60.61 30.24 30.24 DU 90%
Irbesartan 46.42 23.16 53.40
Captopril 38.20 19.06 72.46
Furosemide 31.97 15.96 88.42
Diltiazem 7.87 3.93 92.35 10%
Imidapril 4.24 2.11 94.46
Valsartan 2.88 1.44 95.90
HCT 2.12 1.06 96.96
Lisinopril 1.82 0.91 97.87
Nifedipin 1.82 0.91 98.78
Bisoprolol 1 0.50 99.28
Spironolactone 0.76 0.38 99.66
Ramipril 0.61 0.30 99.96
Nicardipin 0.13 0.06 100
Table II. The value of DDD/100days and DU 90% in 2011
adverse outcomes in patients with type 2 diabetes
(Vijan and Hayward, 2003).
It was recommended to publish standard
of therapy as a guideline for the physicians in
prescribing.
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Types ATC code Name/ dosage form
Appropriate to JNC 7
2010 2011
ACEI C09AA01 Captopril/ tablet
 
Farmoten/ tablet

C09AA03 Interpril/ tablet
 
Noperten/ tablet

CA09AA05 Hyperil /tablet
 
Cardace/ tablet

C09AA16 Tanapress/ tablet

Loop diuretic C03CA01 Furosemide/ injeksi
 
Furosemide tablet
 
Farsix/ injection

Farsix/ tablet
 
Lasix/ injection
 
Lasix / tablet

Thiazide
Diuretic
CA03AA03 HCT/ tablet

ß blocker C07AB07 Bisoprolol/ tablet
 
Angiotensin
Antagonist II
C08CA01 Valsartan/ tablet

C09CA03 Valsartan tablet

C09CA04 Irtan/ tablet
 
Irvask/ tablet
 
Iritensa/ tablet
 
C09CA06 Blopress/ tablet

-
Ca Antagonist C08CA01 Intervask/ tablet - -
Amlodipine/ tab - -
Cardisan/ tablet - -
Divask/ tablet - -
Aldosteron
Antagonist
C03DA01 Spironolakctone/ tablet - -
CCB C08CA04 Perdipine/ tablet
 
C08CA05 Nifedipine/ tablet
 
C08DB01 Diltiazem/ tablet
 
Herbesser/ tablet
 
Herbesser CD/ tablet

Table III. Antihipertensive compare to JNC 7 in 2010 and 2011
c. Hospital Formulary
From Table IV, showed that
antihypertensive drugs compared to Hospital
Formulary were not appropriate namely
Cardace, Noperten, Irtan, Intervask in 2010, not
appropriate was 16%. Also showed that
antihypertensive drugs compared to Hospital
Formulary were not appropriate namely
Tanapress, Irtan, Intervask in 2010, not
appropriate was 10%.
In accordance with results it was
suggested to review Hospital Formulary in order
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Types ATC code Name/ dosage form
Apropiate to hospital formulary
2010 2011
ACEI C09AA01 Captopril /tablet
 
Farmoten /tablet

C09AA03 Interpril /tablet
 
Noperten/ tablet -
C09AA05 Hyperil /tablet
 
Cardace /tablet -
C09AA16 Tanapress/tablet -
Loop diuretic C03CA01 Furosemide /injection
 
Furosemide/ tablet
 
Farsix /injection

Farsix/ tablet
 
Lasix/ injction
 
Lasix/ tablet

Thiazide diuretic CA03AA03 HCT/tablet

ß bloker C07AB07 Bisoprolol/ tablet
 
Angiotensin II
antagonist
C08CA01 Valsartan/ tablet

C09CA03 Valsartan/tablet

C09CA04 Irtan /tablet - -
Irvask/ tablet
 
Iritensa/ tablet
 
C09CA06 Blopress/ tablet

Ca Antagonist C08CA01 Intervask/ tablet - -
Amlodipine/ tablet
 
Cardisan/ tablet
 
Divask/ tablet
 
Aldosterone
antagonist
C03DA01 Spironolactone/ tablet
 
CCB C08CA04 Perdipin/ tablet
 
C08CA05 Nifedipin/ tablet
 
C08DB01 Diltiazem/ tablet
 
Herbesser/ tablet
 
Herbesser CD/ tablet

Table IV. Antihipertensive compared to Hospital Formulary in 2010 and 2011
to make drug inventory more effective and
efficient.
CONCLUSION
The general results lead to conclusion that
the widely used antihypertensive drug was
amlodipin. The utilization of antihypertensive
drugs was changed in 2010 and 2011. Types of
antihypertensive appropriate to the DOEN,
however were not appropriate to the Hospital
Formulary and JNC 7 Guideline.
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UTILIZATION ANALYSIS OF ANTIBIOTICS FOR TYPHOID
FEVER IN HOSPITALIZED PATIENT IN 2010 AND 2011 AT X
HOSPITAL IN BANTUL WITH ATC/DDDMETHOD
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Abstract
Backgroud. Typhoid fever caused by Salmonella typhi is still endemic disease in Indonesia.
Antibioticis a group of drugs often used today to treat typhoid fever.
Objectives. The purpose of this study was to determine the pattern of antibiotic use for
treatment of typhoid fever in hospitalized patients, the suitability of the use of antibiotics were
comparedto the hospital formulary and DOEN.Futher more the change of antibiotic usage patterns
of typhoid fever in hospitalized patients in 2010 and 2011 atX hospital in Bantulwas seen from the
DU90%.
Method. The study design was descriptive.We used ATC/DDD as means to increase the quality
use of medicines with an average maintenance dose per day was estimated for the adult indication.
The study subjects were all data of antibiotics used for treatment of typhoid fever in adult patients
hospitalized at X hospiltal in Bantul in 2010 and 2011were obtained in medical record.
Outcame :This study of ultization medicine was to increase quality use of antibiotic for
thypoid fever treatment especialy for hospitalized patient.
Results. The antibiotic use for treatment of typhoid fever in hospitalized patientsin 2010 were
ceftriaxone (45,83 DDD/100days), cefrozil (19,87 DDD/100days), ciprofloxacin (11,28
DDD/100days), cefixime (6,73 DDD/100days), levofloxacin (3,21 DDD/100days), ceftazidime (1,60
DDD/100days), cefadroxil (0,64 DDD/100days). In 2011 antibioticsuse for treatment of typhoid
fever in hospitalized patients were ceftriaxone (96,79 DDD/100days), ciprofloxacin (15,51
DDD/100days), levofloxacin (12,82 DDD/100days), cefotaxime (11,54 DDD/100days),
azithromycin (3,21 DDD/100days), ceftazidime (2,56 DDD/100days), metronidazol (2,56
DDD/100days), cefadroxil (1,28 DDD/100days), ofloxacin (1,28 DDD/100days).
Conclusions. Most antibiotic used in 2010 and 2011 was ceftriaxone. In 2010 the appropriate
antibiotic usedaccording to hospital formulary were 89% while in 2011,reached into 100%. The use
of antibiotics that also existed in DOEN were cefriaxone and ciprofloxacin. There were two different
antibiotic used in 2010 and 2011, which were levofloxacin and cefotaxim (2010) and cefprozil and
cefixime (2011). However ceftriaxone and ciprofloxacin still used in 2010 and 2011.
Keywords : Typhoid Fever, Antibiotics, ATC/DDD, DU90%.
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INTRODUCTION
Typhoid fever still remains a health
problem in developing countries, mostly in the
tropics such as in Indonesia, where the case
number increase in the season and at the
beginning of the rainy season. Incidence number
of typhoid fever in Indonesia on average 900,000
cases / year with a mortality rate more than
20,000 which 91% of cases occur in age of 3 -19
years.
In the last four decades, typhoid fever has
become a global health problem. The incidence
number of this disease estimated reach 13 – 17
million cases worldwide with a mortality rate of
up to 600,000 people per year. Endemic typhoid
fever spread across various continents, from
Asia, Africa, South America, the Caribbean, to
Oceania. The majority of cases (80%) are found
in developing countries, such as Bangladesh,
Laos, Nepal, Pakistan, India, Vietnam, and
including Indonesia.
Antibioticis a group of drugs often used
today to treat typhoid fever. Selection of
appropriate antibiotics in patients with typhoid
fever is very important, because it can prevent
complications and reduce mortality.
OBJECTIVES
The purpose of this study was to
determine the pattern of antibiotic use for
treatment of typhoid fever in hospitalized
patients, the suitability of the use of antibiotics
were compared to the hospital formulary and
DOEN.Futher more the change of antibiotic
usage patterns of typhoid fever in hospitalized
patients in 2010 and 2011 atX hospital in
Bantulwas seen from the DU90%.
METHODS
The study design was descriptive.We used
ATC/DDD as means to increase the quality use
of medicines with an average maintenance dose
per day was estimated for the adult indication.
The study subjects were all data of antibiotics
used for treatment of typhoid fever in adult
patients hospitalized at X hospiltal in Bantul in
2010 and 2011 were obtained in medical record.
Outcame
We hope this study of utilization drug can
increase knowledge about application methods
ATC / DDD in the study of drug use.Provide an
overview of the suitability of antibiotic therapy
in the treatment of typhoid in the hospital
formulary and its concept.Provide an overview
of information regarding the use of antibiotics in
the treatment of typhoid patients was particularly
useful for pharmacy in pharmaceutical
management.This study was expected to be the
input for other researchers on the analysis of
ATC / DDD.Also the important was to increase
the quality use of antibiotic for thypoid fever
treatment especialy for hospitalized patient.
RESULTS
Types and quantity of antibiotics for
thypiod fever treatment of adult patients
hospitalized were obtained from medical record
card X hospital in Bantul. Rute of administration
of antibioticmustobtain concernbecause in the
ATC / DDD there are some medications with
different values DDD between oral and
parenteral administration.To determine the
quantity use of antibiotic in thypiod fever
patients using DDD based WHO Collaborating
Center for Stasistic Methodology in 2010.
Number of inpatient days in this study were
obtained from the number of days of
hospitalization entire adult typhoid fever patients
for one year. Adult typhoid fever patients
hospitalized at X hospital in Bantul in 2010 was
468 days whereas in 2011 was 468 days. Data on
the number of stay is needed to calculate the use
of antibiotics in the inpatient unit of DDD/100.
Antibiotic utilization data shown on the
table below.
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From the table I and the table II it can be
seen that thehighest antibiotic use for patients
with typhoid fever are 3rdcephalosporins, namely
ceftriaxone, this may be due to sefalosforin have
high stability against gram-negative and
gram-positive thus more effective in killing the
bacteria that causes typhoid fever (Tan and
Rahardja, 2007).
In small-scale study (Sutardi 2010),
ceftriaxone was more effective when given only
2-3 days although recurrence rates with
short-term treatment can not always be
measured.Some studies show the superiority of
ceftriaxone as antibiotic selected for typhoid
fever.
In 2010 antibiotics were included in
segment DU90% is ceftriaxone, cefrozil,
cefixime and ciprofloxacin. Whereas in 2011 the
antibiotics included in the segment DU90% is
ceftriaxone, cefotaxime, ciprofloxacin and
levofloxacin. There was a difference when
compared segment DU90% use of antibiotics in
the treatment of typhoid fever between 2010 and
2011. The use of levofloxacin increased in 2011,
this shows a shift in the use of antibiotic class
quinolones is more widely used for the treatment
of typhoid fever than the epidemic in 2010.
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Generic name DDD/100 bed days % use Cumulative Segment
Ceftriaxone 45.83 51.40 51.40 DU 90%
Cefrozil 19.87 22.29 73.69
Ciprofloxacin 11.28 12.65 86.34
Cefixime 6.73 7.55 93.99
Levofloxacin 3.21 3.60 97.59 10%
Ceftazidime 1.60 1.79 99.37
Cefadroxil 0.64 0.73 100
Table I. Antibiotic use for typhoid fever in 2010
Generic name DDD/100 bed days % use C umulative Segment
Ceftriaxone 96,79 65,60 65,60 DU 90%
Ciprofloxacin 15,51 10,51 76,11
Levofloxacin 12,82 8,69 84,80
Cefotaxime 11,54 7,82 92,62
Azithromycin 3,21 2,18 94,80 10 %
Ceftazidime 2,56 1,73 96,53
Metronidazole 2,56 1,73 98,26
Cefadroxil 1,28 0,87 99,13
Ofloxacin 1,28 0,87 100
Table II. Antibiotic use for typhoid fever in 2011
From the table III, use of antibiotics in
2010, there was 1 (11%) types of antibiotics that
are not included in the hospital formulary, which
Fixiphar that is the trademark of cefixime. While
in 2011 (table IV) all of antibiotics (100%)
which is used to treat typhoid fever was
accordance with the hospital formulary. It has a
good indication, means the doctor has complied
with the hospital formulary and ensure patients
obtain prescription drugs.
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Types Patent name Generic name Rute Hospital formulary DOEN
1stcephalosporins - Cefadroxil Oral

3rdcephalosporins - Cefotaxime Parenteral

- Ceftazidime Parenteral

- Ceftriaxone Parenteral
 
Elpicef Ceftriaxone Parenteral
 
Strarxon Ceftriaxone Parenteral
 
Quinolon - Ofloxacin Oral

- Ciprofloxacin Oral dan parenteral
  (oral)
Cetafloxo Cetafloxo Parenteral

- Levofloxacin Oral

Cravox Levofloxacin Parenteral

Cravit Levofloxacin Oral

Makrolide - Azithromycin Oral

Imidazole - Metronidazole Parenteral
 
= appropiate , - = not appropiate
Table IV. Antibiotic use in 2011 compare to hospital formulary and DOEN
Types
Patent
name
Generic name Rute Hospital formulary DOEN
1stcephalosporins - Cefadroxil Oral

2ndcephalosporins Lizor Cefrozil Oral

3rdcephalosporins - Ceftriaxone Parenteral
 
Zidifec Ceftriaxone Parenteral
 
Elpicef Ceftriaxone Parenteral

- Cefixime Oral

Fixiphar Cefixime Oral -
Maxpro Cefixime Oral

Quinolon - Ciprofloxacin Oral dan parenteral
  (oral)
Cravox Levofloxacin Oral

 = appropiate , - = not appropiate
Table III. Antibiotic use in 2010 compare to hospital formulary and DOEN
DOEN was an essential drug list which
was very important for supply drug in Indonesia.
DOEN were structured to ensure the availability
of drugs that seem to be more equal and
accessible by the public. Antibiotics used for
typhoid fever in hospitalized adult patients at X
hospital in Bantul in 2010 and 2011 were
ceftriaxone and ciprofloxacin contained in the
list.
CONCLUSIONS
Most antibiotic used in 2010 and 2011 was
ceftriaxone. In 2010 the appropriate antibiotic
used according to hospital formulary were 89%
while in 2011, reached into 100%. The use of
antibiotics that also existed in DOEN were
cefriaxone and ciprofloxacin. There were two
different antibiotic used in 2010 and 2011, which
were levofloxacin and cefotaxim (2010) and
cefprozil and cefixime (2011). However
ceftriaxone and ciprofloxacin still used in 2010
and 2011.
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Abstract
Background. Actinomycetes is a group of microorganisms producing many kinds of active
compounds. One of them is antibiotic.
Objective. The purpose of this study is to determine the potency of Actinomycetes (isolate
T34)as antibioticproducer against Staphylococcus aureus and to know the spot of thin layer
chromatography showing activity as antibiotic based on bioautography test.
Methods. The Actinomycetes (isolate T34) was taken from rhizosphere of Tin (Ficuscarica L.)
plant which is grown on Starch Nitrate Agarmedium.The broth culture was prepared using 25 ml of
Starch Nitrate Brothmedium having been givena quarter plate of the Actinomycetes isolate and then
shaken for 5days.After that, the25 µl of actinomycetesbroth culture was put on the well of plate that
had been planted with S. aureus and incubated at 37 °C for 24 hours to measure the inhibition zone
diameter.The active broth culture was extracted using ethyl acetate solvent. Components in the
extract were analyzed by thin layer chromatography and followed by bioautography process on
Mueller Hinton medium having been cultivated with S. aureus for 30 min and incubated for 24 hours.
Outcome measured. Inhibition zone diameter against S.aureusgrowth.
Results. The results shows that the Actinomycetes (isolate T 34) can inhibit S. aureus with 24,2
mm of inhibition zone diameter. The result of the thin layer chromatography using silica gel GF254
as stationary phase and n-hexane : ethyl acetate (2:1) as mobile phase shows that one spot appears by
UV 254 detection and two spots appear by UV 366. One of spots with Rf of 0.56 shows activity as
antibiotic.
Conclusion. Actinomycetes (isolate T 34)produces antibiotic against S. aureus.
Keyword : Actinomycetes, bioautography, Staphylococcus aureus
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INTRODUCTION
Infectious disease is one of the problems
in the health sector that continues to grow.
Infection can be transmitted from one person to
another, from animals to humans. Some
microorganisms that cause infections such as
bacterial, viral, rickettsial, fungal, and protozoal
(Gibson, 1996). One of them is Staphylococcus
aureus. S. aureus can cause infections in humans
both intissues and organs and cause typical signs
such asinflammation, necrosis and abscess
formation. Infection can bemild to the
skinfurunclestobe afatalpiemia (Nelnick, 1994).
This bacterium was resistant to most antibiotics.
MRSA (methicillin resistant S. aureus) were
obtained from the hospital environment and
occurs due to the exposure of a semisynthetic
penicillin and methicillin (Enright, 2003).
Sulistyani et al. (2009) have isolated bacteria
from hospital sewage and found a lot of
resistance occurs in S. aureus primarily on
Betalaktam and erythromycin derivatives.
With increasing misuses of antibiotics, the
serious problems of antibiotic resistance are
developing at an alarming rate. Hence, intensive
search for new antibiotics has become
imperative worldwide (Haqueet al., 1995;
Oskayet al., 2004; Parungaoet al., 2007)
especially from actinomyceteswhich is known as
the greatest source of antibiotics (Ogumnwonyi,
2010).Actinomycetes is best known for their
ability to produce antibiotics and Gram-positive
bacteria consists of a group of unicellular
microorganisms branched. They produce
mycelium branches consisting of two types: the
substrate mycelium and aerial mycelium
(Sivakumar, 2010).
The purpose of this study was to find out
whether actinomycetes (isolate T34) were
isolated from the rhizosphere of plants Tin
(Ficuscarica L.) has potential as an antibiotic
against S. aureus. In addition, to determine
which patches of thin-layer chromatography
shows potential as an antibiotic against S.
aureus.
MATERIALS AND METHOD
A. Materials
Materials used in this study are sterile
distilled water, the bacteria S. aureus, Nitrate
Starch Agar (SNA) medium, Starch Nitrate
Broth (SNB), Mueller Hinton agar (MH), Brain
Heart Infusion, Standard McFarland, nystatin
100 mg / mL, glycerol 20% v / v, n-hexane, ethyl
acetate, silica gel GF254.
B. Procedure
1. Turification of the Actinomycetes (isolate
T34).
Actinomycetes isolates cultured from the
rhizosphere samples of tin plant (F.carica L.)
was done by streaking on SNA plate (Rante,
2010), then incubated at 28 ° C for ± 10 days.
Observation of morphological characteristics
of Actinomycetes (isolate T34) was carried
out toward the pigment, aerial mycelium and
vegetative mycelium.
2. Preparation of S.aureus culture
Several colonies of bacteria growing on agar
taken 24 hours,were suspended in 1 mL of
BHI broth and incubated 4-8 hours at 37 ° C.
The suspension was added with sterile
distilled water up to a certain turbidity in
accordance with the standard concentration
of 108 CFU/mLof bacteria.
3. The activity test of antibiotic-producing
Actinomycetes with the wells diffusion
method a quarter plate of isolates included in
25 mL of Starch Nitrate Broth (SNB)
medium, incubated at room temperature for 5
days with the shaking. To obtain the cell-free
supernatant, the culture broth was centrifuged
at 8000 rpm for 10 min. The culture of
S.aureus with concentration of 108 CFU/mL
was spread using sterile cotton on Mueller
Hinton Agar (MH), and then made three wells
with diameter of 5 mm and each well
wasloaded with 25 L of the clear
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supernatant. The dishes were preincubated at
4.0 °C for 2 hours to allow uniform diffusion
into the agar, then followed by incubation for
24 hours at 37 º C, then measured the
diameter of inhibition zone (Oskay, 2009).
4. Extraction of secondary metabolites the broth
cultures were centrifuged, then the
supernatant was extracted with ethyl acetate
using a ratio of 1:1 (Sulistiyani, 2006). The
extraction was conducted twice (Rante,
2010), strongly shaken and then left in place
to form ethyl acetate phase and liquid phase.
Phases were separated and the ethyl acetate
phase was evaporated in a hood.
5. Thin-layer chromatography and
bioautography
Bioautography test was conducted to
determine spotting potentially active
compounds as antibiotics by using thin layer
chromatography. Bioautography was done
with spotting of extract on silica gel GF254
plate, then developed with the appropriate
mobile phase for the separation of
compounds contained in the fraction. The
mobile used phase in this study is n-hexane:
ethyl acetate (2:1). Chromatogram plate were
placed on a agar surface that has been spread
with S. aureus suspension, chromatograms
were left clinging on agar for 30 minutes so
that the active compound diffuses into the
agar medium, then carefully removed and the
dish was incubated for 24 hours.
Furthermore, it can be seen patches that
provide clear zone (zone of inhibition) that
suggest the potential as antibiotics.
RESULTS AND DISCUSSION
1. Isolation and Purification Actinomycetes
The actinomycetes (isolate T34) was
isolated from the rhizosphere of Tin plant
(Ficuscarica L.) were obtained from Gergunung
(North Klaten). The rhizosphere taken was
located 5-10 cm below the soil surface. In the
process of isolation, the rhizosphere samples
were dried at room temperature until completely
dry or no water content again, evidenced by the
absence of water absorbed by the paper after
tested with put on paper. Then the dried soil
samples was carried propagules sediment
extraction by making serial dilutions 10-1-10-5,
after that, each dilution was inoculated on media
SNA to do selective isolation and purification
Actinomycetes.
Actinomycetes are soil bacteria that have a
slower growth rate when compared with other
soil bacteria that isolation requires a technique
that allows maximum bacteria isolated
Actinomycetes. Some methods used are:
pre-treatment by heating the sample at a
temperature of 50 º C for 10 minutes to prevent
the growth of other bacteria, the addition of
nystatin 100 mg/mL in order to prevent the
growth of fungus and selective use of media that
can eliminate the growth of other bacteria.
Selective media were used to grow
Actinomycetes in this research that Starch
Nitrate Agar (SNA), this medium can be used by
microorganisms including Actinomycetes as a
source of nitrogen is a nutrient for growing
Actinomycetes. Thus, the purification of
Actinomycetes is done by planting the alleged
Actinomycetes isolates on solid medium SNA.
In the process of isolation of
Actinomycetes from tin plant rhizosphere (F.
carica L.), Actinomycetes colonies grow slowly,
showing the consistency of powdered, firmly
attached to the surface of the agar and have a
different appearance from each other (Rao,
1994), including a variety of different colors
both the vegetative mycelium and aerial
mycelium (Holt et al., 1994).
2. The morphology of colonies of
Actinomycetes (isolate T34)
Gram staining is one way for microscopic
identification of Actinomycetes.
Actinomycetesisa group of Gram-positive
bacteria. Gram staining was conducted to
determine whether the classification of
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Gram-positive microorganisms (results are
purple) or Gram negative (red result). The Gram
staining result showed that the Actinomycetes
(isolate T34) has the characteristics of class
members Actinomycetes that have branched
mycelium and purple. Picture of the Gram
staining result of Actinomycetes (isolate T34) is
presented in Figure 1.
Figure 1 shows there sult of painting is
colored purple orare Gram positive, so that it can
be concluded that these isolates have
characteristics of Actinomycetes asgram-
positive bacteria. The observation of the
morphological characteristics of Actinomycetes
(isolate T34) suggests that it has the
characteristics of class members of
Actinomycetes that their colonies are initially
relativelys mooth surface but then form a kind of
wovenaerial my celium which can manifest
granularnya like powder, velvet, produces
pigments that cause colors inaerial my celium
and vegetative my celium. This Actinomycetes
isolate has moss green color aerial my celium
and brownish green color vegetative my celium.
3. The Potency of Actinomycetes (Isolate
T34) as Producer Antibiotics against S.
aureus
In this study, the activity test of
Actinomycetes as antibiotics producers use S.
aureus as test bacteria. The method used to test
the activity of antibiotic-producing
Actinomycetes is wells diffusion method. The
wells diffusion method is done by making a hole
in the solid medium that had been inoculated
with bacteria. The number and location of holes
were adapted to the purpose of the study, then the
hole is filled with the sample to be tested. After
the incubation, bacterial growth was observed to
determine the presence or absence of inhibition
areas around wells. The advantage of this
method is much easier to measure the diameter of
inhibition zone formed by the activity of the
compounds in the test sample that is not only on
the surface of the nutrient agar but also get to the
bottom (Kusmayati and Agustini, 2007). The
figure of potential test results of Actinomycetes
(isolate T34) as producers of antibiotics against
S. aureus is presented in Figure 2.
The strength of antibiotics to inhibit the
growth of bacteria is classified by Davis Stout as
very strong (inhibitory area 20 mm or more),
strong (inhibitory region 10-20 mm), medium
(5-10 mm inhibitory region) and weak (local
inhibitory 5 mm or less) (Sulistiyani, 2006). At
the test potential of Actinomycetes (isolate T34)
activity as a producer of antibiotics, it is done
three planting replication in a liquid culture
plate. The first major inhibitory diameter was
23.7 mm, the diameter of the second inhibitory
diameter is 24.5 and the third inhibitory diameter
was 24.5 mm. Based on this measurement, it is
known that the Actinomycetes (isolate T34) has
the potential to produce antibiotic categorized
very strong inhibitory activity in inhibiting the
growth of S.aureus (average diameter of 24.2
mm barrier region (not including the 5 mm
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A B
Figure 1. The morphology of Actinomycetes (Isolate
T34), microscopic (A) and the colony (B)
Figure 2.The Activityof Actinomycetes (Isolate T34)
against S. aureus
diameter wells)) with SD values of 0.46 and
1.9% CV values.
4. Thin Layer Chromatography (TLC) and
Bioautography
Before doing Bioautography-TLC, it is
previously carried out the extraction of
metabolite from the culture broth of
Actinomycetes (isolate T34) using ethyl
acetate.The metabolite extractyield results are
0.102% w/v. Antibacterial activity of this extract
then is tested by bioautography, the method
previously performed TLC to separate the good
patches for gettinge specially active spot as an
antibacterial. Bioautography-TLC testinthis
studyaims to determine the spots of TLC which
shows activity as antibiotics against
S.aureus.The TLC mobile phase used in this
study are n-hexane: ethyl acetate in the ratio of
2:1 and the stationary phase is silica gel GF254.
The TLC results shows the presence of one spot
that appears on the detection using a 254 nm UV
light and two spot on observations with the 366
nm UV light. The bioautography results indicate
a potential spot as the antibiotic on the spot with
Rf of 0.56. The figure of bioautography
chromatogram and test results are presented in
Figure 3.
Bioautography method is done
bychromatography plate is placed on the surface
of the media, so that the compounds that have
been separated into spots on the chromatogram
will be able to diffuse into the agar medium.
Chromatography plate affixed for about
30minutes on solid medium previously spread
S.aureus.During attachment, the content of the
compounds contained in the chromatogram spots
diffuses into the agar medium. If the sepatches
have potential as antibiotics,it will form a clear
zone, which is an inhibitory zone of the
chromatogram spot of metabolites extract of
Actinomycetes(isolate T34) culture broth
against S.aureus.
CONCLUSION
Based on theresults ofthe studyit can be
concludedthat:
1. The Actinomycetes (isolate T34) produce
antibiotics that inhibitsthe growth of
Staphylococcu saureus.
2. The TLC with mobile phase of n-hexane:
ethyl acetate in the ratio of 2:1 and the
stationary phase of silicagel GF254 shows
that the TLC patch of ethyl acetate extract
of Actinomycetes (isolate T34) culture
broth containing antibiotics against
S.aureus has Rf of 0.56.
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Figure 3. The chromatogram of ethyl acetate extractof
Actinomycetes (isolate T34) culture brothon detection
with 254 nm UV light (A), UV 366 nm (B) and the results
of the TLC bioautography against S. aureus (C)
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Abstract
Background. Antioxidants have an important role to health, for example is the implications of
the oxidation reaction in the body that can lead to cardiovascular disease, cancer, and aging. Natural
antioxidants in plants can come from one or more components such as in Henna leaf, its compound
can inhibit the oxidation reaction.
Objective. The aims of this study is to determine the chemical compound groups in Henna leaf
extract that have antioxidant activity.
Methods. Powder of Henna leaf were macerated and frequently shaken with various of solvent
such as water, methanol and chloroform for an hour. The filtrate of each extract was made up to
concentration 10% w/v. Five microliter of each extract were spotted on silica gel F254 plates and
eluated with mixture of chloroform: methanol 17:3 v/v as mobile phase. Spots that appear on the
chromatogram were identified for flavonoids, naphthoquinone, polyphenols and also were sprayed
with DPPH reagent to determine the spot that active as antioxidants.
Outcome measured. The active antioxidant Henna leaf constituents were detected as yellowish
white spots produced by bleaching of DPPH by resolved bands on the TLC plates. All spot that have
active antioxidant were identified by Rf value, characteristics spot under UV254, UV365, and spot
colour after sprayed with specific spray reagent.
Result. The results of chromatogram showed that water extract, methanol extract and
chloroform extract have antioxidant activity and were identified as flavonoids, naphthoquinone and
polyphenols group. Potential antioxidant from the lowest respectively were chloroform extracts,
water extract and methanol extract. Methanol extract have 4 spots, water extract have 3 spots and
chloroform extract only have 1 spot were detected have antioxidant activity.
Conclusion. Methanolic extract of Henna leaf had the greatest antioxidant activity than water
or chloroform extract. The active compounds as antioxidant were flavonoids, naphthoquinones and
polyphenols group.
Keyword : Lawsonia inermis L, antioxidant, DPPH, TLC.
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INTRODUCTION
Antioxidants have an important role to
health, for example the implications of the
oxidation reaction in the body that can lead to
cardiovascular disease, cancer, and aging
(Nelson et al., 2003). Some synthetic antioxidant
such as BHA and BHT are carcinogent and
potentially toxic. Previous studies indicated that
a high intake of antioxidants was positively
associated with the reduced risk of coronary
heart diseases and ageing related diseases (Flora,
2007; Valko et al., 2007). Indonesia has a fairly
extensive tropical forests and biodiversity, both
flora and fauna. One of the plants with the
potential to be developed as antioxidant is henna
(Lawsonia inermis L.). Natural antioxidants,
such as in henna leaves, can inhibit the oxidation
reaction.
L. Inermis L. have many biological
activities besides used as a dye. Water and
methanol extracts of the henna leaves have a high
potential as an antioxidant and can
simultaneously inhibit oxidative cell toxicity of
MDA-MB-435S and pBR322 DNA induced Cr
(VI) (Guha et al, 2009). The antioxidant activity
of the methanol extract is higher than the water
extract. This compares with total phenolic
compounds extracted with methanol greater than
the water extract of 2.56 mg / g and 1.45 mg / g
calculated as tannins with Folin-Ciocalteu
method (Hosein & Zinab, 2007). Henna plant
have broad antimicrobial activity including as
antibacterial, antiviral, antimycotic and
antiparasitic (Babu and Subhasree, 2009).
Chloroform extract can inhibit the growth of
Malassezia in concentrations of 3 and 4 (v / v%),
methanol extract at 0.25 and 3 (v / v%), while the
water extract at 0.25 and 0.5 (v / v%) ( Berenji,
et.al., 2010). Based on the description above, so
in this experiment were used various of solvent
such as water, ethanol and chloroform for henna
leaves powders extraction to produce extract that
have antioxidant activity. So the results of this
study can be used as a reference for the
preparation of henna extracts with high
antioxidant activity.
MATERIALS AND METHODS
1. General
Silica gel 60 F254 TLC plates (Merck,
Germany) were used for TLC bioautography
analysis. 1,1-Diphenyl-2-picrylhydrazyl radical
(DPPH_) purchased from Sigma-Aldrich
(Steinheim, Germany). All solvents used for
chromatography were pro analytical grade and
extraction solvent used pharmaceutical grade.
2. Plant Materials
Leaves of L. inermis L. was collected from
Yogyakarta province, Indonesia, in April 2012,
and authenticated in Biology Phaculty of Ahmad
Dahlan University, Yogyakarta, Indonesia.
3. Preparation of Henna Leaves Powder
Fresh free disease henna leaves was
collected from Celeban Baru, UmbulHarjo,
Yogyakarta then washed with running water and
drained. The leaves material was then dried in
oven at temperature 50oC for 2 day until
completely dry or easily crushed by hands. Dried
leaves were powder by mechanicaly.
4. Preparation of water, methanol, and
chloroform extract from henna leaves.
Five hundred milligrams of henna leaf
powder was macerated using 5 ml of a suitable
solvent while shaken for 1 h. The filtrate
obtained by filtration using filter paper then
volume was made to 5.0 ml by adding
appropriate solvent.
5. Preparation of standard solution
Standard solution was made 0.1% w/v
concentration in methanol.
6. Thin Layer Chromatography of
Bioautographic Antioxidant Assays
A set of four plates of silica gel 60 F254
were used one plate for detection of
bioautographic antioxidant assay and three
another plates for detection of flavonoids,
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polyphenols and naphthoquinones groups in
each extract. Five µl 20% w/v of water, MeOH,
and chloroform extract, were applied on TLC
plate 1 and also 5.0 µl of naphthoquinone
(lawsone) standard solution. On TLC plate 2 and
3 was used 5.0 µl of quercetine as standard
solution. On TLC plate 4 was used lawsone and
quercetine as standard solution. The plates were
then developed with chloroform-MeOH (17:3,
v/v) (Zainab, 2012). The dried TLC plates 1-4
were inspected under UV light (254 nm and 366
nm). TLC plate 1 was visualization with 5%
KOH methanolic for naphthoquinone
identification. TLC plate 2 was visualization
with 1% AlCl3 for flavonoids identification.
TLC plate 3 was visualization with 1% FeCl3 for
polyphenol identification. TLC plate 4 was
sprayed with 0.05% DPPH solution in methanol
and allowed to stand for 30 minutes at room
temperature. Spots which active compound as an
antioxidant will be detected as a yellowish white
spot with a purple background. All spots that
have antioxidant activity were recorded the Rf
values, characteristic of the spots under UV and
given a score. Quercetin and lawsone were used
as a positive control, and blank TLC plate was
taken as negative control (Kannan et al, 2010).
RESULTS AND DISCUSSION
1. Determination plant
Determination was performed at Faculty
of Biology, University of Ahmad Dahlan,
Yogyakarta. The Results of determination is: 1b
- 2b - 3b - 4b - 12b - 13b - 14b - 17b - 18b - 19b -
20b - 21b - 22b - 23b - 30b - 31a - 32a - 33a - 34a -
35b - 37b - 38b - 39b - 41b - 42b - 44b - 45b - 46a
- 50a - 51b - 53b - 54b - 56a - 57b - 58b - 59b -
72B - 73b - 74a - 75b - 76a - 77a - 78b - 103A -
104b - 106b - 107b - 186b - 287b - 288b - 289a -
290b - 291a - 292b - 293a - Lythraceae - 1a - 2a -
Lawsonia inermis L. (Backer, 1965).
Based on the result of determination, it can
be seen that the plant will be determined and used
in this study is correct species of Lawsonia
inermis L.
2. Preparation of henna leaves powder
The Henna leaf was taken on April 2012 in
Celeban Baru, Umbulharjo, Yogyakarta. The
main material is taken from a certain place
designed to avoid variations in the chemical
constituents of plants. If the plants are taken from
different places, then the influence of climatic
and environmental conditions can lead to
variations of active compounds in plants.
The dried leaves was powdered with
blender and then sieved with sieve flour to get
uniform powder size. The powder size was
influence the effectivity of solvent contact with
the powder, more small powder more effective
so the active substance more extracted to the
solvent. From 316.0 g of henna fresh leaves
obtained 98.6 g of dried henna leaves, so the
obtained yield was 31.20%. Dried henna leaf
powder then was measured by graphimetric
method and obtained 3.45% value of lost on
drying.
3. Phytochemical Screening with Thin Layer
Chromatography
3.1. The results of TLC screening for
naphthoquinone identification
Identification of naphthoquinone groups
compounds in water, methanol and chloroform
extract was done by TLC with silica gel F254 as
stationary phase and mixture of chloroform:
methanol (17:3) v/v as mobile phase. The results
of TLC test can be seen in Table I. All the spots
of naphthoquinone showed quenching in
UV-254 nm. After sprayed with 10% methanolic
KOH reagent, naphthoquinone showed red
fluorescence in UV-366 nm and red to red-brown
in visible light (Wagner and Bladt, 1996).
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The chromatogram results of
naphthoquinone identification showed that
water, methanol and chloroform extract
contained of naphthoquinone groups. The water
extract showed 2 spots at Rf 0.09 and 0.19,
methanol extract showed 4 spots at Rf 0.05, 0.09;
0.19, 0.39 and chloroform extracts showed 2
spots at Rf 0.19; 0.39 which is detected as
naphthoquinone groups.
3.2. The result of TLC screening for
flavonoids identification
Identification of flavonoids groups
compounds in water, methanol and chloroform
extract was done by TLC with silica gel F254 as
stationary phase and mixture of chloroform:
methanol (17:3) v/v as mobile phase. The results
of TLC test can be seen in Table II. All the spots
of flavonoids on the chromatogram shows
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No
Rf value Detector
Naphtho-
quinoneWater
Extract
MeOH
Extract
CHCl3
Extract
UV254 UV366 Vis + KOH
1 - 0,05 - Q orange red orange +
2 0,09 0,09 - Q orange red orange +
3 - 0,14 - Q yellow yellow -
4 0,19 0,19 0,19 Q orange red orange +
5 0,23 0,23 - Q blue yellow -
6 - 0,26 - Q - - -
7 - 0,39 0,39 Q orange red orange +
8 - 0,47 0,47 Q blue yellow -
9 - - 0,66 Q blue yellow -
Rf standard of lawsone : 0,19 Q orange red orange +
Note:
Q = Quenching
Table I. Result of thin layer chromatography of naphthoquinone identification
No
Rf value Detector
FlavonoidsWater
Extract
MeOH
Extract
CHCl3
Extract
UV254 UV366 Vis + AlCl3
1 - 0,05 - Q orange - -
2 0,09 0,09 - Q orange - -
3 - 0,14 - Q yellow yellow +
4 0,19 0,19 0,19 Q orange - -
5 0,23 0,23 - Q blue yellow +
6 - 0,26 - Q - - -
7 - 0,39 0,39 Q orange - -
8 - 0,47 0,47 Q blue yellow +
9 - - 0,66 Q blue yellow +
Rf Quercetin Standard: 0,25 Q yellow yellow +
Note:
Q : Quenching
Table II. Result of thin layer chromatography of flavonoids identification
queching under UV-254 nm light. Depending on
the type of flavonoids structure, flavonoid spots
will show yellow, green-yellow, green, blue,
dark violet, orange or red fluorescence under
UV-366 nm and turn yellow after sprayed with
citroborat or AlCl3 reagent in visible light
(Wagner and Bladt, 1996; Markham, 1988).
The results of chromatogram showed that
water, methanol and chloroform extract
contained of flavonoid groups. Water extract had
one spot Rf 0.23, methanol extract had three
spots at Rf 0.14; 0.23; 0.47 and chloroform
extracts had two spots at Rf 0.47; 0.66 were
detected as flavonoids groups.
3.3. The result of TLC screening for
polyphenol identification
Identification of class of polyphenolic
compounds content in water extract, methanol
and chloroform was done by TLC with silica gel
F254 stationary phase and mobile phase mixture
of chloroform: methanol (17:3) v / v. TLC test
results can be seen in Table III.
All the spots on the chromatogram shows
the outage polyphenols under UV-254 nm.
Depending on the type of structure of
polyphenols, spots of polyphenols can
fluorescence or not under UV-366 nm and
blue-black or green-black after being sprayed
with FeCl3 reagent under visible light (Wagner
and Bladt, 1996; Markham, 1988).
The results of polyphenolic identification
on water, methanol and chloroform extract are
shown in Table III. All of extract contained
polyphenols group. The water extract had three
spots Rf 0.09; 0.19 and 0.23 that detected as
polyphenol. Methanolic extracts had seven spots
that detected as polyphenols at Rf 0.05, 0.09;
0.14; 0.19, 0.23; 0.39 and 0.47. Chloroform
extracts had four spots were detected as
polyphenols at Rf 0.19, 0.39; 0.47 and 0.66.
3.4. The Results of Bioautografi Antioxidant
Henna Leaves
Thin-layer chromatography bioauto-
graphy antioxidant was used to rapidly detect
chemical components in the extract that have
antioxidant activity. This method components
that have antioxidant activity with the ability to
capture free radicals DPPH marked as yellowish
white spots with purple background (Gu, et al.,
2009). Capture reactions of free radicals by
antioxidant compounds can be seen in Figure 1.
Results of thin-layer chromatography detection
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No
Rf value Detector
PolyphenolWater
Extract
MeOH
Extract
CHCl3
Extract
UV254 UV366 Vis + AlCl3
1 - 0,05 - Q orange grey +
2 0,09 0,09 - Q orange grey +
3 - 0,14 - Q yellow grey +
4 0,19 0,19 0,19 Q orange grey +
5 0,23 0,23 - Q blue grey +
6 - 0,26 - Q - - -
7 - 0,39 0,39 Q orange grey +
8 - 0,47 0,47 Q blue green +
9 - - 0,66 Q blue green +
Rf standar Quercetin : 0,25 Q yellow grey +
Note
Q : Quenching
Table III. Result of thin layer chromatography of polyphenol identification
of antioxidant compounds can be seen in Table
IV.
Table IV showed that the water, methanol
and chloroform extract contained an active
component as an antioxidant. In the water
extracts was detected 3 spots that active as an
antioxidant. There were 2 spots that identified as
naphthoquinone with Rf 0.09 and 0.19 and 1
spots detected as flavonoids with Rf 0.23. In the
methanol extracts was detected 4 spots that
active antioxidant. There were 2 spots with Rf
0.05, 0.09 detected as naphthoquinone and 2
spots were detected as flavonoids with Rf 0.19
and 0.23. In the chloroform extract was detected
only 1 spot that has antioxidant activity at Rf
0.19 and was detected as naphthoquinone.
Compared among of the three extracts the
components of methanol extract have greates of
antioxidant activity with the highest intensity of
the yellow color. Results of other studies also
showed that the water extract and methanol
extract of henna leaves has great potential as an
antioxidant and can simultaneously inhibit
oxidative cell toxicity of MDA-MB-435S and
pBR322 DNA induced Cr (VI). This compares
with total phenolic compounds extracted with
methanol greater than the water extract of 2.56
mg / g and 1.45 mg / g of tannins equivalen with
Folin-Ciocalteu method (Guha et al, 2009;
Hosein & Zinab, 2007). So that the methanol
extract was more potent as an antioxidant than
the water and chloroform extract.
CONCLUSION
In general water, methanol and
chloroform extract of henna leaves had
antioxidant activity and were identified as
flavonoids, naphthoquinone and polyphenols
groups. The potency of antioxidant from the
lowest respectively were chloroform extracts,
water extract and methanol extract. Methanol
extract have 4 spots, water extract have 3 spots
and chloroform extract only have 1 spot were
detected have antioxidant activity. Our finding
suggested that methanolic extract of henna
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Figure 1. DPPH free radical capture reaction by an
antioxidant compounds
(Gu, et al., 2009)
No
Rf value
Vis + DPPHWater
Extract
MeOH
Extract
CHCl3
Extract
1 - 0,05 - yellow
2 0,09 0,09 - yellow
3 - 0,14 - -
4 0,19 0,19 0,19 yellow
5 0,23 0,23 - yellow
6 - 0,26 - -
7 - 0,39 0,39 -
8 - 0,47 0,47 -
9 - - 0,66 -
Spots active
antioxidant
3 spots 4 spots 1 spot
Score +++ ++++ +
Table IV. Result of thin layer chromatography of antioxidant identification
leaves more suitable to used as further research
for antioxidant activity.
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Abstract
Background. The use of liposom in drug delivery system have been developed rapidly in
order to increase terapeutics effect of anticancer.
Objective. This research was aimed to find an optimal condition of thymoquinon liposom
formulation which have a good characteristic of liposom i.e. liposom size, polidispersibility index
(PI), and potential zeta, which can increase a terapeutics effect.
Methods. The formulation method of thymoquinon liposom was Mozafari methode which had
been modified. In this research the concentration of phospholipid and thymoquinon had been
optimized. Characterization of liposom used the Particle Sizer Analysis (PSA) for determination the
size of liposom and polidispersibility index, Zeta Sizer Analysis for determination the potential zeta of
liposom, and Transmition Electron Microscopy (TEM) for describe the morphology of liposom.
Outcome measured. liposom size, polidispersibility index (PI), and potential zeta
Results. The result showed that the formulation of thymoquinon liposom had 80,8 nm in
liposom size (a good liposom have 10-100 nm in size), 0,348 in polidispersibility index (PI) (a good PI
is under 0,5), and -15,34 in potential zeta (its related to the liposom stability). From the TEM analysis
could be seen the morphology of thymoquinon liposom.
Conclusion. From this result could be conclude that thymoquinon liposom has a good
characteristic so it can be developed as a potent anticancer agent.
Keywords thymoquinon, liposom, nano-carrier, anticancer
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INTRODUCTION
Liposomes have long been recognized as
drug delivery vehicle for cancer therapy (Khan,
2010; Khan et al., 2008; Wang et al., 2008; Allen
and Cullis, 2004). They can accommodate both
hydrophilic and hydrophobic drugs by storing
them either in their internal aqueous core or their
phospholipid bilayer, respectively. Liposomes
are generated from phospholipids, that makes
them an ideal candidates for drug delivery
systems because they are nontoxic,
biocompatible, biodegradable and
nonimunogenic (Wang et al., 2009; Washington
et al., 2001). Liposomal treatment has been
shown capability to reduce some of the
traditional side effects associated with
chemotherapy when compared to
unencapsulated drugs. An important physical
aspect associated with the clinical successes of
liposomese-based drugs is the size of the
nanocarrier (Ian MacLachlan, 2007).
Thymoquinon is the main bioactive
component of the volatile oil of the black seed
(Nigella sativa, Linn). Previous studies reported
that thymoquinone exhibited inhibitory effects
on cell proliferation of many types of cancer cell
lines and can induce cells apoptosis
(Gali-Muhtasib et al., 2006; Yi et al., 2008;
Ivankovic, 2006; El-Mahdy, 2005).
Cancer cell can effluxs the drug or another
substances which entered to it, so the maximum
therapy cannot be achieved, but nanoparticle can
entered to the cancer cells easily (Yuan et al.,
2010). To solve this problem, preparation of
nanocarrier as drug delivery system have been
developed. In this research thymoquinon as an
active ingredient had been formulated to
nanoliposomes which have good characteristic
i.e. liposomes size, polidispersibility index (PI),
and potential zeta, which can increase a
terapeutics effect as anticancer. The formulation
method of thymoquinon liposomes was
Mozafari methode which had been modified. In
this research the concentration of phospholipid
and thymoquinon had been optimized.
METHODS
1. Thymoquinon Nanoliposomes
Formulation (Mozafari et al., 2008)
Formula optimization had been done with
two factor were optimized, phosphatidilcholine
concentration (9,5 mg/mL and 19,5 mg/mL) and
thymoquinon concentration (5 mg/mL dan 10
mg/mL). Formula 1 (F1) with 9,5 mg/mL
fosfatidilkolin and 5 mg/mL thymoquinon, and
Formula 3 (F3) with 19,5 mg/mL fosfatidilkolin
and 10 mg/mL thymoquinon. The characteristic
of liposomes thymoquinon had been measured,
that were the size of liposomes, polidispersibility
index, potensial zeta, and morphological of
thymoquinon liposomes.
Lipid phase had been made with mixture
the soya phosphatidilcholine with cholesterol
1:1, on the hotplate stirrer (e.g. RET basic
IKAMAG 1 Safety Control, IKA), the speed was
1000 rpm, and the temperature was 40oC during
45-60 minutes, under the nitrogen circulation.
Then glyserol was be added (the final
concentration of glycerol was 3% v/v).
Thymoquinon was be added after the
temperature was decrease, and the condition was
under the nitrogen circulation until 1 hour to get
a stabil nanoliposomes.
2. Characterization of Thymoquinon
Nanoliposomes (Wang et al., 2009)
a. Measurement of liposomes size and
liposomes size distribution
(polidispersibility index) used the
Particle Size Analyzer (PSA) and for
measured the potential zeta was used
Nano Series ZS Zetasizer (Malvern
Instruments Ltd, Worcestershire, UK)
b. Determination the liposomes morphology
used the negative staining Transmission
Electron Microscopy (TEM).
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RESULT AND DISCUSION
The result showed that the 1 Formula (F1)
had 175 nm in liposomes size, with 0,356 in
polidispersibility index, and the potential zeta
was -12,58. The liposomes size distribution can
be seen in figure 1.
Formula 3 (F3) showed that the liposomes
size was 80,8 nm, polidispersibility index was
0,348, and potential zeta was -15,34. The
liposomes size distribution can be seen in figure
2.
The comparation between F1 and F3
showed that liposomes size of F3 was smaller
than F1, that is 80,8 nm (< 100 nm), so F1 was
better to be developed as anticancer than F3.
Liposomes with 10-100 nm in size have better to
be accumulated in cancer cell. In fact, previous
studies have shown that liposomes which have
size over from 100 nm are removed fast from
circulation. These systems remain in circulation
long enough such that they can be accumulated
within tumor tissue at levels great enough to have
the intended cytotoxic effect. An important
physical aspect associated with the clinical
successes of liposomes-based drugs is the overall
size of the nanocarrier (Wang et al.,2009 ;
Zauner et al.,2001).
Polydispersibility index (PI) describe the
size distribution of liposomes. PI < 0,5 is
called good, liposomes size distribution is
homogeneous. Besides that the potential zeta is
an important factor because its related with
liposomes stability. The higher of potential zeta
(negative or positive) showed the better stability
of liposom (Couvreur et al., 2002; Parida, 2011).
From the TEM determination we can see
the result in figure 3 and 4.
From the figure above, we can see the
morphologic of the thymoquinon liposomes, its
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Figure 1. Liposomes size distribution for F1
Figure 2. Liposomes size distribution for F3
Figure 3. Result from F1 TEM determination
Figure 4. Result from F3 TEM determination
described the lamellarities of liposomes, and the
drug can be entrapped into the liposomes.
Conclusion
From the formula optimization between
F1 and F3, it could be concluded that F3 is the
better formula than F1, because F3 has smaller
size of liposomes (80,8 nm) than F1 (175 nm),
and the potential zeta of F3 (-15,34) is more
negative than F1 (-12,58), so thymoquinon
liposomes of F3 can be developed as a good
anticancer which has capability to increase the
anticancer activity.
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Abstract
Background. Propranolol is a -blocker agent with low oral bioavailability (15-23%) so that
transdermal route can be used as alternative drug delivery.
Objective. This study was purposed to know the influence of VCO (Virgin coconut Oil) to the
propranolol release rate in cream base preparation.
Methods. Cold cream base in various conentrasion of VCO, i.e 0%(F0), 14%(F1), 28%(F2),
42% (F3) contained 7% propranolol HCl were tested their dissolution using dissolution tester
(paddle shaped stirrer). Acetat buffer solution 0,01 M pH 5 was used as medium, the temperature was
set up at 36°C, stiring rate was controlled at 100 rpm. The parameter of this study was DE
(dissolution efficiency) value.
Outcome measured. Dissolution Efficiency value (DE30)
Results. The result showed that DE30 value (in %) of F0, F1, F2, and F3 were 4,73x10
-3±0,53
x10-3; 6,41 x10-3±0,63 x10-3; 9,18 x10-3±1,78 x10-3; 12,65 x10-3±2,08 x10-3 respectively.
Conclusion. It can be concluded that VCO increase propranolol dissolution significantly
(p<0,05) and the optimum VCO concentration as cold cream base was 42% with DE30 propranolol
value 267% compare with control formula.
Keywords : Propanolol , VCO (Virgin Coconut Oil), Dissolution, Cream, Cold Cream.
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INTRODUCTION
Propranolol is an unselective ?-antagonist
with low oral bioavailability (15-23%)
(Katzung, 2001), so that it is needed to develope
an alternative delivery. Transdermal delivery
can be choiced, because of its adventages, i.e. (1)
it is convenient because of non invasive, (2) it
can be used by patient as self delivery, (3) it can
be design as one daily dose or less frequent, and
(4) the plasma level can be maintened at constant
value because of its zero order kinetic delivery
(intra venous infusion like kinetics) (Nugroho,
2005).
There are many kinds of dosage form used
transdermally. Cold cream is suitable dosage
form to deliver propranolol transdermally
because it is lipophyl, while propranolol is
hidrophyl. This contradictive propertiescan
enforce propranolol release from its base and
difuse through the skin.
The dissolution is the first step of
absorbtion, and it makes available the drug to be
absorbed. This process is releasing the drug
from the cream base on the interphase of the
cream and thin film water on the skin. Since the
drug on this interphase was releasing, the drug
concentration on this interphase was below than
in the bulk phase, and the diffusion from bulk
phase to this interphase will be happened
simultanously (Martin et al, 1993).
In the cold cream dosage form, oil is
needed as disperse medium. In this research,
VCO (Virgin Coconut Oil) was used. VCO
contains 92% saturated fatty acid, composed of
48% - 53% lauric acid, 1.5% - 2.5% oleic acid,
and anothers, i.e. caprilic acid and capric acid
(Syah, 2005). Oleic acid and lauric acid enhance
the rate of permeation of estradiol, progesteron,
acyclovir, 5-fluorouracyl, salicilic acid (Niazy,
1991), and piroxicam (Santoyo and Pygartua,
2000) through the skin. It is hoped that
propranolol cold cream has a good dissolution
and permeation properties. In this research,
dissolution properties was observed.
MATERIAL AND METHOD
Material
Pharmaceutical grade of propranolol HCl
was purchased from PT. Indofarma,
Jakarta.VCO (Virgin Coconut Oil)is Vinuto®
produced by Wira Husada Yogyakarta was
purcahsed from Apotek Nurani, Godean,
Yogyakarta. As base materials were used
pharmaceutical grade of cera alba, cetacium,
olive oil, and aquadest.The acetic buffer pH 5,
0,01 M (made from E Merk analytical grade
glacial acetic acid and acetic sodium) was used
as dissolution medium. The dissolution
observation was performed using using paddle
stirrer DissolutionTester(Erweka DT600) as
shown in figure 1. The cream was filled in the
diffusion cell and covered by stretched
cellophane membrane. The propranolol
concentration was measured using
Spectrophotometer UV-Vis (Shimadzu 1700).
Method
Propranolol Coldcream Formulation
The propranolol coldcream composition
was listed in table I. Cera alba and cetacium
were melted in water steamer, than olive oil and
VCO were added and mixed in mortir porcelen.
Propranolol HCl was dissolved in warm water
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Figure 1. Erweka Dissolution Tester,A: chamber
dissolution medium, B: Paddle, C: space betwen paddle
and dissolution cell,D:Dissolution cell, E:
Thermometer,F: sampling line.
and added to the oil phase. The strong blending
will homogenize this coldcream.
Propranolol Coldcream Physical
Characteristic Observation
Before dissolution observation, the
physical characteristics of propranolol
coldcream were determine, including
spreadability, adhesiveness, water protection,
and its pH.
Propranolol Coldcream Dissolution
Observation
The propranolol coldcream was filled in
cilindric diffusion cell (2 cm in diameter and 0,4
cm height). The cellophane was swollen by
soaking in aquadest for 30 minutes, than put on
the diffusion cell to cover the coldcream. This
cell was put in Erweka Dissolution Tester, the
paddle was moved down, and stirred 100 rpm.
The themperature was maintened in 37°C ±
0,5°C. The dissolution was began by filling the
dissolutin chamber with acetic buffer pH 5, 0,01
M. The aliquot 5,0 ml of dissolution samples
were wthdrawn in various minute: 0, 5, 10, 15,
20, 25, 30, 60, 90, and 120. The propranolol
concentration in these samples were determined
using spektrofotometer UV-Vis (Anggraeni et
al., 2012). The propranolol HCl solution (40
µg/ml) in 0,01 M acetic buffer pH 5 was scanned
its absorbance at 200 – 300 nm to identify its
maximum wavelength. The same solution, in
various concentration of propranolol HCl (1 –
100 ìg/ml), was determined its absorbance at
maximum wavelength to construct calibration
curve.
RESULT AND DISCUSION
Propranolol Spectrum
Propranolol Calibration Curve
The calibration curve was needed to
calculate the concentration of propranolol. The
absorbance of propranolol HCl solution in
various concentration was recorded in 288 nm
based on the maximum wavelength shown in
figure 2. The linear curve and its
regresion-correlation between absorbance and
concentration was shown in figure 3. This
callibration curve has a high corellation since
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Material
Concentration in coldcream (%)
F0 F1 F2 F3
Propranolol HCl 7 7 7 7
VCO - 14 28 42
Olive oil 56 42 28 14
Cera Alba 12 12 12 12
Cetaceum 12,5 12,5 12,5 12,5
Aquadest 14 14 14 14
Table I. The propranolol coldcream formulation
Figure 2. The spectrum of propranolol HCl 40 g/ml in
0,01 M acetic buffer pH 5. It is shown () that this
solution has maximum wavelength at 288 nm.
rcalculated (0,993) is higher than rtable for 12 degree
of freedom (0,532) and can be used to calculated
the propranolol concentration.
Physical Characteristics of Propranolol
Coldcream
Physical characteristic of cream support
patien convenient and delivery of the drug to and
through the skin. This coldcream characteristics
were listed in table II. The VCO has less
consistency than olive oil, so that the higher the
VCO concentration the higher the spreadability,
and the cream is more easy to use. The
adhesiveness of these coldcream, insures the
enought contact time betwen cream and skin to
deliver propranolol. This coldcream is w/o
emulsion base, so that it can resiste the water
difusion. It is the adventage of coldcream,
because of its capability to increase the skin
hidration. The skin hidration enforce the skin
fluidity and enhance the drug permeability.
Propranolol Coldcream Dissolution
Observation
Propranolol coldcream dissolution make
available the propranolol on moleculer size in
water layer of skin. Based on Fick's Law,
concentration is the driving force of simple
diffusion process. Enhancing the rate of
dissolution make the higher concentration of
propranolol available to be absorbed, so that the
rate of absorbtion will be increase. In this
research, the dissolution of coldcream tested
using Paddle Dissolution Tester, and the datas
were shown in figure 4.
It is shown in figure 3 that the dissolution
profile is affected by VCO concentration in the
coldcream formula. The higher the
concentration of VCO, the better the dissolution
profile, and from the value of standard deviation,
it can be predicted that their differences are
significant. In formulas 1, 2, and 3, some olive
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Figure 3. The calibration curve of propranolol has a linear
regression y = 0,011x + 0,019.
Formula Spreadability (cm
2
)
Adhesiveness
(minutes)
Protection (for 5
minutes)
pH
F0 3,1 >15 able to protect about 5
F1 5,9 >15 able to protect about 5
F2 6,8 >15 able to protect about 5
F3 10,2 >15 able to protect about 5
Table II. Physical characteristics of propranolol coldcream
Figure 4. Dissolution profile of propranolol coldcream in
average from 5 replication. The standard deviation (SD)
was shown by É symbol.
oil was repleaced by some VCO increase
respectively. VCO has saturated fatty acid
(92%) (Syah, 2005) more than olive oil. Since
the saturated fatty acid is more lipophilic than
unsaturated fatty acid, the oil with higher
containing of fatty acid will be more lipophilic,
and the hidrofilic drug, including propranolol
HCl, will be released more rapidly. The other
reason is the spreadability of coldcream. It is
shown in table 2 that formulas with VCO have
the higher value of spreadability. This phisical
characteristic is linear with coldcream fluidity,
and the fluidity is linear with diffusion coeffisien
(D). From the Fick’s equation (Martin et al,
1993), it can be evaluated that the diffusion will
be easier in an unviscous matterial.
The disolution parameter can be
calculated from its dissolution profile. There are
many kind of dissolution parameters, including
DE (dissolution efficiency), tx% (time necessary
to release x % of drug), and txmin (percent drug
released in x minute) (Costa and Lobo, 2001).
The DEx parameter is a ratio between area under
curve of dissolution profile for x minute and area
of rectangule shaped by times of x minute
dissolution time and amount of drug in tested
pharmaceitical dosage form (Khan, 1975). The
parameter txmin is the simplest expression and
frequently used by pharmacopies (i.e. t45=80%).
But this expression is powerless if aplicate in
semisolid dosage forms dissolution test using
cell diffusion which are the mass of dosage forms
introduced in medium can be varieted, because
only some of the dosage form contact with
dissolution medium in a constant area. In this
research we introduced new definition of t45 minute
in semisolid dosage form as the drug disolved in
45 minutes dissolution test in a cm2 area of
dosage form-medium contact. The value of DE30
and t45 minute of propranolol were shown in table
III.
Statistical analysis (Anova test followed
by Tukey HSD) showed that there are no
significant differences in DE30 and t45 minute
between formula 1 and control (formula 0), but
the formula 2 and 3 showed the significant higher
value in DE30 and t45 minute compare with control
(F1).
CONCLUTION
The VCO (Virgin Coconut Oil) can be
used as base material for propranolol coldcream
instead of olive oil. VCO containing propranolol
coldcream has the better dissolution
characteristics and spreadability compare with
olive oil alone, but they have the same
characteristic in adhesiveness, water protection,
and pH.
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Abstract
Background. Free radicals cause cell`s damage in the body which manifestate as disease. The
increase prevalence of degeneratife diseases caused by free radicals in Indonesia has motivated
scientists to explore natural antioxidant compounds. Sirsak (Annona muricata L) is one of plant used
as anticonvulsant, antioxidant, and anticancer.
Objective. This study was purposed to investigate antioxidant activity of ethanolic extract of
Annona muricata L
Methods. This research comprised ethanolic extract of Sirsak leaves using maceration method
and antioxidant in vitro examintation used 2,5; 5; 10; 20; and 40 ug/mL of DPPH. The method used
for antioxidant assessment was true ability of antioxidant to capture DPPH.
Outcome measured. ES50 of DPPH technique
Results. The ES50 result of ethanolic extract on Sirsak leaves was 22.23 ± 0,64 µg/mL
Key words : Annona muricata, DPPH, antioxidant
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INTRODUCTION
The diseases caused by ffree radical
comprise the degeneratife illness, early aging
and the general inflammation. Free radicals able
to interfere the healthy cell`s nucleus then
initatite mutation wich transform the cell into
tumour cell or cancer (Thompson, 2004). Apart
from that, free radical damages blood vessel wall
because it creates inflammation which finally
resulted in the coronary heart disease. It also
causes the hypertension illness, stroke and
diabetes mellitus (Adeyemi et al., 2008).
Sirsak (Annona muricata L) is one of the
plants that is used for detoksication, antioksidan
and anti-cancer. The scientific data about the in
vitro and in vivo anti-cancer activity of Sirsak is
still very limited (Fang et al., 2009). Annona
muricata is used as antioxidant, medicine
anticonvulsant, the stamina enhancer,
anti-cancer, and cytotoxic. The compounds
which are contained in Sirsak (Annona muricata)
are flavonoid and acetogenin .(Adewole and
Ojewole, 2009).
The Sirsak (A. muricata L) has the
anticonvulsant activity, anti-cancer, and
antiinflammasi. The leaves extract has the
anti-cancer activity HEP2 (Human epidermoid
cancer cells) that shows the strong cytotoxic
activity. The cytotoxic activity or anti-cancer is
also due to the antioxidant effect. This is because
cancer is also caused by oxidants or the free
radicals (Baskar et al., 2007)..
The DPPH method is based on the
capacity of antioxidant to hinder the free radical
to donorthe hydrogen atom. The change in the
purple DPPH colour became purple
reddish/yellow indicate the activity of the
compound antioxidant. This method uses the
positive control as the standard to asertain
theantioxidant activity of the sample. The
antioxidant activity assay DPPH method used
1,1-difenil-2-pikrilhidra-zil (DPPH) as the free
radical. The principle is that the scavengers of
hydrogen by DPPH from the antioxidant
compound will change it into
1,1-difenil-2-pikrilhidrazin (Sharma and Bhat,
2008). The scavenging activity of antioxidant
toward free radicals is calculated into Electron
scavenging 50 (ES50) (Locatelli et al., 2009).
Based on the background that has been
presented, the research question is outlined
which is how many ES50 of ethanol extract of
sirsak leaves in capturing DPPH. It is hoped that
in the future, the phytopharmacy agency of
Sirsak can be patented.
METHODS
Materials and Methods
Instrument
The instruments which were used for the
antioxidant assay of ethanol extract of sirsak
leaves were glass equipment, balance, electricity
stove, blender, electric stirer, separation funnel,
Buchner funnel, uv vis spectrofotometer.
Materials
The material that were used for the leaves
ethanol extraction of sirsak leaves was quality
materials technic, that was: aquadestilata,
ethanol. The material for the antioxidant assay
were aquadest, DPPH, and ethanol p.a.
Research Procedures
1. Plant Determination
This stage aims to validate the main
material which was Sirsak (A murricata). This
activity was conducted in the Farmakognosi
Laboratory, Ahmad Dahlan University. Sirsak
determination was conducted using the guidance
of the Flora book of Java (Van steenis, 2000)
2. Extraction
Two hundred fifty gram of Sirsak was
macerated using 2 litres of ethanol 70%, the
maceration process was maximised using
electric stirer for 3 hours, then was kept in room
temperature for 24 hours. The filtrate was
received used a Buchner funnel and was called as
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first maseration. Extract residue resulted from
the first maceration process then was macerated
again using ethanol 70% totalling 1 litre, so that
second and third maceration were obtained.
Ekstrak liquid ethanol evaporated to obtain thick
extract. This process is illustrated in figure 1.
3. Antioxidant assay
a. Operating time determination
Each of 1,0 ml the sample solution was
stired with 1,0 ml of the DPPH solution 0.15
mM, afterwards it was observed absorbacy him
for 60 minutes in long the wave 517 nm.
b. The determination of Maximum
Absorbancy Wave Length.
The determination of wave length (  of
the maximum absorption of the DPPH was
carried out as follows: l,0 ml the DPPH solution
0.15 mM was combined with 1,0 ml of absolute
ethanol,and was mixed homogeneous then was
measured by the absorption of 400-600 nm wave
lenght.
c. The determination of free radicals
scavenger absorbation using DPPH
method
Each of 1,0 ml the sample solutions and
the solution to the standard with various
concentration was mixed with 1.0 ml the DPPH
solution 0.15 of mM. This mixture was kept in
the dark place during operating time. Afterwards
the absorbansi was measured to ascertain the
maximal DPPH absorption with
spectrofotometer UV-Vis. Blanko solution
which was used is abolut ethanol
d. Data Analysis
The data obtained using the previous
procedure was % ES50 and the concentration of
the tested compound afterwards was analyzed
using linear regression to obtain the
concentration of the the radical scavenger 50 %
(ES50).
% free radical scavenger =
negatif control absorbance - sampel absorbasnce
negatif absorbance





	 x 100%
The value of free radical percentage was
regress toward the log of concentration . The
value of ES50 which was obtained from the
antilog x where Y=5.
RESULT AND DISCUSSION
The mechanism of the occurrence of the
illness was often caused by the existence of the
oxidant that was abundant in the body. These
illnesses including hypertension, cancer,
diabetes melitus, and the decline illness in the
degenerative function of the other body. Up til
now investigation antioxidant has been carried
out by looking for the synthesis compound and
from the nature material (Richards et al., 2009).
The need was received antioxidant especially
from the nature material was caused by the
source that often was available in Indonesia.
The mechanism of the occurrence of the
illness was often caused by the existence of the
oxidant that was abundant in the body. These
illnesses including hypertension, cancer,
diabetes melitus, and the degenerative function
of the body. Up til now investigation antioxidant
has been carried out by looking for the synthesis
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250 gram of Sirsak simplisia
Residue
Macerat
Thick Extract
Maserated using 2 L EtOH 70%
Antioxidant assay of DPPH, to obtain ES50
Figure 1. Ethanol Extract and antioxidant
Activity Assay
compound and from the nature material
(Schiffrin, 2010).
The main content from the leaves sirsak
that played a role as antioksidan was flavonoid.
This flavonoid had many double bonds and the
hydroxil cluster that could play a role as free
radical scavenger (Hidalgo et al., 2010). After
scavenge the free radical it change itself into
radicals however it could stabilise itself via
autoresonance. The extract was tested by the
activity antioxidant by testing towards the ability
of DPPH free radical scavenging. The assay was
carried out by 3 times so as to be received by the
ES50 value.
Based on the data the ES50 can be obtain
by making the curve of log relations the level of
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Concentration (µg/ml) Abs % Antioxidant Probit
2,500 0,773 4,6072 3,36
5,000 0,718 11,3945 3,77
10,000 0,625 22,8712 4,26
20,000 0,484 40,2715 4,75
40,000 0,198 75,5656 5,71
Table I. The result of the association of concentration and absorbacy and % of ethanol extract antioxidant first
replication.
Concentration (µg/ml) Abs % Antioxidant Probit
2,500 0,770 4,9774 3,36
5,000 0,735 9,2966 3,66
10,000 0,637 21,3904 4,19
20,000 0,482 40,5183 4,77
Table II. The result of the association of concentration and absorbacy and % of ethanol extract antioxidant second
replication.
Concentration (µg/ml) Abs % Antioxidant Probit
2,500 0,780 3,7433 3,25
5,000 0,729 10,0370 3,72
10,000 0,641 20,8968 4,19
20,000 0,479 40,8885 4,77
40,000 0,206 74,5784 5,67
Table III. The result of the association of concentration and absorbacy and % of ethanol extract antioxidant third
replication
vs probit. The ES50 value is ilustrated in the
Table IV.
Based the result of ES50 which was 22.23
± 0,64 ug/mL it can be concluded that the
antioxidant capacity of ethanol extract of Sirsak
is relatively low as the standard of antioxidant
which usually has ES50 less than 2 µg/mL.
Further research to lower the ES50 value by
carrying out purification of the extract is
recommended.
CONCLUSION
The extract of leaves ethanol sirsak has the
ES50 of 22.23 ± 0,64 µg/mL towards the
scavenger of the free radical DPPH.
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Abstract
Background. Angiogenesis plays an important role in tumor progression. Modern treatment of
cancer currently has an alternative way to inhibit cancer through antiangiogenesis process. It is
expected to inhibit the formation of new blood vessels around the tumor, the supply of nutrients and
oxygen by the blood to the tumor can be inhibited.
Objective. This study aims to determine the antiangiogenesis activity of ethanol extract of
green algae (Spyrogyra Sp) Purified by using the method of chorio allantoic membrane (CAM).
Methods. In this study used 8 groups: Group I was a control that content only paper discs,
paper discs contain a group II + PBS, group III contain a paper disc + PBS + bFGF, group IV, V, VI,
VII, VIII as a treating were given 10, 20, 40, 160, and 320 ug / ml of ethanol extract of green algae
respectively. CAM is Obtained from embryonated chicken eggs aged 8 days. Incubated for 3 days
afterward. The macroscopic observation is used to see the inhibitory activity of blood vessels.
Statictical analysis used Kruskal-Wallis test to compare among each other Significantly, continuated
by Mann Whitney test (P <0.05).
Outcome measured. Inhibitory activity ( IC50)
Results. The results showed that the ethanol extract of green algae purified with concentration
10 ug / ml (p = 0:03) can inhibit angiogenesis of embryonated chicken eggs Compared to bFGF
control.
Conclusion. In conclusion, the ethanol extract of green algae has antiangiogenesis activity in
chorio allantoic membrane.
Keywords : antiangiogenesis, CAM, green algae, Spyrogyra Sp
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INTRODUCTION
Cancer is a disease characterized by the
uncontrolled proliferation of cells and the cells
can invade and damage other part of bodies. The
disease is still one of the leading causes of death
in developed countries and the second leading
cause of death in developing countries
(Ahmedin, et al., 2011).
Melatonin is an alkaloid compounds and
potent as inhibitors of cancer activity (Veronique
et al., 2004). Melatonin works with three action
in inhibiting cancer activities, which working
with specific cytotoxic, slow cleavage
(proliferation) of Cancer cells, and negate the
toxic effects of heavy metals (epigenetic
carcinogens). Mechanism of the latter action is
because melatonin can stimulate cancer cells to
synthesize metallothioneins (MTs) (Imbesi et
al., 2008). These compounds are intracellular
proteins that can protect cells by removing toxic
effects of metals (metal) And other epigenetic
agents (Korkmaz et al., 2008). Melatonin
produced by the pineal gland in the human body
and vertebrate animals. However, melatonin
production in the body is very low (less than 100
mg) (Lerner et al., 1960). Based on this, it is
necessary to melatonin intake from outside the
body to inhibit the activity of the cancer and to
eliminate the effects of toxic substances
epigenetic.
Green algae (Spirogyra sp.) is a plant with
a phytomelatonin content (Kolar and
Machackova, 2001). Phytomelatonin is
compound melatonin contained in the plant
(phyto). Levels of compounds phytomelatonin in
green algae at 240 ug / kg wet weight (Kolar and
Machackova, 2001). Phytomelatonin in green
algae can be isolated by using thin layer
chromatography (TLC) (Lerner et al., 1960).
Usefulness of these compounds can be seen as a
barrier to cancer activity (cancer inhibitor
activity) To test the cytotoxicity and
antiproliferative test. Cytotoxicity test using the
IC50 parameters or the concentration of the active
substance that kills cells by 50% from the
baseline, whereas the antiproliferative test using
the parameter doubling time or length of time
required by the cell in order to splitting into two
times of the original amount (Katzung, 1995).
This study aims to investigate
anti-angiogenesis effect of ethanol extract of
purified green algae. Purification is done to
obtain the fractions that containing of more
melatonin and separated from the other
components. By knowing how to purify green
algae and determine the activity of anti
angiogenesis then be developed the ethanol
extract of green algae with melatonin
standardized. This standardized extract may be
developed as an anti angiogenesis in cancer
therapy.
METHODS
Tool :The tools used in this study include
the chamber chromatography, silica gel GF 254,
the Soxhlet set, watch glass, rotary evaporator,
glass objects, incubator, mini drill, LAF, camera,
injection syringes, Eppendorf, micropipette,
scissors and tools glassware.
Ingredients: Materials used in this study
is the ethanol extract of green algae (Spirogyra
sp.) Were extracted by the sohxlet method in
Chemistry Laboratory of Pharmacy Faculty,
Ahmad Dahlan University, bFGF, chorio
allantoic membrane (CAM) of chicken eggs
with 8 days ages, paper disc. Other chemicals
were 96% ethanol, antiseptic solution, PBS,
ethyl acetate, petroleum ether, and sterile aqua .
Green Algae Extract preparation: Green
algae plants cleaned and put in a container filled
with water, allowed to stand for 24 hours: 12
hours of irradiation phase and 12 hours of phase
embezzlement. Algae taken from the container
after 5-6 hours of embezzlement phase and then
dried under the sun with a black cloth covered.
Algae pollinated, pollen extracted by Soxhlet
device using 96% ethanol. Pollen was
evaporated to obtain thick extract.
Ethanol extract purified preparation: A
total of 1000 mg of ethanol extracts obtained
added with 15%acetic acid as much as 15 ml.
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The solution then filtered by using filter paper
and a Buchner funnel. The filtrate was extracted
with 15 ml of petroleum ether 3 times. Acidic
water fraction added NH4OH until become pH
10, then extracted again with ether. Sari ether
evaporated until obtained the thick extract. Test
solutions were made in PBS solution.
Identification of Melatonin on green
algae: Fraction of the ether which is obtained
from thick extract spotted on silica gel KLT plate
using capillary tube. The first spotted is the
standard phytomelatonin, second spotted is
purified of ethanol extract and third spotted is
ethanol extract. Further silica gel GF 254 plates
petted with a mobile phase n-Butanol-acetic
acid-water (12:3:5). The results identified under
UV light (254 nm).
Preparation of bFGF as an inductor of
angiogenesis: Created stock levels of 50 ng /mL
using a solution of 10 mM Tris-HCl pH 7.5 and
then diluted to obtain a level of 0.5 ng / mL.
BFGF levels are given for each treatment
induced egg is 10 ng (Sun et al., 2004).
The inhibition of angiogenesis test: SPF
chicken eggs that have been purchased, age 0 day
immediately incubated in a laboratory incubator
at a temperature of 390c. After eggs is 8-9 days
old, the embryos location known through
candling the egg. Egg shell at the pole containing
the air space and egg shell above the embryo
disinfected with iodine solution. Later in the two
areas was made drill a small hole using a mini.
The air from air chamber Aspirated with a rubber
ball to move from the shell poles to the top of the
egg. This treatment is done with egg horizontal
position, in the dark, and through candling, and
then the artificial air space formed in the embryo
can be seen. Egg shell above the embryo was cut
with a saw (mini drill) to make a rectangular
window with an area of ??1x1 cm. Through this
window, bFGF and isolates test was implanted
into the chorio allantoic membrane (CAM).
Eggs subjects test were divided into 8 groups
(each treatment consisted of 4 eggs), as follows:
1) Group 1 is the egg with the implantation of
paper disc.
2) Group II group with implantation of paper
disc + Solvent (PBS) 10 mL.
3) Group III bFGF control group + solvent is the
group of eggs with the implantation of the
paper disc which is to content 10 ng bFGF +
solvent (PBS) 10 mL.
4) Group IV, V, VI, VII and VIII are eggs used
to see the inhibitory effect of the test solution
with levels of variation is equal to 10 ug / ml,
20 ug / ml, and 40 ug / ml, 160 ug / ml and 320
ug / ml extracts.
Eggs in this treatment group were given
implantation paper disc and added 10 ng bFGF
and test solutions of polar fractions of green
algae with concentration various by 10 mL.
Once treated, the eggs were incubated at a
temperature of 37-39 ° C with a relative humidity
of 60% for 3 days or 72 hours (Ribbati et al.,
1997), then the egg is opened (age 12 days) and
the contents of eggs laid. After that chorio
allantoic membrane (CAM) which is attached to
the shells was observed macroscopically and
counted the number of new blood vessels grow
on the surface and the edge of the paper disc.
Macroscopic observation can be done with the
aid of a magnifying glass (Jennie et al., 2006).
Data Analysis: Parameters observed in
the study is the number of new blood vessels at
the edges and surfaces of paper disc. To reduce
the subjectivity of observations, then the
observations made by three people, so the result
is an average of the three observations.
Observation of new blood vessels that form on
the edges and surfaces of paper disc, must be
distinguished from the main vein / origin of
CAM. Where the main vein in CAM has a larger
size, while the new blood vessels are arteries
finer / smaller (Ribatti et al., 1999). After that the
data obtained were analyzed statistically. Results
of quantify the amount of new blood vessels can
be calculated % inhibition by using the formula:
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Results quantify the amount of new blood
vessels then statistically analyzed using the
Mann Whitney and Kruskal Wallis method (p =
0,05).
RESULTS AND DISCUSSION
Identification of melatonin Compound on
ethanol extract purified
Test compound is a ethanol extract
compound purified because it was partitioned by
using several solvents in order to obtain extracts
whose composition is almost pure. The stage of
purification performed with ethanol extract and
added 15% acetic acid to its alkaloid content
tends to acidic. Subsequently partitioned with
Petroleum Ether. Acetic acid extract was taken
and added NH4OH to pH 10. Then the solution
was extracted with ether and the solvent was
evaporated to obtain a purified extract.
Identification of purified ethanol extract
was carried out by thin layer chromatography
method. On the identification of stationary phase
used was silica gel GF254 while mobile phase
used was a mixture of n-butanol ratio: 15% acetic
acid: water (12:3:5). Identification results can be
seen in Figure 1. Based on the identification can
be seen that the ethanol extract of purified yield
results spotted amount less than the ethanol
extracts alone and active content of compounds
melatonin in the ethanol extract is purified still
look dominant.
Parameters on thin-layer chromatography
is retardation factor (Rf), a comparison of the
distance of analyte from the origin to the distance
from the point of origin of the mobile phase. In
the result it shows one spot on the standard and
some spots on the samples, but one sample
patches have the same Rf price with the Rf price
of standard patches 0.68. This suggests that in
the test solutions there are melatonin
compounds.
Rf values 0,68 on samples compounds are
different due to different and vary levels of polar
compounds. Polar compounds with polar
stationary phase will be retained on the
stationary phase. It can also be caused due to the
non-polar compounds with non-polar mobile
phase will elute higher than compounds that are
more polar. In the picture looks not just one spot
melatonin had with the test compounds but also
there are some spots that appear on the elution
results, it can be caused due to a lack of
purification so that not only melatonin
fraksinated. Such compounds may be able to
support or reduce the activity of melatonin as an
anticancer so we need more research to
determine the contained of compounds in the
purified ethanol extract.
Antiangiogenesis test
Angiogenesis is the formation of new
blood vessels from existing blood vessels. The
formation of blood vessels occurs either due to
the effects of physiological and pathological
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a b c
Description:
a = melatonin standard
b = ethanol extract purified
c = ethanol extract
Figure 1. Qualitative identification of the ethanol extract,
ethanol extract purified by comparison melatonin. = Silica
gel stationary phase and mobile phase = 254 n-butanol:
15% acetic acid: water (12:3:5)
% Inhibition =
control blood vessel of bFGF - treatment blood vessel
New blood control vessel
x 100%


effects, one of which occurs in cancer cells.
Cancer cells secrete bFGF to form new blood
vessels, so the research is conditioned as in
cancer cells. bFGF is one of the pro-angiogenic
factor that plays a role in the process of new
blood vessel formation. bFGF is used as an
inductor of angiogenesis in the test object. BFGF
induction for each egg is equal to 10 ng. This
dose has given the differences significant growth
of blood vessels when compared with controls
(Sun et al., 2004). The results of the calculation
the average number of blood vessels in each
control group and the group fed ethanol extract
of green algae purified can be seen in Table I.
Table I. The results of the calculation of average
number of blood vessels in each treatment group.
Treatment group
The average number of
blood vessels
(X ± SD)
Paper disc
PBS
bFGF
10 ug / ml
20 ug / ml
40 ug / ml
160 ug / ml
320 ug / ml
0
0
20:00 ± 0
4:33 ± 0:57
3.67 ± 12:57
2.67 ± 12:57
1:33 ± 0:57
1:00 ± 0:57
Macroscopically observations indicate
that the test compound is purified ethanol extract
could inhibit the growth of new blood vessels or
angiogenesis in the CAM induced by bFGF. Test
results angiogenesis purified ethanol extract
showed the higher levels, the higher the
inhibition of angiogenesis that occurs in
bFGF-induced CAM is characterized by a
decrease in the density of new blood vessels
score. On eggs with test compound
concentrations of 10 ug / ml seen the growth of
new blood vessels in the area around the paper
discs were decreased when compared with
controls bFGF. The growth of new blood vessels
is experiencing a reduction in the concentration
of 20 ug / ml, 40 ug / ml, 160 ug / ml and 320 mg /
ml.
Price% inhibition can also be obtained by
finding the difference between the number of
blood vessels in the bFGF and control the
amount of blood vessels in each test solution
concentration, divided by the number of blood
vessels in the control group bFGF and multiplied
by 100%. Price% inhibition of purified ethanol
extract is shown in Table II.
Table II. % (percent) inhibition of purified ethanol
extract
Concentration of Test
Solution
% Inhibition of Blood
Vessels
(X ± SD)
10 ug / ml
20 ug / ml
40 ug / ml
160 ug / ml
320 ug / ml
78.33 ± 2.89
81.67 ± 2.89
86.67 ± 2.89
93.33 ± 2:22
95.00 ± 00:00
Purified ethanol extract have
antiangiogenesis activity with the highest
percent inhibition at a concentration of 320 ug /
ml. Percent inhibition proportional to the
concentration of the test solution, the higher the
concentration of the test solution % inhibition of
the higher percent.
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(1). Paper disc (2). PBS solvent (3). BFGF
(4). 10 ug / ml (5). 20 ug / ml
(6). 40 ug / ml (7). 160 ug / ml (6). 320 ug / ml
Figure 2. Observations macroscopically CAM
Test Result Statistics
In this study, the data obtained were
normally distributed, but the data are not
homogeneous, so that the analysis followed by
Kruskal Wallis and Mann Whitney. This
analysis was conducted to determine differences
in treatment between groups. Mann Whitney test
results showed a significant difference between
groups. Here is a summary of the results of the
Mann Whitney test for each treatment group.
Comparisons between the control group
paper disc with bFGF control group showed
significantly different results. This suggests that
bFGF used in the study actually influence the
process of angiogenesis. In contrast to the results
of the analysis between the control group paper
disc with PBS control. The analysis showed that
there was no significant difference between the
two treatment groups, so it can be concluded that
the PBS solvent used in the study does not give
effect to the formation of new blood vessels.
In the ethanol extract purified with various
concentration 10 ug / ml, 20 ug / ml, 40 ug / ml,
160 ug / ml and 320 ug / ml showed significantly
different results with the significance of bFGF
control which means it can provide as an
antiangiogenesis effect, this directly
proportional to the inhibition of the growth of
new blood vessels at every level variations in the
concentration of ethanol extract purified.
In this study, purified ethanol extract
shown to have activity as an inhibitor of
angiogenesis inhibition mechanism itself,
although it is not certain. Mechanism of
inhibition of new blood vessel formation by
purified ethanol extract test solution can not be
determined related to the method used, the
limitations of the method chorio allantoic
membrane (CAM). This method is only aware of
the antiangiogenesis effects based on the number
of existing blood vessels after treatment, while
the other responses that influence the
angiogenesis inhibitor compounds can not be
known. However, the mechanism of inhibition of
a compound that may occur to the formation of
new blood vessels associated with angiogenesis
mechanism itself, among other mechanisms of
inhibition of angiogenesis is the inhibition of
invasion, motility, and cell adhesion, inhibition
of endothelial cell activation, interfere with
angiogenic growth factors or their receptors,
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Variation
Control
paper disc
BFGF
control
PBS
control
10 ug / ml 20 ug / ml 40 ug / ml
160 ug /
ml
320 ug /
ml
BFGF
control
S
PBS control TS S
10 ug / ml S S S
20 ug / ml S S S TS
40 ug / ml S S S S S
80 ug / ml S S S S S S
160 ug / ml S S S S S TS
320 ug / ml S S S S S S TS
Description: S = Significant contrast / contrast Meaningful (p = 0.05),
Unlike TS = Not Significant / Contrary Not Meaningful (P> 0.05)
Table III. Summary of statistical analysis of antiangiogenesis test group and the control group treated with a test
compound using Mann-Whitney test.
inhibition the enzymes involved in the process of
angiogenesis, and vascular targeting (Liekens et
al., 2001).
In this study, which gives the effect of
antiangiogenesis compounds in purified ethanol
extract allegedly not only indicated by the
presence of melatonin in the compound tested
solutions but can also be supported by the
presence of other compounds contained in the
test solution. This can be seen from the results
shown on the identification of melatonin has
been done but more research needs to be done to
determine the types of compounds contained in
the test solution.
CONCLUSION
Ethanol extract of purified compounds
containing melatonin have antiangiogenesis
effect on chorio allantoic membrane (CAM) of
chicken egg-induced basic fibroblast growth
factor (BFGF) levels begin 10 ug / ml. The
higher concentration of ethanol extract of
purified, the higher the inhibition angiogenesis.
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Abstract
Background. The increased of geriatric population is increased along with life expectation.
Geriatric population is identical with the decline of physiological functions that can cause various
diseases.
Objective. This study aim to investigate self medication in geriatrics requires special care from
the pharmacist.
Methods. This study was observational study carried out by survey. Subjects of this study were
geriatric patients aged 60 years or more who did self medication in pharmacies which involved in this
study. The pharmacies used were representing the northern, eastern, southern, western, and central
area in Gunungkidul regency. Data was collected in May-July 2012 using questionnaire. The
percentage of geriatric self medication prevalence was formulated by comparing between the number
of geriatrics who did self medication with the overall population who did self medication. Supportive
factors of geriatric self medication were analyzed with chi square test with 95% confidence level,
followed by binary logistic test to determine the most supportive factors.
Outcome measured. Supportive factors : monthly income, distance of residence from the
nearest health services, and the types of illness
Results. There were 154 respondents of this study. The prevalence of geriatric patient who did
self medication was 10,11%. The chi square test's result that monthly income, distance of residence
from the nearest health services, and the types of illness were supportive factors of geriatric patient
self medication in pharmacies Gunungkidul regency (p <0.05) and binary logistic test's result that
distance of residence from the nearest health services was the most supportive factors (p<0,05) with
OR value was 6,727 (confident interval 95%: 1,163-38,911).
Conclusion. The geriatric who did self medication were affected by supportive factors
Keywords : geriatric, self medication prevalence, supportive factors
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 123
INTRODUCTION
WHO declares that elderly in indonesia
will reach 11,34 % in 2020 (Anonim, 2009).
Increased life expectancy will affect the growing
of geriatric population. It is not directly and
epidemiology contributes to degenerative
diseases, chronic diseases and
non-communicable diseases, including can not
be cured and need more time recovery diseases.
This condition Influences on the increase of
health service needs (Megawati, 2004).
Geriatric population is a population that
has experienced a decline of physiological
functions. With the decline in physiological
function, the process of absorption, distribution,
metabolism and excretion of drugs will also
change (Prest, 2003). Kuntjoro states (2002),
there are four characteristics that can be
categorized as a Geriatric patients and
Psikogeriatri:
a. Body functional limitation associated with
the increasing of age.
b. Accumulation of degeneratif deseases.
c. Elderly are psichosocially in crisis if : there is
dependence on others (need others’ services),
isolate themselves from social activities.
d. The things that can cause impaired balance
(homeostasis) so it brings geriatric towards
damage / decrease (deterioration) which are
mainly progressive especially sudden
psychological aspects, such as confusion,
panic and depression.
Previous research in Jakarta states that the
public interest do self medication in pharmacy is
increasing, the majority of drug selection served
by assistant pharmacists (95%) and by
pharmacists (5%) (Purwati et al., 2004). Self
medication according to the WHO definition is
the selection and use of modern medicine, herbal
or traditional medicine by an individual to cope
with the disease or symptoms of diseases (WHO,
1998). Self medication is considered by the
World Health Organization (WHO) to be an
international health policy, because self
medication not only reduce the burden on health
care costs but also to increase patient compliance
and improve treatment outcome (You et al,
2011).
According to the newest data of
Department of Social Province DIY 2010, the
total of elderly in Province DIY is 29.724 people,
while 11.565 people (38,88%) are in
Gunungkidul regency (Anonim, 2011). The aim
of this reseach is to know prevalency and
supporting factors of geriatric patient self
medication in pharmacies Gunungkidul regency.
RESEARCH METHODOLOGY
Research design : research design used is
observational with survey method. The data are
taken as prospective in 3 months, started on May
2012. Evaluation is conducted based on
questionnaire on May to July 2012.
Research population: the population of
this research is 60 years old and above of
geriatric patients in Gunungkidul regency who
come to the pharmacies Gunungkidul regency to
buy medicine without doctor prescription on
May to July 2012.
Research Subject: the sample of this
research is geriatric patient in Gunungkidul
regency who come to pharmacies Gunungkidul
regency to buy medicine without doctor
prescription on May to July 2012 with criteria
inclusion and exclusion. Inclusion criteria is that
geriatrics who are able to fill the questionnaire
correctly while exclusion criteria is geriatrics
who are not able to fill the questionnaire of this
research.
In the research:
The research is conducted at pharmacies
Gunungkidul regency and uses sampling area
technique. The data of Health Department year
2011 shows that there are 22 in pharmacies
Gunungkidul regency. The total sample
minimum pharmacy is taken by using formula +
n + 1 ( 22 + 1= 6 pharmacies). Choosing
research subject as respondent in this research is
decided by sampling purposive with the geriatric
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criteria above 60 years old people who come to
the pharmacies to conduct self medication and
they agree become the subject of this research.
The data taken are data from the complete
questionnaire filled by the research subjects at
the pharmacies. Questionnaires are distributed
continually on May to July 2012 to all of
pharmacies in this research. Self medication
prevalence of geriatric patient is shown in
percentage. Statistic test uses SPSS 16.0
program for Windows. Supportive factors of
geriatric patients self medication in Gunungkidul
regency were analyzed with chi square test with
95% confidence level.
Research Obstacle
The obstacles this study are not all
pharmacies located in Gunungkidul are willing
to participate in this research and not all of
geriatric patients who come to self medication
are willing to be the subjects in this study so that
the sample may not have been able to represent
the actual population size.
RESULT AND DISCUSSION
The result of this research shows the
prevalence of self medication geriatric patients
in pharmacies Gunungkidul regency is 10.11%
(presented in Table 1). The data were obtained
from nine pharmacies that meet the sampling
area; the northern, eastern, southern, western,
and central to the inclusion and exclusion
criteria. Compared with other regions, the central
regency has the highest percentage, it is 4.67%.
The high of self medication prevalence of
geriatric patients in the central regency is due to
the number of samples used pharmacies in the
central regency more than other regency. Middle
regency which is the capital of Gunungkidul is
urban areas, where the practicality and the speed
become everyday lifestyle including the efforts
of curing the disease.
The total of geriatric patients who
participated in this study is 154 respondents.
Geriatric patients who do self medication in
pharmacies Gunungkidul regency was 44.59%
(presented in Table II). The results are similar to
studies conducted Vacas,. Et al (2009) in primary
health care (PHC) center Spain, it is known that
31.2% of patients on independent treatment,
where pharmacies are the most common sources
for getting medications (49.3%).
This is understandable because the drug is
one of human rights, the provision of essential
medicines is an obligation for the government
and health care institutions, both public and
private (Anonim, 2008). Provision of essential
drugs in health services such as pharmacies will
provide easy access to their own medical needs
or self medication.
In this study as much as 96.75% of the
respondents expressed the drug information by
officers while performing their own treatment. In
addition as many as 96.75% respondents
expressed the needs for information on the
independent medication treatment. The
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Region
Patients with self medication
Prevalence (%)
Geriatric All patients
Northern 9 365 2,47
Eastern 4 720 0,60
Southern 6 1379 0,44
Western 15 776 1,93
Central 120 2566 4,67
Total 10,11
Table I. Prevalence of self medication geriatric patients in pharmacies Gunungkidul regency
existence of drug information by pharmacists is
expected to increase patients’ knowledge about
drugs so that patients are able to use drugs
rationally to maximize therapy and minimize
side effects. Research conducted by Satibi and
Oetari (2001) shows that the medicine
information affects the selection of and the use of
caught medicine in the independent treatment in
the Godean regency . Amoako EP et al (2003) in
his study concludes that geriatric may not be
aware of the risks associated with poor
concurrent use of pain medications, alcohol, high
blood pressure medications, and the regular use
of caffeine.
As 96.20% of the patients in this study
express satisfaction with independent medical
care. This is understandable because it will
facilitate the acquisition of OTC drug (over the
counter-drug) availability and drug cost savings.
Results of analysis using the chi square
test shows that there are 3 factors that support
self medication significantly of geriatric patients
(p <0.05), such as the amount of income each
month, distance of residence from the nearest
health services, and types of illness (presented in
Table III).
The Public Health Action Support Team
(PHAST) in 2011 proposed the health aspects
that can be considered in four things: 1).
Effectiveness, related to the health benefits
measured through improved health, 2).
Efficiency, associated with the cost and the
health benefits, 3). Acceptability, related to
social acceptance, psychological and ethical
about the way people are treated in health, 4).
Equity, related to the fair distribution of health
among individuals or groups.
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Self medication number percentage (%)
Option for getting medications if sick
Self medication 70 44,59
Other health services 87 55,41
Self medication frequency per month
Not sure / if sick 17 10,76
1x/ month 59 37,34
2x/ month 47 29,75
1-2x/ month 4 2,53
3x/ month 9 5,70
2-3x/ month 2 1,27
>3x/ month 9 5,70
Availability of drug information when self medication
Yes 149 96,75
No 2 1,30
Need of drug information on self medication
Yes 149 96,75
No 3 1,95
Satisfaction with the self medication
Satisfied 149 96,20
Not satisfied 2 1,27
Table II. Self medication in pharmacies Gunungkidul regency
Self medication is one of treatment option
that can reduce the cost burden on health services
as disclosed by You et al, (2011), this is in
accordance with the PHAST which include
efficiency as assessed health aspects.
Independent health cost can not be separated
from the income of an individual, in this case the
geriatric patients. It shows that income is one
factor supporting self medication. Through this
research it can be concluded that the amount of
monthly income can significantly affects s self
medication of geriatric in pharmacies
Gunungkidul regency. Another study conducted
by Atmoko and Indria (2009) states that the cost
of expensive treatment gives positive effects to
the consumer decision to do self medication.
Geriatric patients who have more than a
kilometer to the nearest health facilities are more
often do self medication in pharmacy because of
the pharmacy is considered closer to making it
easier and faster to get the medicine. Decreased
physiological conditions that ultimately decrease
the geriatric patient’s physical condition will
cause their limited space, so the distance of
pharmacy where they do self medication
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supporting factors self medication geriatric patients
Number of respondents
p-value
self
medication
Other health
services
Sex Male 43 56
0,809
Female 25 30
Job Entrepreneur 48 49
0,099
Does not work 18 33
Amount of monthly income <1.000.000 7 4
0,035*
>= 1.000.000 8 21
Distance of residence from the nearest health
services
<= 1Km 26 52
0,003*
>1 Km 33 23
Insurance ownership ASKES/Jamkes 14 21
0,296
No 52 58
Types of illness Chronic 39 70 0,001*
Not Chronic 29 16
Amount of illness 1 illness 62 75 0,285
>1 illness 5 11
Originally financing medication if sick self/family 62 73 0,403
company /ASKES 6 12
Completeness facilities of pharmacies complete 65 83
0,209
not complete 2 0
Provision of information by the pharmacist Yes 66 83
0,333
No 0 2
Need of drug information on self medication Important 66 83 0,918
Not Important 1 2
Satisfaction with the service of self medication
at the pharmacy
Satisfied 66 83 0,918
Not satisfied 1 1
Table III. Results of analysis using the chi square test of supporting factorsself medication geriatric patients in
pharmacies Gunungkidul regency
relatively close to their house will be very
supportive of the actions of undertaken self
medication of geriatric patients if they are sick.
Types of illness factors significantly
influence geriatric self medication in pharmacies
Gunungkidul regency. Types of illnesses
suffered by elderly patients who do self
medication are degenerative diseases such as
hypertension, gout, rheumatism, and so on. The
degenerative diseases requiring long-term
medication and under a doctor’s supervision as
prone to complications and require monitoring of
drug side effects that may occur as infrequently
do not need a lot of medication at the same time.
The use of drugs in degenerative diseases
can not be separated from the drugs included in
the list of mandatory drug pharmacy, which can
be submitted without a prescription at
pharmacies with medication administration
records only on the basis of the doctor’s
treatment replicates (Kemenkes, 1999).
Christiane, et al., (2008) states that there are 30%
of advers drug reactions that cause elderly
patients hospitalized due to NSAID.
The role of the pharmacist at the time self
medication is needed in terms of drug selection
and dosage appropriate circumstances to the
geriatric patients. Provision of clear information
regarding the efficacy, rules of use, security,
drug side effects, drug interactions, and storage.
The purpose of giving information is to make
sure patients are able to use the drugs properly so
the goal of treatment can be achieved.
CONCLUSION
It can be concluded that:
1. Self medication prevalence of geriatrics in
pharmacies Gunungkidul regency is on May
to July 2012 is 10, 11%.
2. Supporting factors that support geriatric
Patient to do Self medication in in pharmacies
Gunungkidul regency is monthly income,
distance of residence from the nearest health
services, and the types of illness (p <0,05).
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Abstract
Background. Diabetes mellitus is one of chronic metabolic disorder characterized by
hyperglycemia and abnormalities in carbohydrate, fat, and protein metabolism because of insulin
insufficiency. Diabetes mellitus is a chronic disorder which have consequencies in patients' quality of
life.
Objective. The research aimed to find out the description about quality of life in diabetic
patients and the influence of delivering drug information to the quality of life in diabetic patients who
got oral diabetic agents in Puskesmas Umbulharjo 1 Yogyakarta.
Methods. The research was a cohort study at Puskesmas Umbulharjo I. The inclusion criteria
were all diabetic patients who got oral diabetic agents and had been receiving the medication for at
least one month in Puskesmas Umbulharjo I, patients who are willing to be the respondents, dan the
living place of the patients can be reached by the researcher. The exclusion criteria was a patient who
had complicated disorder. There were 18 patients in the research who had inclusion criteria. The
data being analyzed was a primary data to identify quality of life that was measured using SF-36
questionnaire Indonesian version.
Outcome measured. Quality of life domain in diabetic patients
Results. The result of the research indicated that 8 domains were a (1) general health
perceptions (2) physical health problem (3) physical activities (4) emotional problems, (5) social
activities (6) bodily pain (7) vitality and (8) general mental health. The result from eight domains
showed that there was no corellation between the provision of drug information and quality of life in
diabetic patients (p > 0.05). In the other results showed that there was a significant corellation
between patient's adherence and quality of life in diabetic patients in three domains such as general
health perceptions, vitality, and general mental health (p < 0.05).
Conclusion. In conclusion, the provision of drug information did not affect the quality of life of
patients with diabetes mellitus (P>0.05), whereas the effect of compliance to quality of life resulted
that compliance of patients significantly influenced the quality of life of patients with diabetes
mellitus in 3 domains, namely physical activities, vitality, and general mental health (p <0.05).
Keywords : Diabetes mellitus, quality of life, delivering drug information , SF-36 questionnare
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INTRODUCTION
Diabetes mellitus is defined as a disease or
a chronic metabolic disorder with multiple
etiology characterised by high blood sugar levels
accompanied with disturbance of carbohydrate
metabolism, lipid and protein as a result of
insulin function insufficiency. Insufficiency of
insulin function may be caused by impaired or
deficient production of insulin by the beta cells
of Langerhans pancreas gland, or due to the lack
of responsiveness of body cells to insulin
(Anonim, 2005).
The development of the concept of
HRQOL (Health-related Quality of Life) or the
relationship of health and quality of life
improved in line with world health clinical
research in healthcare. HRQOL instruments are
divided into general and disease specific
instrument. Instruments Study Short Form 36
(SF-36) is one common instrument that has been
widely used to measure the HRQOL disease
chronic pain and other common illness (Magnus
et Al, 2007).
Research on quality of life is expected to
obtain an overview of the level of quality of life
of patients with diabetes mellitus who consumed
oral hypoglycemic drugs, so it will obtain the
suitable model for the provision of drug
information on patients with diabetes mellitus.
METHODS
Subjects
The study subjects were all the patients of
diabetes mellitus and get oral hypoglycemic
drugs in Puskesmas Umbulharjo I in April-May
2012 who meet the criteria for inclusion and
exclusion criteria. Inclusion criteria for the study
were all patients of diabetes mellitus that receive
oral hypoglycemic drugs and were undergoing
treatment at least 1 month in Puskesmas
Umbulharjo I, patients who were willing as a
respondent, and the respondent could be reached
by researchers. Exclusion criteria for the study
were patients who experienced complications of
other diseases.
Research Data Collection
Data collected in the form of primary data
obtained from research subjects by using an
instrument that has been tested, the Indonesian
version of the.SF-36. The patient's quality of life
data collection done at home while visiting a
patient's home, to see the remaining amount of
oral hypoglycemic drugs that have been drunk.
Before conducting interviews and
questionnaires, it should be ensured that the
selected respondent is in compliance with the
criteria of inclusion.
Analysis of results
In this stage, the processing and analysis
of the results of the study are to analyze the
influence of drug information and adherence to
the quality of life of patients with diabetes
mellitus who consumed oral hypoglycemic
drugs. Quality of life of patients assessed by the
SF-36 questionnaire, which contained 8-will do
assessment domains, namely the domain of
general health perceptions, physical health
problem, physical activities, emotional problem,
social activities, bodily pain, vitality, and general
mental health. From the domains, then do the
scoring with a scale of 0 to 100 with 100 being
the highest level.
RESULTS AND DISCUSSION
This study was conducted on 18 patients
who fit the inclusion and exclusion criteria.
Measurement of quality of life is intended to
compare and differentiate between two different
therapy with moral values and high morbidity
(Spilker, 1996). To measure the quality of life of
the patients, the study used the SF-36 instrument.
The SF-36 instrument is a general instrument
that can be used to measure the quality of life of
patients in various clinical disorders whether the
type is chronic illness or specific diseases.
Diabetes mellitus is a chronic disease
type, so it can analyze the patient's quality of life
using SF-36 instrument. The SF-36 has 8-scale
profile of functional health; the limitation of
physical activity due to existing health problems,
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social activity limitations due to physical and
emotional problems, whole body pain, general
mental health, restriction of daily activities due
to emotional problems, vitality of life, and
general health outlook (Wata, 2007). Seven
domains are analyzed by the Independent T-test
with a level of 95% while the emotional state of
domain analyzed by 2-related samples.
In Table I are data on the effect of drug
information to the quality of life. Provision of
drug information was limited to how to take the
medicine and the rules of use, due to time
constraints. The results showed that
administration of drug information does not
differ significantly (P> 0.05) on the quality of
life of patients in either eight domains, namely
general health, physical functioning, physical
condition, emotional state, physical function,
bodily pain, vitality, and mental state.So it can be
concluded that the provision of drug information
to patients does not affect the patient's quality of
life. This can occur because the information
presented is only how to take the medicine and
the rules of use, so there are some other things
that can affect the patient's quality of life such as
compliance of the patient.
Influence patient compliance to the
quality of life can be seen in Table II.
Compliance is defined as the extent to which a
person's behavior in terms of using medication
(is defined by how far a person's behaviour in
terms of drugs usage), following a diet, or
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Function
Domain
Average ± SD P Significance
With Drug Information
Without Drug Information
KU
56.93±17.19
58.79±16.33
0.817 Not Significant
With Drug Information
Without Drug Information
FF
67.22±33.64
82.22±15.43
0.242 Not Significant
With Drug Information
Without Drug Information
KF
38.88±39.74
30.55±42.89
0.675 Not Significant
With Drug Information
Without Drug Information
KE
363.495±125.896
363.495±125.896
0.181 Not Significant
With Drug Information
Without Drug Information
FS
72.22±27.79
76.38±14.58
0.696 Not Significant
With Drug Information
Without Drug Information
NT
58.61±22.77
63.05±18.65
0.657 Not Significant
With Drug Information
Without Drug Information
V
53.33±19.36
56.66±17.13
0.704 Not Significant
With Drug Information
Without Drug Information
KM
69.77±19.09
68.00±21.07
0.854 Not Significant
Table I. The Effect of Drug Information on Patient's Quality of Life
changing inlife style in accordance with medical
advice or health workers advice. As increasing
patient compliance does not arise, it is expected
that drug resistance can be detrimental (can
harm/can be harmful) to the patient itself, the
environment, recurrence and death (Melanie,
2009).
Oral hypoglycemic drug compliance seen
from the remaining number of oral
hypoglycemic drugs provided by the
pharmacists in Puskesmas Umbulharjo I that
were drunk by patients, whether in accordance
with the amount that should be taken or not, and
be seen as doing the interview at the patient’s
home.
From the results gained, showing that
compliance was not effected significantly (P >
0.05) in five domains, namely the domain of
general health, physical functioning, emotional
health, social functioning, and bodily pain. But
compliance significantly effects (P < 0.05), on
the 3 domains, namely the domain of physical
health, vitality, and mental health. It can be
concluded that compliance significantly
influence the quality of life of patients.
Overall, based on the test results of the
Independent T-test, it showed that the provision
of drug information and patient compliance give
no significant effects on the public health
domain. Itcan be seen in the table the value of
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FunctionDomain Average ±SD P Significance
Obedient
Disobedient
KU
59.58±18.11
55.71±14.61
0.632 Not Significant
Obedient
Disobedient
FF
85.00±10.27
61.87±35.14
0.064 Not Significant
Obedient
Disobedient
KF
52.50±44.79
12.50±18.89
0.032 Not Significant
Obedient
Disobedient
KE
362.995±126.224
362.995±126.224
0.181 Not Significant
Obedient
Disobedient
FS
78.75±15.64
68.75±27.54
0.345 Not Significant
Obedient
Disobedient
NT
61.50±17.00
60.00±25.10
0.082 Not Significant
Obedient
Disobedient
V
62.50±16.20
45.62±15.90
0.042 Significant
Obedient
Disobedient
KM
78.80±11.63
56.50±20.88
0.011 Significant
Table II. Compliance Influenceon Patient’sQuality Of Life
significant effect of drug information on the
quality of life of patients is 0.817 (> P 0.05) and
the value of the significant influence of
compliance to the quality of life of patients,
namely 0.632 (> P 0.05).
In the domain of physical function, it can
be assessed how the ability of a patient's daily
activities such as walking, bending, and lifting
heavy loads,whether the health conditions of
physical function may result in limitations of the
patient through physical activity. From the
research, the provision of drug information does
not affect the physical function domain. It can be
seen the value of significance is 0.242 (P > 0.05),
and compliance did not affect the physical
function domain, can be seen the significant
value is 0.064 (P > 0:05). It can be concluded that
the provision of drug information and patient
compliance has no effect on physical function
domain, whereas Wiyanti (2012) stated that the
physical function domain effect on age.
In the domain of physical conditions can
be assessed how much physical state interfere in
the work and activities of daily living. From the
research data that the provision of drug
information does not affect the physical state
visible domain of significant value in the table is
0.675 (P > 0.05), whereas the effect on patient
compliance domain visible physical state of
significant value in the table is 0.032 (P > 0.05),
so it can be concluded that the given drug
information or not given drug information does
not affect the quality of life of patients but
blindly obedient or not patients have a
significant effect on the quality of life of patients
is the physical state that disrupt their work and
daily activities.
In the emotional state domain, it used
statistical analysis with 2 related samples, it can
be seen some aspects of the patient-related mood
in doing the work and activities of daily living.
Provision of drug information and patient
compliance has no effect on the emotional state
of the domain, can be seen from the data table of
significance values are 0.181 and 0.181 (P>
0.05), so it can be concluded that with the drug
information was given or not, and how the
patient obedient or not, can not affect the
patient's emotional state. From patient
interviews, most of them stated that emotional
disorders such as anxiety do not interfere the
patient in performing daily activities or their
work.
In the domain of social function, it can be
evaluated that the patient's health or emotional
disturbance can disrupt activities or social
activities of the patient's family, friends,
neighbors, or groups. Provision of drug
information and patient compliance has no effect
on physical function domain can be seen in the
table of significance values 0.696 and 0.345.It
can be concluded that given or not given the drug
information and how the patientobedient or not,
has no effect on social functioning of patients.
And from the interviews, it is found that many
patients say health or emotional disorder that is
often felt they did not interfere with patient's
activity or social activities to family, friends,
neighbors, or groups.
In the bodily pain domain, it can evaluate
pain intensity and impact of pain on daily
activities both at work and activities inside and
outside the home. Provision of drug information
and patient compliance has no effect on bodily
pain domain views of significant value in the
table, namely 0.657 and 0.882. It can be
concluded that given or not given the drug
information and how the patientobedient or not
had no significant effect on the patient's pain.
In the domain of vitality, it evaluate the
level of fatigue, fatigue, and lethargy are often
perceived by the patient. Provision of drug
information does not affect the vitality domains,
but the effect on patient adherence vitality
domain can be seen from the significant value of
0.657 (P> 0.05), and 0.042 (P <0.05). How
obedient or not the patient will have an impact on
patient quality of life, especially its vitality
because one of the complaints experienced by
patients with diabetes mellitus is weak body,
then the non-adherent patients taking the
medication more frequently complain of weak
entities.
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In the mental health domain, it evaluate
general mental health including depression,
anxiety, and behavior control emotions by the
patient. Provision of drug information does not
affect the mental health domain, but the effect on
patient compliance mental health domain, it can
be seen from the significant value of 0.854 (P>
0.05), and 0.011 (P <0.05). How obedient or not
the patient will have an impact on the quality of
life of patients, especially in mental health
patients, as diabetes mellitus is a disease that is
difficult and long to be cured, it can make mental
health patients reduced the impact on patient
adherence. In the study of Wiyanti (2012),
quality of life of diabetes mellitus patients, there
are 2-type influential domains, one of them is
mental health, that is influenced by the duration
of the disease.
CONCLUSION
Based on the results of a study of 18
patients with diabetes mellitus and the use of oral
hypoglycemic drugs, showed that of the 8
domains tested, provision of drug information
does not affect the quality of life of patients with
diabetes mellitus (P> 0.05), whereas the effect of
adherence to quality measurement life result that
compliance of patients significantly influence
the quality of life of patients with diabetes
mellitus in 3 domains, namely physical health,
vitality, and mental health (p <0.05).
RECOMMENDATION
It is still needed to conduct research on
patients' compliance and quality of life with
diabetes mellitus for evaluating treatment with
time to improve the provision of information and
frequency of medications, as well as increasing
the number of research samples.
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Background. The drug information service is a part of pharmaceutical care to increase the
quality of life of patient. To prevent unappropiated drug use and to improve patients knowledge and
understanding on drug use leads to the treatment compliance and the success of therapeutical
management. Therefore, it is extremly important to give drug information service for the patients and
their family.
Objective. This study was aimed to identify the realization of drug information service
implementation at pharmacy in Yogyakarta.
Methods. This study was non-experimental study with descriptive observational design and
quantitative approach
Outcome measured.: Drug information aspects : the name of the drug and aim of treatment,
the rule of drug use, the schedule of drug use, and the period of using the drug.
Result. The result showed that the implementation of drug information service at pharmacy in
Yogyakarta had been conducted well. There were four information aspects was gived to the patients.
Based on the observation, 70 % patients experienced drug information service on the name of the
drug and aim of treatment, the rule of drug use, the schedule of drug use, and the period of using the
drug. However, information on the side effect of the drug and the drug storage were ungived. There
were less than 70 % patient giving the information. Moreover, the number of patients giving
information on drug toxicity and things to do related to drug toxicity reached merely 33,33%,
whereas patient who come to pharmacy is out-patient who is responsible to the use of the drug.
Conclusion. Implementation of drug information service at pharmacy in Yogyakarta had been
well conducted. Nevertheless, some aspects of drug information were not implemented optimally.
Keywords : implementation, drug information, pharmacy
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INTRODUCTION
Strategy implementation is the total
activities and choices which were required for
the execution of a strategic plan. It is the process
which objectives, strategies, and policies a
process are put into action trough the
development of programs, budgets, and
procedures. Although an implementation is
usually considered after strategy has been
formulated, an implementation is a key part of
strategic management. Strategy implementation
involves establishing programs to create a series
of organizational activities. The purpose of a
program is to make a strategy action oriented.
The evaluation of strategy implementation is a
process that monitors activities and actual
performances result which can be compared with
the standard (Hunger and Wheelen, 2006).
Pharmaceutical care was including the
drug production, quality control of
pharmaceutical preparations, safety,
procurement, storage and drug distribution, drug
management, drug prescription, drug
information services, drug development, and
traditional medicine. Pharmaceutical care is a
direct and responsible service to patients,
relating to pharmaceutical preparations in order
to achieve results that are sure to improve the
quality of life of patients (Anonymous, 2009)
The prices of drug and added costs of
health care more expensive, causing people tried
to self medication with drugs that are sold over
the counter in pharmacy or the market
(Sulistyarini, 2010). Before tried to self
medication some one must be recognize that
happened complaint, then can choose what is
appropriate remedy to overcome the such
complaints, and knowledge when to the drug
used.
The drug information service is an activity
to give accurate drug information and objective
in relation to patient care, drug information
services is essential in order to support the
management culture and rational drug used.
(Julianti and Widayanti, 1996). Pharmacist must
give the drug information is a true, clear and easy
to understand, accurate, unbiased, ethical,
thoughtful and up to date. The drug information
service to patients is high quality of information
includes a description of drugs that includes
basic information about a drug component.
Pharmaceutical care has shifted from the
drug oriented to the patient oriented. The
consequence of changes in oriented, pharmacists
are required to improve the knowledge, skills
and behaviors in order to carry out the direct
interaction with the patient. The other forms of
interaction between the implemention drugs
information, monitoring the drug used to
determine the final destination as expected and
well documented (Anonymous, 2008).
The standard of pharmaceutical care in
pharmacy, the pharmaceutical care has
developed standards that have been set out in the
decree of the Ministry of Health of the Republic
of Indonesia No 1027/MENKES/SK/IX/2004 is
a parameter used to assess the quality of
pharmaceutical care in the pharmacy
(Anonymous, 2004). The drug information
services and aspects of drug information give by
pharmacists is part of pharmaceutical care at the
pharmacy. Pharmacists practice in
pharmaceutical care is integrated activity with
the aimed of identifying, preventing and
resolving related problems to health, especially
in terms of drug used.
The role of pharmacist in the pharmacy,
drug information services is extremly important
to give for the patients and their family patients,
especially for self medication patients. The self
medication patients get the drug information
from the experience of others, advertising in the
mass media are often less complete, less precise,
even plunged (Sulistyarini, 2010). We was
known for many drugs in circulation and reach
thousands of types of drugs, so as to confuse the
public in choosing the right drug and safety drug
for him. For that pharmacists should give
accurate drug information and objective so that
patients can use the drug correctly.
The study was aimed to identify the
realization of the drug information service
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implementation at pharmacy in Yogyakarta.
From the result, it is expected for pharmacy can
select the right step. So that the drug information
services as the strategic plan to improve the
pharmacy service quality, that has been planned
can reach the target that has been established. So
it can support the pharmaceutical care in
pharmacy that has high quality to increase the
quality of life of patient.
RESEARCH METHODOLOGY
This type of research is non experimental
study with observational descriptive design with
quantitative approach. The data was obtained
from the questionnaires distributed to
respondents, patients with a doctor's prescription
and self medication patient at pharmacy in
Yogyakarta. The observation of the drug
information services by pharmacist and the
required patient. While primary data was taken
form answereds the questionnaire respondents.
The tools of this study used the
questionnaires, the questionnaires used to
determine the implementation of drug
information services give and needed patients at
pharmacy. The questions contain questionnaires
used to regarding the factual drug information
services give and required patient.
The study used non experimental design.
The quantitative data was obtained from filled
patients questionnaires. The sampling was
conducted using purposive sampling or aimed
sampling. The samples were patients and their
family was comed to the pharmacy. The
inclusion criteria of adult patients aged over 17
years, the prescription patients or self medication
patients who is willing to be respondents and
exclusion criteria are not willing to be a
respondent. The amount of data based on Roscoe
who said the amount of data should be more than
30 and less than 500 (Sekaran, 2003).
The study was conducted at pharmacy in
Yogyakarta, the pharmacy criteria is a pharmacy
where located represents the area of the city in
Yogyakarta. Each of the two pharmacies, located
in the center, north, east, south and west of the
city in Yogyakarta. Where the pharmacy has
been providing counseling space, at least two
pharmacists practice.
Data as analyzed descriptive statistics
methode to identify the drug information
services implementation. In the analisys, the data
of drug information services implementation that
is was obtained from the questionnaire
respondents. Data factual description of drug
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Factual description of Respondents Total Percentage (%)
Visit to the pharmacy before Often visit 90 90.91
Rarely visit 9 9.09
Drugs purchased in pharmacy Prescription drug 36 36.36
Self medication 63 63.64
Status of the respondents Their self 67 67.68
Other self 32 32.32
Need for drug information services Need 99 100.00
Needn't 0 0.00
Ever get the full drug information services Ever 58 58.59
Never 41 41.41
Table I. Factual description of Respondents
information services give and needed patients
are presented in table.
RESULT AND DISCUSSION
The result showed that the implementaion
of drug information service at pharmacy in
Yogyakarta had been conducted well. The
respondents involved in this study were 99
respondents, with a factual overview of the
respondents are presented in table I
The factual of respondents in Table I
showed that 90.91% of respondents were
costumers pharmacy where research, their often
visit the pharmacy. Respondents drugs
purchased at pharmacies without a prescription
or self medication as much as 63.64%, is greater
than the prescription drugs that reached 36.36%.
The majority of respondents status were patients
on drugs purchased by 67.68%, which is only
58.59% of respondents who had give the full
drug information services. From the statement of
100% of respondents require drug information
services.
The implementation of the drug
information service at the pharmacy, was
description in Table II. The drug information
services was observed form aspects of drug
information.
The implementation of the drug
information service at the pharmacy in Table II,
showed that the aspects of drug information had
been conducted well. There were four
information aspects was give to the patients.
Based on the observation, 70% patients
experienced drug information service on the
name of the drug and aimed of treatment, the rule
of drug used, the schedule of drug used, and the
period of drug used. However, the information
on the adverse effect of the drug and the drug
storage were not implemented optimally. There
were less than 70% patient giving the adverse
effect of the drug and drug storage information.
Moreover, the number of patients giving
information on drug toxicity and things to do
related to drug toxicity reached merely 33,33%,
whereas patient who come to phramacy is out
patient who is responsible to the drug used.
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Aspects of Drug Information
Percentage
(%)
Parameter
The information of drug name and aimed of
treatment
89.90
Pharmacists give the information of drug name,
efficacy and aimed of treatment
The information of frequency or schedule of drug
use
93.94
Pharmacists give the information of frequency or
schedule of drug use and drug dose
The rule of drug use information
93.94
Pharmacists give the rule of drug use, especially
for special drug use
The period of drug used
75.76
Pharmacists give the period of drug used
information
Adverse effect of the drug
67.68
Pharmacists give the information at general
adverse effect of the drug in most of the patients
drug used
The drug toxicity and things to do related to drug
toxicity
33.33
Pharmacists give the drug toxicity information and
things to do related to drug toxicity
The drug storage 60.61 Pharmacists give the drug storage information
Table II. Aspects of Drug Information Service
next study can used another methods to analysed,
and completely analysis of the data.
CONCLUSION
Implementation of drug information
service at pharmacy in Yogyakarta had been well
conducted. Nevertheless, some aspects of drug
information were not implemented optimally
1. Patients at pharmacy in Yogyakarta overall
needs drugs information services
2. There were four information aspects was give
to the patients
3. Implementation drug toxicity and things to do
related to drug toxicity information reached
merely 33.33%
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Abstract
Background. Oxidative stress is one cause of death of neurons in the brain. The reduced
number of neurons from oxidative stress disrupt memory functions of the brain that causes dementia.
Turmeric (Curcuma domestica Val.) contains curcumin, which has antioxidant activity.
Objective. This study aims to determine the effect of ethanol extract of turmeric (Curcuma
domestica Val.) to plasma lipid peroxide level on Wistar rat induced by trimethyltin chloride.
Methods. This study performed 45 male Wistar rats, divided into 6 groups randomly. Group I
was a healthy control group, which the rat given CMC-Na solvent. Group I as a negative control was
given trimethyltin (TMT) 12.5 mg/kg intraperitonially on 9th day. Group III as a positive control, was
given by Piracetam dose 500 mg/kgBW. The groups IV, V and VI were given turmeric ethanol extract
dose 120 mg/kgBW, 240 mg/kgBW and 480 mg/kgBW orally. All treatments carried out for 8 days. On
9th day, groups II, III, IV, V and VI induced by 12.5 mg/kg TMT intraperitoneally. After 24 h of TMT
injection, the blood were taken to measure malondialdehyde (MDA) level which is a biomarker of
lipid peroxidation using TBARSC18 (Thiobarbituric Acid Reactive Substance C18) method. MDA
levels of data were statistically analyzed using the test for normality and homogeneity test followed by
ANOVA and Post Hoc Least Significant Difference (LSD).
Outcome measured. MDA levels using TBARSC18 (Thiobarbituric Acid Reactive Substance
C18) method
Results. The results showed that administration of ethanol extract of turmeric for 8 days can
reduce plasma MDA level on rat induced by TMT. Piracetam dose 500 mg/kg body can lower MDA
level 85.53%. While turmeric ethanol extract dose 120, 240 and 480 mg/kgBW lowered MDA levels
respectively 46.80%, 61.36% and 81.17%.
Conclusion. Ethanolic extract of turmeric for 8 days can reduce plasma MDA level on rat
induced by TMT
Keywords : lipid peroxides, antioxidants, dementia, trimethyltin, ethanol extract of turmeric
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INTRODUCTION
Oxidative stress is an important
pathogenesis of dementia. Brain cells are
particularly vulnerable to oxidative damage
because of their high utilization of oxygen and
the substantial polyunsaturated fatty acid
content, and this organ has limited ability to
combat oxidative stress (Halliwell and
Gutteridge, 1985; Halliwell, 2001). Oxidative
damage to lipid (lipid peroxidation) and protein
(protein carbonyl formation) can lead to
structural and functional disruption of the cell
membrane, inactivation of enzymes, and finally
cell death. Oxidative damage to lipid can lead to
formation of breakdown products such as
malondialdehyde (MDA), 4-hydroxy-2,
3-nonenal (HNE), acrolein, etc. Antioxidant
agents from diet have a significant therapeutic
influence on various neurodegenerative
disorders associated with oxidative stress
(Ahmad et al., 2005; Ishrat et al., 2006).
Turmeric contains curcumin which has
been known to have antioxidant activity
(Rochmaulana, 2009). Curcumin can reduce
oxidative stress and amyloid pathology
associated with Alzheimer’s dementia (Menon
and Sudheer, 2007). This study aim is to
determine the antioxidant effects of turmeric
(Curcuma domestica Val.) ethanol extract on
MDA plasma levels of rat dementia model
induced by trimethyltin.
METHODS
1. Material
Turmeric were obtained from Samigaluh,
Kulonprogo, Trimethyltine (TMT) were
purchased from Sigma Chem. Other chemicals
such as curcumin, H3PO4, Tiobarituric Acid,
Tetraetoxiprophylene were obtained from
Integrated Research and Testing Laboratory,
Gadjah Mada University.
2. Animal Treatment
Male adult Wistar rats of 100–20 g BW
were used for all experiments. They were housed
in separate cages under 12 h light and 12 h dark
periods. Rats had free access to standard food
and water ad libitum. 45 male Wistar rats,
divided into 6 groups randomly. Group I was a
healthy control group, which the rat given
CMC-Na solvent. Group I as a negative control
was given trimethyltin (TMT) 12.5 mg/kg
intraperitonially on 9th day. Group III as a
positive control, was given by Piracetam dose
500 mg/kgBW. The groups IV, V and VI were
given turmeric ethanol extract dose 120
mg/kgBW, 240 mg/kgBW and 480 mg/kgBW
orally. All treatments carried out for 8 days. On
9th day, groups II, III, IV, V and VI induced by
12.5 mg/kg TMT intraperitoneally. After 24 h of
TMT injection, the blood were taken to measure
malondialdehyde (MDA) level which is a
biomarker of lipid peroxidation using
TBARSC18 (Thiobarbituric Acid Reactive
Substance C18) method
3. Extraction of turmeric
A total of 250 grams of turmeric powder
were weighed and then put into a stirred
maserator electric, added 1.0 liters of 96%
ethanol, stirred for 3 hours, allowed to stand for
24 hours. The filtrate was evaporated, weighed,
and then counted its yield.
4. TLC densitometry-test
TLC test aims to ensure the presence of
curcumin in turmeric extract and determine
levels of curcumin in the extract. Previously
made standard stock solution of curcumin
concentration of 1 mg / ml. The standard stock
solution was diluted to 0.125; 0.25, 0.5, 1, 2, 4
mg / ml. Sample solution was prepared by
dissolving 100 mg of the extract into 10 ml of
96% ethanol. Standard solution and the sample
spotted on the fixed phase 60 F254 silica gel and
eluted with mobile phase chloroform: methanol
with a ratio of 9: 1. Paches were read by
TLC-densitometer at a wavelength of 426 nm.
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5. Determination of MDA Level
Levels of MDA was determined using the
or Reactive Substance C18 (TBARSC18) method
(Wuryastuti, 2000). Lipid peroxide precipitation
is done by mixing 0.75 m H3PO4, TBA 0.25 mL,
0.05 mL of sample / blank / standard TEP and
0.45 mL H2O with a vortex for 2 minutes, then
heated in a waterbath for 60 min at 100 ° C. The
mixture then was cooled for 1-2 hours until the
temperature reaches 30oC. The mixture was
eluted on C18 column, then placed in a 1 cm
cuvette for absorbance read with a
spectrophotometer at a wavelength of 532 nm.
MDA levels is in units (mmol / L)
RESULT AND DISCUSSION
The yield of 96% ethanol extract of the
rhizome of turmeric (Curcuma domestica Val.)
suggests that as many as 1000 g powder turmeric
extract obtained weighing 297.7 g extract. While
based on the TLC test showed spots of
compounds curcumin extract is at Rf 0.65 and
standard curcumin is at Rf 0.65. It is proved that
turmeric extract containing curcumin compound,
with curcumin levels were obtained at 15.78% w
/ w.
The level of MDA was determined by
TBARSC18 method using a spectrophotometer
with a maximum wavelength of 532 nm.
Principle of the assay by reading the absorbance
of the complex MDA-TBA2 (pink). The
complex formation reaction MDA-TBA2 was
shown in Figure 2.
The reaction between one molecule of
malondialdehyde (MDA) and two molecules
tiobarbiturat acid (TBA) as a nucleophilic attack
involving all five of TBA carbon and carbon to
one of MDA followed by dehydration and the
same reaction occurs in the molecule into two
TBA-MDA complex formed TBA2 pink (Grotto
et al., 2009).
Based on statistical tests showed that
trimethyltin administration can significantly
increase plasma levels of MDA. TMT selectively
can reduce the population of neurons in the brain,
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A : Spot of curcumin standard
B : Spot of extract
1 : Curcumin
2 : Demetoxicurcumin
3 : Bisdemetoxicurcum
Figure 1. The Profil of Thin Layer Chromatography of
Turmeric Extract
Figure 2. Reaction between MDA and MDA-TBA into
TBA2 (Grotto et al., 2009)
Group Treatment Average of MDA levels (mmol/L) ± SD
I Control 0,0808 ± 0,0392
II TMT group 2,0742 ± 0,0996
III Pirasetam group 0,3000 ± 0,1095*
IV Extract 120 mg/kgBB 1,1035 ± 0,0860*
V Extract 240 mg/kgBB 0,8014 ± 0,0752*
VI Extract 480 mg/kgBB 0,3905 ± 0,0643*
*differnce significant with TMT group (p<0,05)
Table I. The average of MDA level in all groups
especially the hippocampus formation that plays
a role in the memory process. Trimethyltin lead
to activation of NMDA receptors and cainic acid
toxin that produces a number of free radicals or
reactive oxygen species ROS group (Shin et al.,
2005). NMDA receptor activation causes the
increasing of ROS. ROS are free radicals of
oxygen reactive group that includes the triplet
(3O2), single (singlet/1O2), superoxide anion
(O2. -), hydroxyl radical (-OH), nitric oxide
(NO), peroxynitrite (ONOO-), hipoklorus acid
(HOCl), hydrogen peroxide (H2O2), alkoxyl
radical (LO-), and peroxyl radicals (LO-2)
(Hadyathma, 2010). Free radicals can attack
polyunsaturated fatty acids (PUFA) in the nerve
cell membrane and induce lipid peroxidation
resulting in increased lipid peroxidation product
such as malondialdehyde. The increasing of
malondialdehyde has been reported to occur in
patients with Alzheimer's dementia (Devore et
al., 2010).
The groups administered by turmeric
extract dose 120 mg / kg, 240 mg / kg, 480 mg /
kg can decrease MDA levels as many 46.80%,
61.36%, 81.17% respectively compared with
TMT group.
Turmeric extract can reduce levels of
MDA plasma. The largest decrease was shown in
the group given 480 mg kg / BW of turmeric
extract. Turmeric containing curcumin known as
an antioxidant. Curcumin is a lipophilic
compound that can enter the blood-brain barrier.
The antioxidant activity of curcumin the
methoxy group and phenols that can capture free
radicals, such as superoxide anion radicals,
hydroxyl radicals and nitrogen dioxide radicals
(Chattopadhyay et al., 2004). Binding of free
radicals by curcumin produce more stable
products such as vanillin, ferulic acid and
curcumin dimer (Fujisawa et al., 2004).
Decrease the amount of free radicals by
curcumin prevents oxidative stress resulting in
lower risk of lipid peroxidation and increased
lipid peroxidation products such as
malondialdehyde. Therefore, turmeric is
expected to be used for the treatment of
dementia.
In the group given pirasetam indicate that
piracetam can also reduce levels of MDA.
Pirasetam (2-oxo-pyrrolidone) is nootropik drug
which is structurally related to GABA. Pirasetam
have various effects on glutamate
neurotransmission at micromolar levels while
also piracetam potentiate potassium-induced
release of glutamate from hippocampal nerve.
Pirasetam have an effect on the subunits of
glutamate NMDA receptors are involved in
learning and memory. Pirasetam can give
comprehensive effect on brain
neurotransmission via modulation of ion
channels (ie, Na +, K +). Additionally, pirasetam
protects neurons against oxidative stress by
normalizing activity associated cell membrane
(Alkuraishy et al., 2012).
CONCLUSION
The results showed that administration of
e turmeric ethanol extract for 8 days can reduce
plasma MDA level on rat induced by TMT.
Pirasetam dose 500 mg/kg body can lower MDA
level 85.53%. While turmeric ethanol extract
dose 120, 240 and 480 mg/kgBW lowered MDA
levels respectively 46.80%, 61.36% and 81.17%
compared with TMT group.
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Group Treatment The percentage of decreasing MDA levels
III Pirasetam group 85,5%
IV Extract 120 mg/kgBB 45,80%
V Extract 240 mg/kgBB 61,36%
VI Extract 480 mg/kgBB 81,1%
Table ll. The percentage of the decreasing of MDA levels
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Abstract
Background. Hyperuricemia and gout appear to be rapidly increasing worldwide and
frequently cause symptom metabolic syndrome. Mimosa pudica L and Manihot utilissima Pohl have
flavonoid can decreasing hyperuricemia.
Objective. Aim of study was investigate the effects ethanol extract Mimosa pudica L and
Manihot utilissima Pohl for antihyperuricemic in poultry.
Methods. Extraction compounds from Mimosa pudica L and Manihot utilissima Pohl by
maceration method. Identification flavonoid using spectrophotometer UV with the scan lambda max.
The study were divided 20 poultry in five groups. Group I is a health control was given food and drink,
group II is hyperuricemia control was given food, drink and chicken liver juice with concentration
100% orally for 2 weeks, group III is positive control was given food, drink, poultry liver juice with
concentration 100% orally for 2 weeks and allopurinol 10 mg/kg BW, group IV ethanol extract
Mimosa pudica L control was given food, drink, poultry liver juice with concentration 100% orally
for 2 weeks and ethanol extract Mimosa pudica L 93 mg/kg BW and group V ethanol extract Manihot
utilissima Pohl control was given food, drink, poultry liver juice with concentration 100% orally for 2
weeks and ethanol extract Manihot utilissima Pohl 93 mg/kg BW. Analyze data using Mann-Whitney
Test and ANOVA with P 95%.
Outcome measured. On day 15 checked uric acid on period I 30 minutes after treatment and
period II 60 minutes after treatment in using Easy Touch Glucose Cholesterol Uric Acid kit.
Results. The data decreasing uric acid level from ethanol extract Mimosa pudica L 1,70 mg/dl
(22%) and ethanol extract Manihot utilissima Pohl 1,43 mg/dl (21%).
Conclusion. Oral administration of ethanol extract Mimosa pudica L and ethanol extract
Manihot utilissima Pohl was be able to reduce uric acid levels in hyperuricemic poultry with no
significant effects compare with allopurinol.
Keywords : Hyperuricemia, Mimosa pudica L, Manihot utilissima Pohl.
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INTRODUCTION
The development of modern life
increasingly demanding technological advances
human participation to more quickly in the
activities. This creates a fully practical lifestyle
including in controlling the intake of unhealthy
food. Lifestyle such as this increase the
occurrence of various diseases, one of which is
marked by an increase of gout uric acid in the
blood.
Uric acid is the substance of the final
product or the nucleic acid purine metabolism in
the body. Uric acid is produced from the primary
metabolism of purine nucleoside purine bases
hipoxantin late, xantin and guanine. When there
is deviation in the process will increase levels of
uric acid, called hiperurisemia conditions
(Murray et al., 2009).
Hiperurisemia an early sign of gout or
pirai. Gout is closely linked to disorders of
purine metabolism which raises the level of
serum uric acid that is> 7.0 mg / dl (Wells et al.,
2000). Hiperurisemia can give rise to kidney
stones result in kidney failure. Uric acid is a risk
factor for coronary heart disease. Unexpectedly
uric acid crystals will damage the endothelial or
vascular coroner. Based on clinic patient data
Cipto Mangunkusumo Hospital (RSCM),
Jakarta, patients with uric acid appears to seven
percent of the patients suffering from rheumatic
diseases. Hiperurisemia prevalence of
approximately 2.6 to 47.2%, which varies in
different populations. While the prevalence of
gout varies between 1 to 15.3%. In a study
obtained 4.9% incidence of gout in the blood uric
acid> 9 mg / dl, 0.5% at a rate of 7 to 8.9% and
0.1% at a rate of <7 mg / dl. The cumulative
incidence of gout achieve up to 22% after 5
years, at the rate of uric acid> 9 mg / dl
(Hidayat,2009).Increase the incidence of
dementia (Herlina, 2010).
Treatment chemically expensive and take
a long time and side effects of medicines gout (eg
intoxification acute kolkisin, gastritis on
NSAID's (Non Steroid Antiinflamation Drugs),
dermatitis allergic to probenecid) (Katzung,
2002) make the community look for drug
alternative. Indonesian nation ancestors leverage
available in the natural plant as medicine. Plants
used traditionally to reduce the levels of uric acid
is the daughter of shame and yam leaves.
Mimosin contains compounds shy daughter,
pipekolinat acid, tannins, alkaloids, saponins,
triterpenoids, sterols, polyphenols, and
flavonoids. Meanwhile yam leaves contain
flavonoids (Anonymous, 2000a).
According to the Coss et al. (1998),
several flavonoid and alkaloid compounds can
inhibit oxidase xantin work so as to inhibit the
formation of uric acid in the body. Susanti study
(2006) showed that plants contain flavonoids
inhibited oxidase activity xantin work can
decrease levels of uric acid in the blood.
Research Anderson et al. (2001) etanolik
fractions containing flavonoids chysin shy
daughter, apigenin, luteolin, kaempferol,
galangin, quercetin, rhamnetin, myricetin,
gossypetin.
Based on the theoretical background and
above, it can be concluded that the hypothesis of
ethanol extracts of herbs giving daughter
embarrassed and ethanol extracts of leaves of
sweet potatoes can lower uric acid induced
chicken liver juice. Provide alternative
information for gout particularly shy daughter
herba and cassava leaves. Enriched scientific
data on the benefits of traditional medicinal
herbs daughter particularly shy and cassava
leaves on gout treatment in order to develop
herbal medicine.
METHODS
Material
Reagent needed include: Powder shy
daughter herbs and leaves yams, ethanol extracts
of herbs and shy daughter yams leaf ethanol
extract, ethanol, diethyl ether, anhydrous
Na2SO4, male chickens with body weight 1.5 kg,
chicken liver juice , 100 mg allopurinol with
potential.
150 Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013
ISBN : 978-979-18458-6-1
Tool
Research tools needed include: analytical
scales to weigh the powder material simplicia
(OHAUS), glass ware, magnetic strirrer, rotary
evaporator, reflux, filter paper, container form
squares, Buchner funnel, porcelain mug, animal
weighing test, oral spuit 10 ml, uric acid plumb
Easy Touch GCU (Glucose Cholesterol Uric
Acid), lancette needle, alcohol as a cleaner, gout
strip, UV spectrophotometer.
Extract Proces
Extracts made by dipping respective shy
daughter of herbal powder and yam leaves with
ethanol extractor squares as possible using a
container with magnetic stirring strirrer.
Extraction is done until all flavonoids extracted
by using FeCl3 checked. Filtrate obtained
filtered using filter paper with a Buchner funnel
and vacuum relief. Dioven then dried, dry
powder is calculated as the yield. Once the
powder is dried and direfluks dikerik for 1 hour
and dievaporasi use rotar evaporator to make it a
thick liquid, then evaporated on a waterbath to
extract thick
Pharmacological Test
Experimental animals used in this study
were male chickens weighing 1.5 kg.
experimental animals first adapted to the
environment for 7 days. Chicken uric acid
increased (made hiperucemia) by way of chicken
liver juice for 14 days 2 times a day for peroral
and on the 15th day is done checking uric acid
increased and given medication. The checking is
done of uric acid in the II period. Period I made a
check at 30 minutes after treatment and period II
performed at 60 minutes after treatment.
Experimental design was used with the group
treated with the negative control group and
comparing the levels of uric acid was treated
before and after being given treatment.
Induction Juice Chicken Liver
Used chicken liver juice concentrate
100% 5 ml / kg body weight morning and
evening for 2 weeks.
Data Analysis
Difference form of the data obtained
decrease levels of uric acid. statistical test data
with the Mann-Whitney test and ANOVA.
Results and discussion determination of group.
Identification is done to prove that the
powder used in this study is shy daughter herbal
powder and leaves yams. Microscopic
identification is done in Laboratory Faculty of
Biology University of Ahmad Dahlan. Based on
the results obtained that the identification of the
powder used in this study are herbal shy daughter
(Mimosa pudica L.) and cassava leaves (Manihot
utilissima Pohl.).
Extract Yield
Manufacture of ethanol extracts of herbs
and leaves shy daughter performed in laboratory
yams Phytochemistry Faculty of Pharmacy
University of Ahmad Dahlan. Obtained extract is
made using maceration method ie with stirring
and soaking liquid extractor rhizome powder that
is 96% ethanol. Ethanol to semipolar compounds
have properties that can be extracted semipolar
nature. A part from that mold and bacteria grow
in the privacy of 20% ethanol, ethanol can be
mixed with water in a variety of comparisons, as
well as a good solvent for hydrophilic and
lipophilic compounds. Extraction method used is
maceration. This method is done by soaking the
plant material that has been refined / milled in the
selected solvent, and then stored in a certain
period in a dark place. Gain maceration method
is simple, and cheap. Maceration method that is
also a lack of a long time (Kiranmai et al., 2011).
Extracts tested qualitatively using UV
spectrophotometer to perform a scan on the
lambda max produced from the extract.
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Measurement of uric acid
After administration of ethanol extracts of
herbs and leaves shy daughter yams, do check
levels of uric acid. Effect of ethanol extracts of
herbs and leaves shy daughter yams seen from a
decrease levels of uric acid. I average yield
reduction of uric acid period after administration
of ethanol extracts of herbs and leaves of yam
shy daughter on oral test animals can be seen in
Table I and Figure 1.
Analysis of the data with the
Kolmogorov-Smirnov test showed that the
distribution of long data retention mice in this
study is not normal. This is demonstrated by the
significant value of p = 0.000 (p <0.05) for the
six groups. Test of homogeneity (Levene test)
also showed the value of p = 0.000 (p <0.05)
which means that the distribution of the data to
the six groups are not homogeneous. From the
results of the tests of normality and
homogeneity, then for subsequent data analysis
using non-parametric analysis Kruskal Wallis
and Mann-Whitney test. Kruskal Wallis test
results show that there is no significant
difference in the decrease in uric acid group mice
between 3 and 4, 3 and 5, 4 and 5. This is
indicated by the value of significance (p>, 05).
Then performed Mann-Whitney test to compare
differences between groups long retention
results can be seen in Table II.
Based on the results of statistical tests in
healthy controls compared with the control
group of drugs (allopurinol), control herbaceous
shy daughter and gained control of cassava leaf
significance <0.05, which means there is a
significant difference in lowering uric acid to the
group. Whereas in the control group with the
control group herbal medicines shy daughter
gained significance> 0.05, which means there is
no significant difference in lowering uric acid in
both groups. Control the drug can lower uric acid
by 4.93 mg / dl (63%), ethanol extract shy
daughter herb can lower uric acid by 1.53 mg / dl
(21%).
On drug control group with the control
group gained significance cassava leaves> 0.05,
which means there is no significant difference in
lowering uric acid in both groups. Control
medication (allopurinol) can lower uric acid by
152 Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013
ISBN : 978-979-18458-6-1
Group
Dose
(mg/kg body
weight)
Average Uric Acid mg/dl ± SD
Uric Acid
Level
Reduction
Of Uric Acid
Margin decline
Normal - 3,16±0,51 2,90±0,45 0,26±0,05
Sick - 8,73±3,25 8,40±3,30 0,30±0,05
Allopurinol 10 7,73±0,66 2,80±0,17 4,93±0,83
Shy daughter herba 93 7,43±2,11 5,90±2,16 1,53±0,71
Cassava leaves 93 6,56±2,10 5,00±1,68 1,43±0,61
Table I. Uric acid reduction of the period I
Figure 1. Histogram purata decrease uric acid period I
4.93 mg / dl (63%), ethanol extract of cassava
leaves can lower uric acid of 1.43 mg / dl (21%).
Based on the results of statistical tests in
healthy controls compared with the control
group of drugs (allopurinol), control herbaceous
shy daughter and gained control of cassava leaf
significance <0.05, which means there is a
significant difference in lowering uric acid to the
group. Whereas in the control group with the
control group herbal medicines shy daughter
gained significance> 0.05, which means there is
no significant difference in lowering uric acid in
both groups. Control the drug can lower uric acid
by 4.93 mg / dl (63%), ethanol extract shy
daughter herb can lower uric acid by 1.53 mg / dl
(21%). On drug control group with the control
group gained significance cassava leaves> 0.05,
which means there is no significant difference in
lowering uric acid in both groups. Control
medication (allopurinol) can lower uric acid by
4.93 mg / dl (63%), ethanol extract of cassava
leaves can lower uric acid of 1.43 mg / dl (21%).
Hyperuricemia control group with the
control group cassava leaves gained
significance> 0.05, which means there is a
significant difference in lowering uric acid in
both groups. Control of herbal extracts shy
daughter can lower uric acid by 1.53 mg / dl
(21%), ethanol extract of cassava leaves can
lower uric acid of 1.43 mg / dl (21%). Qualitative
test results generated from scans lambda max in
ethanol herb extract shy daughter and cassava
leaves indicate the presence of flavonoid
compounds. Ability to reduce uric acid produced
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Compared Group Significancy Results Mean
1 vs 2 0,197 No significant 1 = 2
1 vs 3 0,046 Significant 1 < 3
1 vs 4 0,046 Significant 1 < 4
1 vs 5 0,046 Significant 1 < 5
2 vs 3 0,046 Significant 2 < 3
2 vs 4 0,046 Significant 2 < 4
2 vs 5 0,046 Significant 2 < 5
3 vs 4 0,050 No Significant 3 = 4
3 vs 5 0,050 No Significant 3 = 5
Table II. Mann-Whitney test results decreased uric acid period I
Group Dose (mg/kgBW)
Average Uric Acid mg/dl ± SD
Uric Acid
Level
Reduction
Of Uric Acid
Margin decline
Normal - 3,43±0,15 2,86±0,34 0,56±0,05
Sick - 8,53±3,05 7,90±3,03 0,60±0,05
Allopurinol 10 7,73±0,66 2,36±0,32 5,36±0,40
Shy Daughter Herbs 93 7,43±2,11 5,73±2,24 1,70±0,60
Cassava Leaves 93 6,80±2,51 5,36±2,46 1,43±0,30
Table III. decreasement uric acid period II
by the ethanol extract of herbs and shy daughter
cassava leaves made possible due to the activity
of the flavonoid compounds.
Results Uric Acid Measurement Period II
Uric acid measurement period II
performed at 60 minutes after treatment meant to
know are there any decrease in uric acid levels
after the first period at the time of 60 minutes.
Kolmogorov-Smirnov test results data is
the difference in reduction of uric acid in this
study are normally distributed with (p> 0.05),
whereas the acquired Levene test (p> 0,05).
Subsequent data analysis using parametric
analysis one way ANOVA post hoc test followed
SLD. In the ANOVA significance value of 0.000
(p <0.05), which means that there are significant
differences in the numbers purata difference
between groups decreased uric acid. LSD test is
then performed to determine differences in error
rate of each rat kelompok.Hasil LSD test are
shown in Table IV.
Based on the results of statistical tests in
healthy controls compared with the control
group of drugs (allopurinol), control herbaceous
shy daughter and gained control of cassava leaf
significance <0.05, which means there is a
significant difference in lowering uric acid to the
group. Whereas in the control group with the
control group herbal medicines shy daughter
gained significance <0.05, which means there is
a significant difference in lowering uric acid in
both groups. Control the drug can lower uric acid
by 5.36 mg / dl (69%), ethanol extract shy
daughter herb can lower uric acid by 1.70 mg / dl
(22%).
On drug control group with the control
group gained significance cassava leaves <0.05,
which means there is a significant difference in
lowering uric acid in both groups. Control the
drug can lower uric acid by 5.36 mg / dl (69%),
ethanol extract of cassava leaves can lower uric
acid of 1.43 mg / dl (21%).
Hyperuricemia control group with the
control group cassava leaves gained
significance> 0.05, which means that each
contained a significant difference in lowering
uric acid in both groups. Control of herbal
extracts shy daughter can lower uric acid by 1.70
mg / dl (22%), ethanol extract of cassava leaves
can lower uric acid of 1.43 mg / dl (21%).
Qualitative test results generated from
scans lambda max in ethanol herb extract shy
daughter and cassava leaves indicate the
presence of flavonoid compounds.
Ability to reduce uric acid produced by the
ethanol extract of herbs and shy daughter cassava
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Normal Sick Allopurinol
Shy
daughter
Cassava
leaves
Uric Acid Level 3,43 8,53 7,73 7,43 6,8
Reduction Of Uric Acid 2,86 7,9 2,36 5,73 5,36
Margin Decline 0,56 0,6 5,36 1,7 1,43
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Figure 3. Histogram purata period II decreased uric acid
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Figure 4. Histogram of the percentage difference in uric
acid decreased during the period of II
leaves made possible due to the activity of the
flavonoid compounds.
CONCLUSION
Based on the results of this study
concluded that:
1. Ethanol extract herbal shy daughter dose 93
mg / kg and ethanol extract of leaves of
cassava dose 93 mg / kg body weight can
lower uric acid induced in chicken liver
chicken juice.
2. Purata decrease uric acid levels obtained by
the ethanol extract herbal shy daughter dose
93 mg / kg by 1.70 mg / dl (22%), cassava
leaves ethanol extract dose 93 mg / kg BW of
1.43 mg / dl (21%)
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Background. The tendency to use of herb drug simultaneously with synthetic drug may result
in an interaction. Red ginger contains gingerol and shagaol proven to increase gastric emptying time
and have antiplatelet activity, which causes the blood becomes more dilute, the heart of the work is
lighter, so the smooth blood flow, which in turn may affect the bioavailability of furosemide.
Objective . This study aims to determine the difference between the effect of 2 hours before, 4
hours after coadministration with infusa and red ginger (Zingiber officinale Roxb.) on the
bioavailability of the tablet furosemida in male rabbits.
Method. The cross over design with the same subject was used in this study. The samples
consisted of 80 mg furosemide with 0%b/v, 5%b/v, 7,5%b/v and 10%b/v red ginger infusa, 2 hours
before administration furosemida tablet, 4 hours after administration of tablets furosemida. Blood
sampling is done throught marginalis vein and performed at the 0,5; 0,75; 1; 1,5; 2; 3; 4; 6; 8; and
24. Furosemida levels in blood plasma using the Kelly's method modified by Hakim. Bioavailability
parameters are determined directly from the graph the relationship Cp vs t while the AUC determined
using the trapezium method.
Outcome measurement. The results then were used to evaluated the bioavailability
parameters: tmaks, Cpmaks, and AUC
o- and were analyzed using ANOVA test in the same way as well as
95% trust standart.
Result. Value Cpmax, from treatment respectively for 43.2 ug / ml, 58.3 g / ml, 182 g / ml, and
119 g / ml. Tmax value of treatments A, B, C, and D, respectively for 5.4 hours, 5.2 hours, 5 hours,
and 3.6 hours. Value AUCo- of treatments A, B, C, and D, respectively for 668 g.jam / ml, 867
g.jam / ml, 1808 g.jam / ml, and 1459 g.jam / ml.
Conclusion : The results showed that infusa red ginger (Zingiber officinale Roxb.) with a
variation of the timing of 2 hours before, 4 hours after, and together with the provision may affect the
bioavailability of the tablet furosemida, where prices Cpmaks and AUC on all three treatments is
greater than the control and in each treatment there were significant differences (P < 0,05), while the
price tmaks did not differ significantly with control or equal to controls (P > 0,05).
Key words : Furosemida, red ginger (Zingiber officinale Roxb.) Bioavailability.
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INTRODUCTION
Millions of people use herbal medicine in
conjunction with synthetic drugs without the
doctor's recommendation (Gohil and Patel,
2007). The general public thinks, herbal
medicines can reduce the side effects of drugs
taken and can improve the effectiveness of
treatment (Inamdar et al., 2008). Although
considered natural, many medicinal herbs that
can interact with other medications causing
harmful side effects and or reduce the benefits of
the drug (Gohil and Patel, 2007).
The number of pharmacologically active
compounds in herbal medicine, the interaction is
likely to increase. Theoretically herbal drug
interactions with synthetic drugs is higher than
synthetic drugs because the interaction of two
synthetic drugs usually contain only a single
chemical constituents (Izzo, 2004). The use of
herbal medicine in conjunction with synthetic
drugs is generally not supervised by the
physician or practitioner of herbal medicine, it
can result in harm to the patient, if they use
herbal remedies and potential drug interactions
sintetiknya have. This interaction is generally
not known until the patient is experiencing pain
or serious incident occurs that threatens the
patient's life (Gohil and Patel, 2007).
Herbs can interact with medications
through pharmacokinetic interactions and
synthetic or pharmacodynamic (Rodda et al.,
2010). Pharmacokinetic interactions lead to
changes in absorption, distribution, metabolism
or excretion of synthetic drugs or herbal
medicines that can affect drug action
quantitatively. Pharmacodynamic interactions
qualitatively affect drug action, either through
enhancing effect (synergistic or additive action)
or antagonist effects (Gohil and Patel, 2007).
Interactions between herbal medicines and
antibiotics, such as ginger and metronidazole,
may increase the toxicity of metronidazole, due
to ginger lowers kliren and elimination of
metronidazole (Okonta et al, 2008). On the other
hand, according to Young et al, (2006) Ginger
has a synergistic effect given together with
nifedipine in inhibiting platelet aggregation in
hypertensive patients.
Furosemide chosen as a model drug in this
study because it is one powerful diuretic drug
that is the first line treatment of hypertension
according to JNC VII level I (Chobanian et al,
2003). Furosemide categorized as BCS class II
drug because of poor solubility. Furosemide has
a dose-response curve is steep and high protein
binding, ie by 95% so that furosemide as a
potential drug interactions with objects on drugs,
drugs with food (Mc Evoy, 2002). Red ginger
contains gingerol and shogaol proven to increase
gastric emptying time and have antipletet
activity, which causes the blood becomes more
dilute, the heart of the work is lighter, so the
smooth blood flow, which in turn can affect the
bioavailability of furosemide tablets.
MATERIALS AND METHODS
The main material used is a 9 month old
red ginger obtained from Bantul area. The
chemicals used were pa furosemide powder,
furosemide tablets (Indofarma), ethyl acetate pa
(E Merck), HCl pa (E Merck), phosphate buffer
pH 8 (NaOH and KH2PO4), NaOH pa, heparin
(Invicolt), distilled water (Asia Lab.), local strain
male rabbits aged 3-4 months weighing 1.5-2 kg
(CV <5%). This study used 5 male rabbits of
local strain (n = 5) weighing between 1.5-2 kg
(CV <5%), were studied using a cross-over
design (Table I) with 6 kinds of treatment.
Before the treated rabbits were fasted for 1
day. For each treatment was given 7 days
washout (t1 / 2 preliminary experiments (control
1) is 8.15 hours). After drug administration,
blood was collected at 0.5 hours, 0.75, 1, 1.5, 2,
3; 3.5; 4; 8 and 24, via Marginal ear vein of
rabbits. Blood collected in tubes that had been
given heparin ependrof. The blood levels of
furosemide in accordance with the method set
out Kelly et al. modified by the Judge (1996).
Blood plasma (250 mL) plus 0.1 N HCl (50 mL)
and then mixed disari with ethyl acetate (3.0 mL)
using a vortex for 2 minutes. The organic layer
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(2.0 mL) were taken, added to it a solution of 0.1
M phosphate buffer pH 8 (2.50 mL), and then
in-vortex for 2 min and in-centrifuged (2500
rpm, 10 min). Buffer layer is taken 2.0 mL
acidified with 0.5 N HCl (1.0 mL). Subsequently
the solution was measured at a wavelength of
excitation intensity and maximum emission
using spectrofluorometer (Hitachi F 2500).
Determination of bioavailability parameters
of furosemide
Bioavailability parameters include tmax,
Cpmaks, and AUC0 -  obtained directly from the
curve relationship between drug concentration
and time, and AUC0 -  obtained by the
trapezoidal method.
RESULTS AND DISCUSSION
Determination of furosemide levels in the
blood carried by spectrofluorometer that had
been previously validated. The result of the
excitation and emission wavelengths of
furosemide in blood plasma obtained
respectively 273 nm and 408 nm. Linear
regression equation to calculate the levels
obtained: Y = 1.7448 X + 14.5463, with a
correlation coefficient of 0.9970 is greater than r
table 0.754 (n = 9 and 95% confidence level).
Recovery value of 104.84 ± 1.3 to 118.53 ±
2.42%. Value of plasma levels of furosemide in
blood at any given time are presented in Table II.
With fluctuating results in Figure 5 has
area under the curve (AUC) was determined
using the trapezoidal method, the average of the
levels obtained, while tmax and Cpmaks directly
from the graph of the results of the assay
furosemide in blood plasma for each treatment.
More results can be seen in Table III.
From previous experiments on the effect
of food on the bioavailability of furosemide, said
that the food does not significantly affect the
bioavailability of furosemide (Kelly et al, 1974).
Unlike the other experiments (McCrindle et al,
1996) that furosemide 40 mg were given and
analyzed using HPLC, the food may decrease the
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Rabits
Week
I II III IV V VI
1 F0 F1 F2 F3 F4 F5
2 F1 F2 F3 F4 F5 F0
3 F3 F4 F5 F0 F1 F2
4 F4 F5 F0 F1 F2 F3
5 F5 F0 F1 F2 F3 F4
F0: furosemide 80 mg tablet (control).
F1: Giving with 5 mL of red ginger infusion 5% with furosemide tablets.
F2: Giving with red ginger infusion 5 mL of 7.5% with furosemide tablets
F3: Giving red ginger infusion 5 mL 10% 2 hours before furosemide tablets
F4: Giving with red ginger infusion 5 mL 10% with furosemide tablets.
F5: Giving red ginger infusion 5 mL 10% 4 hours after furosemide tablets Note: delivery volume of 5 mL
infusion administered orally.
Table I. The design of Cross Over in determining the bioavailability of the furosemide tablet infusion
on coadministration of red ginger
bioavailability of furosemide by 30% and other
studies also suggested breakfast can decrease the
bioavailability of furosemide by 30%, but is not
affected by the long Gastric emptying time
(Beerman & Midskov, 1986).
From the results of research conducted, to
see the effect of ginger rhizome infusion
concentration given that the concentration of
5%, 7.5%, and 10% w / v with furosemide, the
price obtained is obtained from the smallest tmax
furosemide treatment concentration of 7.5%,
which is 4 , 4 hours. This indicated that the
coadministration treatment of red ginger
infusion concentration of 7.5%, furosemide is
absorbed more quickly, made possible because
the content of oleoresin of red ginger (gingerol
and shogaol) (Yamahara et al, 1990) increases
the speed of gastric emptying (Hu et al, 2011).
Speed affects the rate of gastric emptying
unstable drug degradation in the stomach
(Devissagoet, 1982).
Area Under the Curve (AUC0-) largest
obtained from coadministration treatment of red
ginger infusion concentration of 10%, ie 1996.46
ug / mL.jam, this is due to the possibility of
active substance (gingerol and shogaol) highest,
which is known to serves as an antiplatelet
(Young et al, 2006). Next will cause the blood
thinner, lighter work of the heart and blood flow
to be smooth, so that the displacement of
furosemide from the intestine into the systemic
circulation has increased.
The maximum concentration (Cpmaks)
mainly from coadministration treatment of red
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Figure 1. Furosemide concentration curve (purata ± SE) in
plasma as a function of time, with each male rabbits
treated orally at a dose of 80 mg.
Time
(hours)
Consentration (µg/mL) ±SE
F0 F1 F2 F3 F4 F5
0 0 0 0 0 0 0
0.5 10.08±3.99 9,71±3.59 16.55±3.10 8.12 ± 0.41 20.13±4.57 38.69 ± 4.72
0.75 12.64±10.87 12,92±3.74 19.33±2.95 8.47 ± 0.64 28.10±5.02 49.76 ± 4.53
1 14.73±4.11 17.77±5.02 22.14±3.47 11.92 ± 1.55 40.54±9.90 53.67 ± 6.82
1.5 25.03±9.23 25.53±10.24 40.89±12.88 14.48 ± 2.37 55.87±15.71 64.84 ± 7.59
2 25.67±9.24 31.12±13.17 49.32±14.30 22.97 ± 1.80 76.32±20.93 77.77 ± 6.30
3 38.84±15.04 47.53±16.76 64.74±14.02 37.25 ± 3.77 100.78±22.27 104.79 ± 11.17
3.5 45.07±14.91 41.27±11.02 72.77±17.36 46.84 ± 2.03 119±19.34 105.65 ± 5.28
4 50.97±14.53 47.99±12.32 82.35±20.28 56.22 ± 5.53 121.85±17.67 71.52 ±4.54
8 58.97±11.27 61.61±9.41 59.57±16.69 44.16 ± 5.29 128.05±29.23 55.52 ± 6.22
24 13.52±2.09 11.13±3.75 9.43±3.34 10.2 ± 1.73 13.26±4.34 18.57 ± 0.79
Table II. Value of furosemide levels in blood plasma (purata ± SE)
ginger infusion concentration of 10%. Cpmaks
will increase with an increase in AUC0-,
because the concentration of the drug will show
the amount of drug that will be absorbed by the
body.
From the results of the study to see the
effect of the timing of the price obtained
furosemide smallest tmax obtained from 4 hours
after treatment administration is 3.6 hours. Area
Under the Curve (AUC0-) largest obtained from
coadministration treatment of red ginger
infusion with furosemide tablet, which is
1996.46 ± 290.08 mg / ml.jam. The maximum
concentration (Cpmaks) mainly from
coadministration treatment of red ginger
infusion concentration of 10% concurrently with
furosemide tablet, which is 154.28 ± 23.49 mg /
ml.jam.
Decrease or increase of Cpmaks, tmax, and
AUC0- possible because of several factors
such as the surface area of the intestinal wall that
allows the drug to the colon greater contact, the
speed in which delay gastric emptying slows
gastric emptying and drug absorption
furosemide at acidic pH height / base more in the
form of ions while the drug is absorbed in the
intestine molecular form (Banker and Rhodes,
1996). The movement of the digestive tract and
into the blood stream absorption and decreased
movement of the drug from the gut can also
affect the amount of drug absorbed, and the
presence of the drug with mineral complex will
also affect drug dissolution rate and amount of
drug absorbed becomes smaller, so that
everything is not directly affect the
bioavailability of the drug. Not only influenced
by it alone, the stability of the drug and the
disease causes a decrease in organ function in
test animals are not known to also affect drug
absorption (Devissaguet, 1982).
These results indicate that infusion of red
ginger affect the bioavailability parameters
Cpmaks and AUC0-, but does not significantly
affect the parameters tmax, this can happen due
to many factors that affect the bioavailability of a
drug, among others, note that furosemide in
Biofarmasetika Classification System (BCS )
including two classes. Ie drugs that have a high
permeability while the low solubility or
dissolution. The active substance of red ginger
rhizome causing increased permeability. This is
due to the active substances in addition to
increase gastric emptying time, as well as
antiplatelet that is a blood thinner and blood flow
more smoothly. If the blood flow smoothly shift
from gastrointestinal to systemic furosemide
increased.
Since the results indicate that furosemide
when administered concomitantly with red
ginger infusion significantly cause changes in
bioavailability parameters Cpmaks and AUC0-,
then the use of furosemide should be careful
when consumed with red ginger infusion.
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Bioavailability
Parameters
Treatment
F0 F1 F2 F3 F4 F5
Cpmaks (g/mL) 61,36± 12,77 70,07±11,48# 87,45±18,05# 58,3 ± 3,9# 154,28±23,49* 119 ± 7,3*
tmaks (Jam) 7,2± 0,80 6,2± 1,11# 4,4± 0,98# 5,2 ± 0,4# 5,5± 1,02# 3,6 ± 0,6*
AUC 0-
(g/mL.jam)
1186,26±
150,45
1071,75±
155,22#
1096,58±
194,28#
867 ± 61#
1996,46±
290,08*
1459 ± 64#
Remark s: * No significant difference (p <0.05) with the control treatment
# No significant difference (p> 0.05) with the control treatment
Table III. Purata furosemide bioavailability parameter values ??in male rabbits
CONCLUSION
At the conclusion of research conducted
as follows:
1. There is no significant difference in the effect
of red ginger infusion by 5 ml at a
concentration of 5% w / v and 7.5% w / v in
conjunction with the bioavailability of
furosemide tablets furosemide, but the effect
on the concentration of 10% Cpmaks, and
AUC0- .
2. There is no significant difference in the
timing of the effect of red ginger infusion 5
ml of 10% w / v two hours before,
simultaneously, and 4 hours after, the
bioavailability of furosemide tablets.
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Abstract
Background. Nutmeg (Myristica fragrans) is original plant from Indonesia has sedative,
hepatoprotective, and anti-seizure activities.
Objective. The aim of this study was to determine the toxic effects of ethanol extract of nutmeg
seed on the rat kidney.
Methods. Male rats grouped into 4 groups and each group consists of 7 animals. Group I as the
control group 0.5% CMC-Na. Group II, III, and IV were given ethanol extract of nutmeg dose of 50
mg / kg, 100 mg / kg, and 200 mg / KgBW respectively. Samples were administered for 31 days, on the
32th day was taking blood from the orbital sinus eye for BUN, creatinine assay and histopathology
examination.
Outcome measured. BUN, creatinine, and histopathological profile
Results. The results showed all doses of ethanol extract of nutmeg seed causes an increase
BUN levels. While on the creatinine levels between the control group and the treatment group showed
no significant difference. Histopathological examination showed no change in renal morphology was
given ethanol extract of nutmeg seeds.
Conclusion. The conclusions this research that the ethanol extracts of nutmeg (Myristica
fragrans Houtt) seed did not cause toxic effects on the kidney.
Keyword : Biji Pala (Myristica fragrans Houtt.), BUN, Creatinine, Histopathological
morphology
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INTRODUCTION
Nutmeg (Myristica fragrans) is original
plant from Indonesia, which originated from the
archipel Malaise Banda and Maluku islands then
spread and grow into islands such as Sumatera,
North Sulawesi, and Papua. Nutmegs including
Family Myristicaceae grow to five genuses of
250 species (Drazat, 2008). Olaleye et al. (2006)
reported nutmeg seed has antioxidant activity,
anti diarrhea, carminative and stimulant. Also
has activity as sedative (Sonavane et al., 2001),
anti microba (O’Mahony et al., 2005), anti
depressant (Dhingra and Sharma, 2006), anti
diabetic (Han et al., 2008), aphrodisiaca
(Tajuddin et al., 2005), cytotoxicity (Lee et al.,
2005), hepatoprotective (Morita et al., 2003).
Nutmeg seed induces apoptosis in leukemia cells
(Chirataworn et al., 2007), anti inflammatory
(Lee and Park, 2011), anti hyperlipidemia
(Kareem et al., 2009).Sonavane et al. (2002)
proved nutmeg seed has anticonvulsant activity.
Ethanol extract of nutmeg has anti-seizure
activity in mice-induced pentylenet etrazoles
(Saiful bachri,M.and yuliani,S., 2011). Nutmeg
has pharmacological activity, also has toxic
effect. Aromatic compounds myristicine, and
safrole elimycine are found 2-18% in seeds and
are inducing hallucinations. Maximum
consumption of 5 grams of powder or nutmeg oil
lead poisoning is characterized by vomiting,
headache and dry mouth (Nurdjannah, 2007).
Myristicine and elimycine have toxic effect
(Jukic et al., 2006).
Materials or medicinal compounds of
plant or animal must go through a series of
pre-clinical tests such as pharmacology tests,
toxicology testing and clinical trials for use in
formal treatment. One of the toxicology tests are
subchronic toxicity tests to get information of
potential toxicity when used in long term.
Among much toxicity evaluation parameters are
biochemical parameters such as creatinine and
blood urea nitrogen are useful to evaluate the
condition of the kidney (Henry JB. 2001,).
It is necessary to study sub-chronic
administration of ethanol extract of nutmeg and
investigated the kidney histopathology.
MATERIALS AND METHODS
Animals
Male wistar (SD) (200±10 g) rats were
purchased from Gadjah Mada university. All
animals were maintained in the institutional
animal facility. Animals were acclimatized for a
week before starting the experiments with
condition, light/dark cycle: 12 hr, in university
animal room and with free access to rodent food
and water ad libitum throughout the
experimental period.
Preparation of the extract
Nutmeg seed powder was purchased from
a Beringharjo market in Yogyakarta Indonesia.
Samples were processed into extract in Biology
Pharmacy Department of faculty of Pharmacy,
Ahmad Dahlan University Yogyakarta,
Indonesia. The 3 kg of powder dried samples was
dissolved three times in 6 liters of ethanol for 3
days, filtered, and evaporated to obtain the crude
ethanol extract (25 g). The crude ethanol extracts
freeze dryer for 3 days to get 15 g dried powder.
Animal Groups and experimental treatment
Animals were divided into four groups
with seven animals in each group; Group I,
Control rats treated with the vehicle only
(CMC-Na 0.5%); Group II, rats treated with
EtOH extract of Nutmeg Seed (50 mg/kg);
Group III, rats treated with EtOH extract of
Nutmeg seed (100 mg/kg); Group IV, rats treated
with EtOH extract of Nutmeg seed (200 mg/kg).
On day 32th, take the blood from orbital sinus for
analysis of creatinine and BUN activities with
spectrophotometer. Then the rats sacrificed, take
the kidney for histopatological examination.
Histopathologic examination was performed in
Pathology Laboratory Animal of Veterinary
medicine faculty, Gadjah Mada University to
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determine the possibility of damage to the
kidney.
RESULT AND DISCUSSION
BUN dan Creatinine Analysis
Table I showed the average BUN levels
between the control group and the treatment
group there is a difference or increasing.
Increased BUN levels can be caused by loss of
extracellular fluid and plasma volume (such as
bleeding, shock, excessive vomiting, lack of
water, salt), which decreased glomerular
filtration rate but no kidney disease. BUN levels
can also be increased with an increase in protein
catabolism as occurs in the gastrointestinal tract
bleeding or tissue (Aslam 2003). Another factor
that led to increased BUN levels, the lack of
nutrients and hepatotoxicity are common effects
of some toxicant (Lu, 2010).
Increased levels of BUN in nutmeg
ethanol extract at a dose of 100 mg / kg and 200
mg / kg body weight may be due to damage to the
kidneys according to existing studies showed
elevated levels of BUN at a dose of 400 mg / kg -
1000 mg / kg (Eweka, et al., 2010; Olaleye et al.,
2006). Whereas at a dose of 50 mg / kg had no
increasing effect when compared with controls.
Urea is the final product of amino acid
catabolism. In the process of solving the amino
acids will form ammonia compounds that are
toxic to the human body. Furthermore ammonia
will be converted into non-toxic compounds,
namely in the form of urea through the urea cycle
formation. Urea in the blood will be reabsorbed
into the renal medulla and immediately excreted
through the urine (Poedjiadi and Supriyanti
2006). The presence of urea in the blood
(calculated as Blood Urea Nitrogen, BUN) and
urea in the urine can be used to determine the
effectiveness of renal function (Lu, 2010). On
the condition of impaired renal function, plasma
urea concentration increases because of the
decrease in glomerular filtration process
(Anonymous, 2006b).
Table I show that the average creatinine
levels between the control group and the
treatment group showed no significant
difference. Normal levels of creatinine in mice
are about 0.2-0.8 mg / dl (Malole and Pramod,
1989). The result on creatinine, the average
levels of creatinine showed all the groups are still
in the normal range. Creatinine is a metabolite of
creatine and excreted entirely in the urine via
glomerular filtration. Thus, increased levels of
creatinine in the blood are an indication of
damage to kidney function (Lu, 2010). Serum
creatinine is considered to be more sensitive and
specific indicator of kidney disease compared
with BUN test. The increase in creatinine levels
themselves are not affected by the intake of food
or drink (Kee, 2008).
The results of this research of BUN and
creatinine levels can be seen that the ethanol
extract of nutmeg seed cause elevated levels of
BUN in the dose group 100 mg / kg and a dose of
200 mg / kg compared with the control group
(CMC-Na), whereas serum creatinine levels did
not increase or decrease that considered normal.
Increased levels of BUN with normal creatinine
levels usually become clues to the cause of
non-renal uremia. Increased levels of BUN
values could be due to loss of extracellular fluid
and plasma volume as lack of water or salt and
can also occur due to increased protein
catabolism that occurs in the gastrointestinal
tract or body tissues (Aslam, 2003).
Synthesis of creatinine is relatively
constant, therefore the blood creatinine levels
can describe of renal creatinine clearance.
Creatinine excretion was excreted through
glomerular filtration process of kidney. If serum
creatinine levels rise mean creatinine clearance
decreased (Wildmann, 1995).
The research shows that the value of
normal creatinine levels, not an increase, so that
the ethanol extract of nutmeg is subchronic for
31 days did not affect renal function, seen from
the blood chemistry parameters levels of urea
and creatinine values, because the normal
creatinine levels indicate that the kidneys are
also normal. creatinine clearance suggests that
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the glomerular filtration rate. The Circumstances
where the normal creatinine levels while
increasing BUN levels can be caused by lack of
fluids in the body or dehydration (hypovolemia)
(Kee, 2008).
Histopathological examination showed no
change in renal morphology was given ethanol
extract of nutmeg seeds (picture not shown).
The Conclusions this research that the sub
chronic administration of ethanol extracts of
nutmeg (Myristica fragrans Houtt) seed did not
cause toxic effects on the kidney.
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Background. Ethanol extract from sirsak leaf (annona muricata L.) reported have
anticonvulsant activities. For studying it deeply ethanol extract must do fractination by using ethyl
acetate, thus resulting ethyl acetat fraction and unsolved ethyl acetat fraction.
Objective. This research aimed to know about anticonvulsant activities from each fraction.
Methods. It research conducted by using mices which divided is to 8 groups, each groups
consist 7 mices which pentylentetrazol induced 90 mg/kg bw. Doses ethyl acetate fraction Groups
(FE) are 100, 200, 400 mg/kg bw, and unsolved ethyl acetate fraction groups are 100, 200, 400 mg/kg
bw. Control group just added Na CMC 0.5% and comparation group added by Phenobarbital dose
50 mg/Kg Bw by using peroral technique. Both ethyl acetat and unsolved ethyl acetat fractions were
given quantificacy test of total flavonoid content by Chang method, calculated as quercetin. All data
should be analyzed by Kruskal Wallis test which continued with Man-Whitney by using reliable level
95%.
Outcome measured. The parameters anticonvulsant activities are clonic and tonic onset,
clonic and tonic incidence , clonic frequency, time and incidence of mortality.
Results. All fractions delayed the onset of tonic and reduced tonic and mortality incidence.
The most decrease of mortality incidence in FE400, while longest delayed the onset of tonic in FT400.
The latency of mortality possessed in FE400, FT100, FT200, FT400 with the higest at FT400. Total
flavonoid of FE is 1,31% and FT is 2,6%.
Conclusion. In conclusion, that all fractions are appeared have anticonvulsive activities mean
while not yet equal Phenobarbital in dose material treatment.
Keywords : Annona muricata, Ethyl acetat fraction, unsolved ethyl acetat fraction,
Anticonvulsant, pentylentetrazol
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INTRODUCTION
Epilepsy is one of the most common
serious neurological disorders. Treatment with
anti-epileptic drugs (AEDs) is generally chronic
even life long. The drugs are synthetic molecules
that exert serious adverse effects, such as
drowsiness, ataxia, gastrointestinal disturbance,
hepatotoxicity, and megaloblastic anemia
(Namara, 2003). Plant extracts can be an
important source for the development of better
and safer drugs for the treatment of epilepsy. The
plant material can be selected, such as sirsak
(Annona muricata). The plant has been used
medicinally in many tropical African countries
for an array of human ailments, especially for
parasitic infections and cancer. It has also been
used in some African herbal medicine systems
for its sedative, antispasmodic and convulsive
seizure properties (Taylor, 2002). N’Gouemo at
al. (1997) have reported that ethanol extract from
sirsak leaf (annona muricata L.) has
anticonvulsant activities. For studying it deeply
ethanol extract must do fractination by using
ethyl acetate, thus resulting ethyl acetat fraction
and unsolved ethyl acetate fraction. This
research aimed to know about anticonvulsant
activities from each fraction.
METHODS
Material
Fresh sirsak leaves are dark green
obtained from Kuningan in September 2011.
Sirsak leaf were identified in the laboratory of
Plant morphology, Department of Biology,
Ahmad Dahlan University Yogyakarta.
Comparative material, used phenobarbital
tablets (KF) obtained from the Apotek Mitra
Bahagia Cirebon, Na CMC obtained from the
Laboratory of Pharmaceutical UAD.
Pentylentetrazol (PTZ) from Sigma Co.
Animal
Healthy, male Balb C mice (Mus
domesticus) weighing 20-30 g were used. The
animals were kept and maintained under
laboratory conditions of temperature, humidity
and light (12-hour day/12-hour night cycle); and
were allowed free access to food (standard pellet
diet) and water ad libitum. The animals were
broadly divided into 8 groups, each groups
consist 7 mices which pentylentetrazol induced
90 mg/kg bw. Doses ethyl acetate fraction
Groups (FE) are 100, 200, 400 mg/kg bw, and
unsolved ethyl acetate fraction groups are 100,
200, 400 mg/kg bw. Control group just added Na
CMC 0.5% and comparation group added by
Phenobarbital dose 50 mg/Kg Bw by using
peroral technique.
Phytochemical screening
The methods of Culvenor-Fitzgerald
(1963) and Simes et al., (1995) were used to
screen the Annona muricata leaf used in this
study for its chemical constituents. The findings
of the phytochemical screening are shown in
Table 1.
Preparation of extract and fractionation
One kilogram (1 kg) of sirsak leaves was
air-dried at room temperature. The plant was
milled into fine powder in a blender and then
macerated in ethanol 96% and extracted twice,
on each occasion with 5 litre at room temperature
for 3 x24 h with occasional shaking. The extract
was concentrated under reduced pressure in a
rotary evaporator at 50oC. The resulting ethanol
extract 146 g (14,6 %). The extract was separated
into ethyl acetat soluble and insoluble parts. thus
resulting ethyl acetat fraction and unsolved ethyl
acetat fraction. Furthermore, each faction is
made in 3 doses, a dose of 100, 200, and 400 mg /
kg.
Thin-layer chromatography
TLC was conducted on sirsak leaf ethanol
extract, ethyl acetate fraction, unsolved ethyl
acetate fraction. Stationary phase such as silica
gel 254 nm, mobile phase BAW upper layer
(butanol, acetate, water = 4: 1: 5). Stains used are
FeCl3, ammonia vapor, UV light 254 by
comparison quercetin.
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Standardization of active substances
Standardization of the active flavonoid
substances conducted by Chang method with a
spectrophotometer Shimadzu UV-1800. Total
flavonoid content of ethyl acetate fraction and
unsolved ethyl acetate fraction of sirsak leaves is
calculated as quercetin.
Evaluation of anticonvulsant property
The anticonvulsant testing method of
Amabeoku et al., (1998) and Visweswari et al.,
(2010) with slight modifications. Each dose
administered orally in animal experiments in
accordance with the group for 7 days and 0.5%
NaCMC as well as controls. Phenobarbital 50
mg / kg given orally on seventh day to 30
minutes before the administration of PTZ. PTZ
90 mg / kg dissolved in physiological saline was
given ip. in all groups 30 min after
administration of each fraction on the seventh
day. Experimental animals were observed for 30
minutes after administration of PTZ. Parameters
observed in the form of onset and incidence of
clonic, onset, duration and incidence of tonic,
clonic frequency, time of death and mortality.
Clonic PTZ seizures were defined as an
episode of muscle spasms involving fore limbs
with or without the loss of the righting reflex.
Tonic PTZ seizures were characterized by an
initial ventroflexion followed by full fore limb
and hind limb extension (N'Gouemo, et al.,
1997).
Statistical analysis
Data were analyzed with the Kruskal
Wallis test followed by Mann Whitney test at
95% confidence level.
RESULTS AND DISCUSSION
Results of determination to indicates that
the true leaves of the sirsak (Annona muricata).
Furthermore, phytochemical screening exhibit
phenolic compounds are indicated by the
formation of a greenish black color by reaction
with FeCl3. Flavonoid compounds identified by
reaction with Mg and concentrated HCl which
gives red color. With shaking formed foam that
indicate the presence of saponin compounds.
Alkaloids and steroids were not identified,
although some studies reported isokuinolin
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samples hRf
Color spot
without
stain
Color spot
with
UV 254
Color spot
with
FeCl3
Color spot
With
amonia
Ethanol 85 Yellow green Slight green Yellow brown
extract 76 Yellow green Slight green
65 Slight green
23 Yelloe green purple yellow
FE 85 Yellow green green Black blue Yellow brown
76 Yellow green Slight purple Slight brown
65 Slight purple Slight brown
FT 41 yellow Purple Black blue Yellow
23 yellow purple Black blue Yellow
kuersetin 76 yellow green Black blue yellow
FE = ethyl acetat fraction
FT = unsolved ethyl acetat fraction
Table I. hRf value and color spot from four samples
alkaloids and phytosterols (Watt and
Breyer-Brandwijk, 1962, cit Adewole and
Ojewole, 2009).
TLC
TLC results in the form of the value of the
hRf and color spot of the four samples that
ethanol extract, ethyl acetate fraction (FE),
unsolved ethyl acetate fraction (FT), and
quercetin can be seen in Table I.
Table I shows that the FE and FT contain
polyphenolic compounds indicated by bluish
black spots after being sprayed with FeCl3
(Harborne, 1987). Quercetin as a comparison
also shows the same color although with
different color intensity. Provision of ammonia
vapor produces color yellow spots, yellow
brown, and brown weak. This means there are
flavonoids at all the sample. According to
Harborne (1987), Flavonoids are phenolic
compounds, therefore it is the color change
when added alkaline or ammonia. The resulting
color depends flavonoids. According Leabouf et
al., (1982), Watt and Breyer-Brandwijk, (1962)
cit Adewole and Ojewole, (2009), sirsak leaves
contain flavonoid.
Quercetin as a comparison was not
detected its presence in all samples, although the
value of the HRF there is similarity in the three
samples is 76 but of different color spots.
Results of active substances standardization
Measurement results of total flavonoid
content of unsolved ethyl acetate fraction is
2.62% and ethyl acetate fraction is 1.31%.
Unsolved ethyl acetate fraction is more polar
than ethyl acetate fraction. Thus, flavonoids
which are water-soluble compounds (Harborne,
1987) more in the unsolved ethyl acetate
fraction.
Results of testing the anticonvulsant effect
The test results showed that the
anticonvulsant effect of different factions and
different doses up to 400 mg / kg BW can not
delay the onset of clonic and do not cause a
decrease in the incidence of clonic seizures that
occur in mice. Based on the results of the Mann
Whitney test for the onset of clonic seizures at
various doses of the fraction of ethyl acetate and
ethyl acetate insoluble fraction showed no
significant differences due to the significant
value of more than 0.05 (p > 0.05) compared to
the control group.
Tonic incidence decreased with increasing
dose, although the ethyl acetate insoluble
fraction doses of 100 and 200 mg / kg have the
same percentage. To the onset tonic, giving ethyl
acetate fraction and insoluble fraction of ethyl
acetate at different doses may prolong the onset
of tonic or may delay the occurrence of tonic
with a significance value of less than 0.05 (p
<0,05). Thus, all the fractions showed
anticonvulsant activity. According to Adeyemi,
et al., (2007) and Ojewole, (2008) the ability of
plant extracts to prevent seizures or prolong the
onset of tonic seizures indicate anticonvulsant
activity. Observation of the duration of the tonic,
ethyl acetate fraction dose of 400 mg / kg body
weight can significantly shorten the duration of
tonic, while the dose of 100 and 200 mg / kg have
not been able to reduce the duration of tonic. For
the insoluble fraction of ethyl acetate, the
shortest duration of tonic occurred at a dose of
200 mg / kg, which is 20.20 seconds, but
statistically the results do not differ significantly
in comparison with controls. According Kasture
et al. (2000), the anticonvulsant activity can be
demonstrated by a decrease in the duration of
tonic in experimental animals. Thus the only
anticonvulsant activity shown by the ethyl
acetate fraction dose of 400 mg / kg.
The test results showed the number of
seizures that occurred an average frequency of
seizures that occur higher than the control group
than the treatment dose FE 100. However, this
value is statistically significantly different from
no more significance than 0.05 (p> 0,05). So,
there was no effect of administration of ethyl
acetate fraction and ethyl acetate insoluble
fraction soursop leaves the number of seizures
that occurred. Thus, the parameter number of
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seizures can not provide information regarding
the anticonvulsant activity of both fractions.
However, this value is not significant.
Observation of the time of death showed
that the ethyl acetate fraction may extend the
time of death at a dose of 400 mg / kg bw, while
the insoluble fraction of ethyl acetate all
treatment doses of 100, 200, and 400 mg / kg bw
able to extend the time of death compared to the
control. To the number of deaths, compared with
the control group, all treatments can reduce the
number of deaths caused by mice with
PTZ-induced seizures decrease in the number of
deaths was highest in ethyl acetate fraction dose
of 400 mg / kg. Data of all test parameters are
presented in Table II.
Of all the parameters that are used to look
anticonvulsant activity, most of the parameters
are the parameters of onset, incidence, and
duration of tonic, time of death and the number
of deaths to support the conclusion that the
fraction of ethyl acetate and ethyl acetate
insoluble fraction showed anticonvulsant
activity.
Anticonvulsant activity of the ethyl
acetate fraction and ethyl acetate insoluble
fraction thought to be related to the presence of
flavonoids in the both fraction. Flavonoids are a
large group of plant polyphenols. Flavonoids
have a variety of activities, such as antioxidant
(Winarsi, 2005). The antioxidative properties
due to the position of hydroxyl groups capable of
scavenging free radicals. Flavonoid initially
oxidized by radicals, then changed to a more
stable and less reactive radicals. Thus flavonoids
can stabilize reactive oxygen compounds
(Korkina & Afanas'ev, 1997 cit Winarsi, 2005).
Adewole and Ojewole (2009), reported a
decrease in reactive oxygen species (ROS),
thiobarbituric acid reactive substances (TBARS)
in rats administered a aqueous extract of leaves
of the sirsak, it means there are antioxidant
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Groups
clonic
onset (sec)
Clonic
Inci-den
ce
Tonic
onset
(sec)
Tonic
Inci-
dence
Tonic
Duratio
n
(sec)
Time
of
death
(sec)
Morta-
lity
Frequensi
Of
seizure
control
92,43 ± 23,28
7/7 (100
%)
266,50
± 47,91
6/7
(86%)
25,20 ±
3,11
306,17
± 60,24
6/7
(86%)
2,43 ± 0,79
Fenobarbital 1800* 0%* 1800* 0% 0* 1800* 0%* 0
FE 100
106,14 ± 12,17
7/7 (100
%)
399,00
±
43,71*
4/7
(57%)
24,25 ±
1,71
424,67
±
178,00
3/7
(43%)
2,00 ± 0,89
FE 200
86,40 ± 11,46
6/6 (100
%)
564,00
±
98,99*
3/6
(50%)
19,00 ±
4,36
561,00
±
470,71
3/6
(50%)
3,75 ± 2,22
FE 400
131,00 ± 39,84
7/7 (100
%)
722,00
±
83,44*
3/7
(43%)
18,67 ±
3,21*
553,00
±
185,26*
2/7
(29%)*
3,00 ± 1,22
FE 100
72,00 ± 27,12
7/7 (100
%)
443,67
±
28,43*
5/7
(71%)
21,00 ±
2,24
908,75
±
201,78*
5/7
(71%)
3,43 ± 1,13
FE 200
90,57 ± 36,71
7/7 (100
%)
532,00
±
244,99*
5/7
(71%)
20,20 ±
5,07
831,50
±
302,97*
5/7
(71%)
4,20 ± 0,45
FE 400
98,67 ± 42,33
7/7
(100%)
976,50
±
132,23*
3/7
(43%)
21,67 ±
2,08
1134,50
±37,48*
3/7
(43%)
2,67 ± 1,37
*p < 0,05 to control (PTZ 90 mg/kg bw i.p + CMC 0,5%)
Table II. Recapitulation of Research Data on multiple anticonvulsants Parameter Testing Activity Induced
in Mice PTZ
activity of aqueous extracts of sirsak leaves.
According Winarsi, (2005) based on its
mechanism of antioxidants can be divided into
three, namely: primary antioxidants
(endogenous antioxidants / antioxidant
enzymatic); antioxidant secondary (exogenous
antioxidants / antioxidant nonenzimatis) and
tertiary antioxidants (antioxidants that act repair
biomolecules damaged by free radicals) .
Oxidative stress is an etiological factor in
the occurrence of epileptic seizures (Shin et al.,
2011) including PTZ-induced seizures. Several
studies have demonstrate this. Bashkatova et al.,
(2003) reported the increase in the formation of
nitric oxide (NO) fivefold, and TBARS more
than twofold in the brain cortex of rats after
administeration of PTZ 120 mg / kg
subcutaneously. NO is a free radical with a short
half-life. NO is considered a disorder of
molecules that play a role in the pathophysiology
of Alzheimer's, Parkinson's, stroke, trauma, and
seizures. Other studies have shown that
administration of PTZ resulted in an increase in
malondialdehyde (MDA), and decreased
glutathione (GSH) (Mehla, et al., 2010; Ilhan, et
al., 2005; Gupta, YK et al., 2003) and increased
catalase (Sharma et al., 2010). PTZ also known
as a selective blocker of the chloride ion complex
for GABA-A receptor and cause a decrease in
function GABAergik (Ilhan, et al., 2005).
Oxidative stress is defined as an
imbalance between reactive oxygen species
(ROS) such as O2-*,*OH, *NO cellular level
with a higher cellular antioxidant defenses. ROS
generation ubiquitous nature as a result of
aerobic metabolism such as oxidation in
mitochondria. In order to scavenge ROS,
different defense systems in the brain in the form
of enzymatic, nonenzymatic, and antioxidants in
the form of food. If ROS are not effectively
eliminated, it can cause oxidative injury is
peroxidation of cell membrane phospholipids,
proteins (receptors,enzymes) and DNA. Brain
tissue is very vulnerable to ROS because, (1) The
brain produces very high ROS as a result of
aerobic metabolism is high, whereas relatively
few enzymatic antioxidant defenses, (2) with a
lipid-rich brain is vulnerable to oxidative
damage, and (3) DNA nerve damaged in adults
ineffective repaired because there is no DNA
replication in the brain.
In this study the ethyl acetate fraction
showed a stronger anticonvulsant activity mainly
on the parameter number of animal mortality.
Ethyl acetate fraction dose of 400 mg / kg body
weight can reduce the number of mortality
dropped 86% in controls to 29%. On the other
hand, levels of flavonoids from the ethyl acetate
fraction lower than the insoluble fraction of ethyl
acetate. Therefore, the estimated potential of
antioxidant fraction of ethyl acetate and ethyl
acetate insoluble fraction is not the only cause of
the anticonvulsant effects of the two fractions.
CONCLUSION
All fractions are appeared have
anticonvulsive activities mean while not yet
equal phenobarbital in dose material treatment.
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Abstract
Background. Seizure is an neurologik issue that relatively much be found. Treatment with
conventional chemical remedies are more expensive beside their limited distribution. conventional
remedies have a lot of side effects. Therefore, needed to find a new alternative treatment that more
safe, effective and selective to suppress seizure as anti convulsant. Pennywort ( Centella asiatica (b)
urb ) has effect as anti convulsant. Ethanol extract of Pennywort herb also known could have sedative
effects on mice because it contains with brahminoshide and brahmoshide glycosides using their
cholinergic mechanism.
Objective. The aim of this research is to know whether ethyl acetat fraction and unsoluble ethyl
acetate fraction of pennywort herb can be used as anti convulsant.
Methods. This research conducted using mice which divided in eight groups which consisted of
7 mices per group. The classification of the group consists of negative control (suspension of CMC 5
%), ethyl acetate fraction group with dose 100mg/KgBW, 200mg/KgBW, 400mg/KgBW, unsoluble
ethyl acetate fraction group with dose 100mg/KgBW, 200mg/KgBW and 400mg/KgBW, and positive
control group (fenobarbital 100mg/KgBW). To make convulsion condition, mice induced using PTZ
dose 80Kg/BW. This test lasted for 7 days. The result was analyzed by using post hoc test and Mann
Whitney method were also used to compare each sample. The significant value was accepted if
P<0.05.
Outcome measured. The parameters of anti convulsant including time of duration. The
histopatology tested on liver and kidney.
Results. Unsoluble ethyl acetate fraction dose 400 mg/KgBB has the ability to reduce duration
time. Histopathology test showed that ethyl acetat fraction dose 100mg/KgBW and unsoluble ethyl
acetat fraction dose 400mg/KgBW significantly increase repairment of kidney damage induced by
PTZ.
Conclusion. Conclusion that not all fractions have the ability as anti convulsant.
Keywords : Anti convulsant, Centella asiatica, ethyl acetate fraction, unsoluble ethyl acetate
fraction, Phentylenetetrazole (PTZ).
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INTRODUCTION
A seizure is a neurologic issue relatively much be
found. Almost 5 % child under 16 years old at
least experienced once seizure during his life
(Schweich and Zempsky, 1999). Seizure
treatment with anticonvulsant drug sometimes
affect on cognitive (Aldenkamp et al., 1993).
Although it is known that the result of seizures
conventional treatment is so beneficial clinically
but there has cognitive side effect of the drug at
dose of therapy. Because their side effects and
the treatment cost, the new treatment options that
are safe, effective and selective to suppress
seizures is crucial to trying to accomplish.
One of medicine plant which alleged has an
effect as anticonvulsant is pennywort (centella
asiatica ( b. ) Urb.). Some studies on the
pharmacology effects of pennywort, it is known
that those plant indicates the activity as
anticonvulsant with the additional benefit of
preventing cognitive decline (Gupta et al.,
2003).
The ethyl acetat and unsolube ethyl acetat
fractions of pennywort against onset time,
duration time and the number of seizures,
mortality, and also liver and kidney
histophatologi on male mice induced PTZ was
studied in this reserach. So it can be used as
medicine alternative which effective as
anticonvulsant drug and can be useful in the
development of traditional medicine in
Indonesia.
METHODS
Materials and Instruments
Materials: Pennywort herb (Centella asiatica (L)
Urb), male Swiss mice (5-6 weeks) with body
weights approximately 25-35 g, ethanol 70%,
ethyl acetat, penthilenetetrazole (PTZ) (Sigma
Co), phenobarbital (Bratachem) dan CMC Na
(Bratachem), NaCl 0,9%, formaldehyde 10%,
hematoxilin-eosin stain.
Instruments: milled machine, sieve which mesh
number 40, oral injection, vacum rotary
evaporator, analytical scale, spectrophotometer
UV-1800 Shimadzu.
Sample Preparation
The pennywort powder sifted by using mesh 40
then will be extracted. The process of maceration
is carried out by using ethanol 70% for 24 hours
until the solvent is clear sight. Fractination of
ethanol extract using ethyl acetate solvent, where
there will be two parts those are the soluble part
of ethyl acetate fraction and insoluble ethyl
acetate fraction.
The sample of ethyl acetat and insoluble ethyl
acetat fractions tested for flavonoid total using
spectrophotometer UV-1800 Shimadzu, where
determination of the flavonoid total according to
the Chang et al method’s (2002).
Adaptation of the Mice
Adult male Swiss mice with body weights
approximately 25-35g were kept in room
temperature and standard (natural) photoperiod
of approximately 12h of light alterating with
approximately 12h of darkness. The mice were
maintained on standard mice feed and potable
water which were made available ad libitum.
The test of this research was conducted to 8
groups of mices which consisted of 7 mices per
group. Each group consisted of positive control
(phenobarbital 100mg/KgWB), negative control
(CMC 0,5%), ethyl acetat fraction group with
doses 100mg/KgBW; 200mg/KgBW; 400mg/
KgBW, insoluble ethyl acetat fraction group
with doses 100mg/KgBW; 200mg/KgBW;
400mg/KgBW. Factions was given for seven
days while positive control group phenobarbital
given at the 7th. On the 7th day one hour after
PTZ induction, observation was done on onset,
duration, number of seizures, mortality and
histopathology observation of liver and kidney.
Statistical analysis
Statistical analysis was done by using
Mann-Whitney Results are expressed as the
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mean ± SD. Statistical significance was defined
as P < 0.05.
RESULTS AND DISCUSSIONS
From the maceration process, rendemen of
extract was obtained 18,54%. Fractination was
done on pennywort extract using ethyl acetat
which having rendemen value about 4,12%.
Insoluble ethyl acetat fraction has rendemen
13,4%. Rendemen value of insoluble ethyl
acetate more higher than rendemen of ethyl
acetate fraction. This is because ethanol 70%
extract more polar than ethyl acetate fractions.
Was known that the largest component in ethanol
extract compound is triterpen compounds that
are polar.
Total Flavonoid
The levels of total flavonoids was measured on
ethyl acetat and insoluble ethyl acetat fractions
using UV-Vis spectrophotometer. The purpose
of determination of flavonoid total levels is to
fullfil standardization extract or faction.
Differences of growing places and
environmental conditions affect the levels of
active substances from plants even on the same
plant species. The largest of total flavonoid level
contained in ethanol extracts there is 3,419%.
Total flavonoids of insoluble ethyl acetate
fraction (1,465%) have higher levels than ethyl
acetate fraction (0,323%). The polarity of ethyl
acetate is lower than ethanol 70%, so not all of
the extract could dissolved in ethyl acetate
solvent which called insoluble ethyl acetat
fraction.
Have been researched previously by zainol, et al
( 2009 ) that some compounds of flavonoids
contained in pennywort are naringin, routine,
quercetin, catechin, luteolin, and apigenin,
kaemferol. This flavonoid compounds have the
effect as an antioxidant. Flora and gupta’s ( 2007
) research concluded that flavonoid of a fraction
pennywort to give the effect protection against
toxicity cells of the neurons in mice by
antioxidant mechanism.
So can be concluded that high flavonoid can
increase the activity of the neuron cell
protection, in the end can serve as agents of an
anti seizure.
Ethyl Acetat and Insoluble Ethyl Acetat
Fractions of Pennywort Herb As
Anticonvulsant
Has been researched before by Ganachari et al
(2004) that ethanol extract 100mg/KgBW
showed potential to extend sleeping time on
experiment animals were given sodium
pentobarbiton and has the activity as
anticonvulsant. Hopefully when ethanol extract
was fractionated with ethyl acetat, it will get
specific compound that will enhance the activity
of pennywort herb as an anticonvulsant.
None of the groups that have different values
significantly to negative control, this indicates
that all the factions have not been able to reduce
onset time of seizure activity. Insoluble ethyl
acetate fraction group dose 400mg/KgBB
showed decreasing the time of duration better
than the other groups. It characterized by
significant differences of duration time
compared to a negative group.
Table I .Onset and Duration Average Time
Group Onset (second) Duration(second)
NEGATIVE CONTROL 172,14±133,74* 333,33±86,22*
POSITIVE CONTROL 0,00±0,00# 0,00±0,00#
EAF 100mg/KgBB 120,83±48,21* 530,00±29,44*#
EAF 200mg/KgBB 130,00±20,98* 507,50±137,75*
EAF 400mg/KgBB 155,00±28,87* 460,75±120,98*
IEAF 100mg/KgBB 220,00±98,99* 569,00±209,36*
IEAF 200mg/KgBB 166,00±108,77* 700,00±124,90*#
IEAF 400mg/KgBB 139,17±80,40* 138,00±131,42*#
*p<0,05 significantly different to positive control (phenobarbital),
# p<0,05 significantly different to negative control.
The content of compounds such as brahmoside,
brahminoside and other triterpen compounds in
insoluble ethyl acetate fraction have possibility
role to decline duration time on seizure mice
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(Amalia, 2009). In addition, a polar compounds
such as flavonoids also have anticonvulsant
effect and lowering anxiolytic (Almeida et al.,
2008).
Number of Seizures and Mortality
Table II. Number of Seizures and Mortality percetae
in Each Group
Group
Number of
Seizures
Mortality
(%)
NEGATIVE CONTROL 1,71±0,95* 100*
POSITIVE CONTROL 0,00±0,00# 0#
EAF 100mg/KgBB 2,29±0,76* 71*
EAF 200mg/KgBB 2,00±0,58* 57*
EAF 400mg/KgBB 2,00±1,00* 43#
IEAF 100mg/KgBB 2,43±0,79* 100*
IEAF 200mg/KgBB 1,50±0,55* 57*
IEAF 400mg/KgBB 1,57±0,98* 71*
*p<0,05 significantly different to positive control (phenobarbital),
# p<0,05 significantly different to negative control.
From the data showed that none of the giving
fraction group can decrease the frequency of
seizures. Meanwhile, the group that showed an
improvement in the percentage of mortality is
ethyl acetate fraction group dose 400mg/KgBW.
The certain mechanism of levels of mortality on
the fractions giving are different wasn’t found.
The limited number of mice using in research
allows one of many determinant steadiness
factor of data.
Liver and Kidney HistopatologyTest
Examination using Hematoxylin-Eosin staining
(HE) and the organs are carried out in the
laboratory of Pathology Anatomy Faculty of
Medicine Gadjah Mada University to made
histology preparations of liver and kidney. Liver
histopathology test in all groups there were no
significant differences at both the negative and
positive control.
Table III. Rapairment Percentage of Liver and Kidney
Group Hepar Histo(%)
Kidney Histo
(%)
NEGATIVE CONTROL 0 0*
POSITIVE CONTROL 20 80#
EAF 100mg/KgBB 20 100#
EAF 200mg/KgBB 20 20
EAF 400mg/KgBB 40 40
IEAF 100mg/KgBB 20 40
IEAF 200mg/KgBB 60 80#
IEAF 400mg/KgBB 40 100#
*p<0,05 significantly different to positive control (phenobarbital),
# p<0,05 significantly different to negative control.
Whereas in kidney histopathology test, ethyl
acetate fraction group dose 100mg/KgBW and
insoluble ethyl acetate fraction dose
400mg/KgBW given a very significant
improvement over the negative control group.
Low percentage of liver repairing happent in
entire group include the positive control group, it
indicate that the induction of PTZ has damage to
liver or leaning to hepatotoxic. Several groups of
fractions also shows the percentage of bad
improvement on the kidney. Besides it
hepatotoxic characteristic, PTZ also allows to
nefrotoxik on mice kidney.
CONCLUSION
Insoluble ethyl acetate fraction dose 400
mg/KgBW has the ability to reduce duration time
however not be able to extend onset time,
minimizing frequency of seizures, and decrease
the number of mortality. Mortality significantly
decreased at dose 400mg/KgBW of ethyl acetate
fraction. Ethyl acetate fraction dose
100mg/KgBW and insoluble ethyl acetate
faction dose 400mg/KgBW showed
improvements against kidney damage induced
by PTZ. However, do not indicate a significant
improvement of liver damage
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Abstract
Background. Annona muricata plant is a medicinal plant using by research and drug for
human healthy including diabetes mellitus.
Objective. This research aimed to determine the effect of ethanol extract and chloroform
extract of the sirsak leaf as antidiabetes mellitus.
Methods. This research was conducted in 9 groups of male Wistar rats consisting of 5 rats per
group, consisting of normal control, alloxan control, glibenclamide control dose of 10 mg/Kg BW,
group of ethanol extract sirsak leaf dose of 50 mg/Kg BW; 100 mg/Kg BW; 200 mg/Kg BW, and group
of chloroform extract sirsak leaf dose of 50 mg/kg BW; 100 mg/Kg BW; 250 mg/Kg BW. Tests carried
out for 2 weeks.
Outcome measured. It also conducted assays of total flavonoids and histopathological tests of
pancreatic  cells.
Results. Results of this research showed that the ethanol extract of sirsak leaves dose of 200
mg/Kg BW has activity in decreasing blood glucose levels better than any other group, with the
percentage of total flavonoid 12.5%. Histopathological results of the ethanol extract of sirsak leaf has
the same capabilities as compared with glibenclamide in reapair the damage of pancreatic  cells.
Conclusion. The conclusion of this research is the ethanol extract of sirsak leaf have activity
antidiabetic mellitus.
Keywords : Annona muricata, antidiabetic, alloxan, blood glucose
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INTRODUCTION
Diabetes mellitus (DM) is one of the most
common endocrine and metabolic disorders in
the 21st century, and a major threat to health
worldwide. Many experimental and clinical
observations have indicated that hyperglycemia
may directly or indirectly contribute to the
formation of excessive free radicals (Ceriello,
2003). Various epidemiological studies have
shown a tendency for an increase in the incidence
rate and prevalence of DM from year to year. For
Indonesia, the WHO predicts rise in the number
of patients from 8.4 million in 2000 to be
approximately 21.3 million in 2030. Diabetes
mellitus is a chronic disease that is characterized
by the presence of abnormalities in the
metabolism of carbohydrates, lipids, proteins
and are associated with insulin deficiency
(Suryawanshi et al., 2006). Among the various
diseases diabetes, more than 95% of people with
diabetes is type 2 diabetes mellitus (T2DM) as
well as the type at most disputed. The symptoms
of type 2 diabetes mellitus, among others, due to
pancreatic dysfunction and increased levels of
lipids, fatty acids and cholesterol in the blood
(lipemia) (K.A. Wadkar. et al, 2008). Annona
muricata is a plant of the family Annonaceae.
Medicinal plants have been used as a natural
remedy for many diseases, one of which is for the
treatment of diabetes mellitus (Adeyemi, et al,
2009). The bark, roots and leaves of Annona
muricata has been reported to be used as an
anti-diabetic. Therefore this study was designed
to confirm the effects of the ethanol extract and
chloroform extract of leaves of Annona muricata
on glycemic control in diabetic rats in the alloxan
induction, so the results of this study may help in
the selection of treatment of diabetes mellitus
even better.
METHODS
Materials and Instruments
Materials : the leaves of soursop (Annona
muricata), ethanol 70%, chloroform, male
Wistar rats aged 2-2.5 months with a weight of
190-210 grams, rat pellets, formalin 10%,
glibenclamide, alloxan, Na CMC, NaCl 0,9%,
aluminum chloride 10%, sodium acetate,
coloring Gomori.
Instruments : analytical balance,
maceration tools, grinding machines, sieve mesh
40 and mesh 30, separating funnel, rotary
evaporator, oral syringes, syringes injection, On
Call Plus Blood Glucose Test Strips, glucometer,
Spectrophotometer Shimadzu UV-1800,
centrifuges, glassware and tools that are
commonly used.
Sample Preparation and Anti Diabetes Test
Leaves of soursop (Annona muricata) is
obtained then do the sorting. Soursop leaves are
dried in the powder and sieved to 30 mesh and
40. Extract prepared by maceration using
ethanol 70% and chloroform. All maserat
collected and evaporated with a rotary
evaporator to obtain the viscous extract, weighed
and recorded randemen obtained. TLC made to
extract the ethanol and chloroform extracts.
Stationary phase such as silica gel 254 nm,
Butanol: Glacial Acetic: Water = 4: 1: 5 by
comparison quercetin. Total flavonoid levels
using a spectrophotometer Shimadzu UV -1800
where determination of total flavonoids in
accordance with the method of Chang et al
(2002).
Adaptation of the rats
Adult Wistar rats aged 2-2.5 months with
190-250 gram weight, male sex are maintained in
wire cages with room temperature and
experience 12-hour cycle of day and night. The
rats were fed with pellets and given drink in
moderation.
Rats were fasted overnight before
intraperitoneal injection of alloxan created using
new. Alloxan at a dose of 160mg/kg body weight
dissolved in normal saline until dissolved.
Fourth day after alloxan injection, blood was
taken via the tail vein in the then measured serum
fasting blood glucose when blood glucose levels
200-300mg/dl then the rat can be categorized as
186 Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013
ISBN : 978-979-18458-6-1
diabetic rats. (Dhandapani, 2002; Chougale et
al., 2007).
Tests were carried out on 9 test groups
each group consisted of 5 rats. Control group
consisted of normal, alloxan control,
glibenclamide control, ethanol extract group
doses of 50mg/kg dose; 100mg/kg; 200mg/Kg,
and chloroform extract group doses of 50mg/kg;
100mg/kg; 200mg/Kg. This treatment performed
for 2 weeks.
Blood Glucose Measurement and
Histopathology
Glucose test performed at baseline before
induction of alloxan, after induction of alloxan,
week 1 and week 2 to see the comparison.
Testing is done by glukometer (On Call Plus
Blood Glucose Test Strips). On day 14 control
rats glibenclamide, pain control, normal, and
ethanol extract group and the chloroform
extracts were sacrificed by total anesthetized
using inhaled chloroform. The pancreas from
each group of rats collected by surgery.
Pancreatic cleaned with normal saline and then
stored in a tissues fluid-filled pot 10% formalin.
Tissue homogenates and then stored for
histopathological test-pancreatic  cells by using
the method of Gomori.
Statistical analysis
Statistical analysis was done by using
Mann-Whitney Results are expressed as the
mean ± SD. Statistical significance was defined
as P < 0.05.
RESULTS AND DISCUSSIONS
Total Flavonoid test
Determination of total flavonoid content
using UV-Vis spectrophotometry. As standard
used quercetin, a flavonoid compound
commonly used identifier and quercetin is a
flavonoid class of active substances which are
biologically very strong. From the calculation of
the percentage of total flavonoid levels of
ethanol extract was 12.5% and the percentage of
total flavonoid levels of chloroform extract was
5.06%. Flavonoids contain a conjugated
aromatic system therefore shows a strong
absorption band in the ultraviolet and visible
area. Determination of flavonoids by using the
method of Chang et al (2002), where the addition
of a sliding AlCl3 reagent causes a bathochromic
shift enables showed in the o-hydroxy group on
ring A. While the addition of NaOAc shift
reagent will cause bathochromic shift indicating
a hydroxyl group (OH) at the C-7 position.
Flavonoid easy to detect using UV light, it
because of phenyl ring on flavonoid (Andersen
and Markham, 2006).
Test of antidiabetic mellitus effects of
ethanol and chloroform extract of soursop leaf to
decrease blood glucose levels
Table I shows the data of blood glucose
rats before and after induction of alloxan. From
the the data shows that after alloxan
administration for 4 days, blood glucose in mice
induced increased.
Before the induced with alloxan, fasting
blood glucose levels did not differ significantly
(p <0.05) between the eight groups of
experimental animals. At 24 hours after alloxan
administration, blood glucose levels were
significantly (p <0.05) higher in the group of
animals ethanol extract 50 mg / kg bw and the
negative control group which showed blood
glucose levels 600 mg / dL. Increased glucose
levels in rats that elevated levels 200 mg / dL
were categorized as diabetic rats.
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Description :
EE 200 : Ethanol Extract dose 200 mg/Kg
BW
EE 100 : Ethanol Extract dose 100 mg/Kg
BW
EE 50 : Ethanol Extract dose 50 mg/Kg BW
EK 200 : Choloform extract dose 200 mg/Kg
BW
EK 100 : Choloform extract dose 100 mg/Kg
BW
EK 50 : Choloform extract dose 50 mg/Kg
BW
SICK : Negative controls, alloxan induced
group dose 160 mg/Kg BW with
blood glucose levels> 200 mg / dL
GLIBEN : Positive controls Glibenklamide
dose10 mg/Kg BW
NORMAL : Group Without giving alloxan
group, glibenclamide, ethanol
extract and chloroform extract
Decrease in glucose levels of instability
that occurred in the first week and the second
week in which the first week of a decline in
glucose levels but after the second week of
increased glucose levels back can be seen from
the above data. A steady decline in glucose levels
only seen in the ethanol extract dose of 200 mg /
kg bw.
Data homogeneity tested by ANOVA
analysis and show that the data are not
distributed homogenous. Data were tested for
normality using one-sample analysis of the
Kolmogorov-Smirnov test showed that the data
were normally distributed for each group except
the group after induced where the data is not
normal. To see a significant difference from each
treatment group can be analyzed using the
non-parametric Mann-Whitney test. Said to be
significantly different values when the value of
significance p <0.05. Alloxan diabetes inducer is
a compound commonly used in addition to
streptozotocin.
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Group Before induced After Induced 1st week 2nd week
NORMAL - 127.6±9,83# 105.5±3,41# 95±9,59#
SICK 102.25±2,06 600±0* 565.4±28,31* 574.8±21,47*
GLIBEN 108.5±9,84 382±57,51*# 205.25±115,79# 135.25±13,69*#
EE 200 104±1,82 386.6±195,18* 216±94,08*# 214±85,14*#
EE 100 94±1,82# 538.25±71,36* 345.4±168,47*# 488.2±153,09*
EE 50 88.75±8,99# 600±0* 600±0*# 600±0*
EK 200 97.25±14,15 275±25*# 551.75±55,72* 600±0*
EK 100 107.25±3,5 556±50,91* 600±0*# 564.5±34,97*
EK 50 92.5±6,45# 575±28,87* 600±0*# 545.67±1,52*#
* p <0.05 significantly different compared to the normal group # p <0.05 significantly different compared with those sick
Table I. Blood Glucose Levels Average During the Treatment
Picture I Blood Glucose Levels Average Graphic
From Each Group
Histopathology of Beta Cell Pancreas
Reading test result pancreatic beta cells
can be seen in Table II and Picture II. the result
showed that the number of pancreatic beta cells
are still normal per surface area of the islets of
Langerhans 400x400 micro. Pancreas were taken
on day 14 one hour after administration of a
preparation. Then the organ was cleaned in a
solution of normal saline and immersed in 10%
formalin solution to prevent organ damage.
Organs are then taken to the Pathology
Laboratory of the Faculty of Medicine,
University of Gadjah Mada made preparations
for pancreatic histology Chromalum Gomori
coloring technique.
The data shows that the normal group had
a number of healthy beta cells are still more than
the other groups. While the alloxan-treated
group had a number of less healthy beta cells,
this is due to the islets of Langerhans of rats
alloxan-induced damage than the islets of
Langerhans of normal rats.
Picture III. Pancreas Histology With
Gomori Chrome Alum Hematoxylin-Phloxine
Staining. Whereas showed alpha cell (A); beta
cell (B); vacuolization cell (C); hyperthropy cell
(D).
From the picture is known that pancreatic
beta cells undergo various damages including
vacuolization, necrosis, and pancreatic beta cells
hiperthropi. Sick group did not differ
significantly with glibenclamide group and the
group of ethanol extract dose of 200 mg / kg bw.
However, glibenclamide group with a group of
ethanol extract dose of 200 mg / kg bw no more
different than the pain group. It can be concluded
that the improvement of pancreatic beta cells by
ethanol extract dose of 200 mg / kg bw
comparable with glibenclamide administration.
On preparations seen a few different
colors, where each color indicates a different
cell. In the islets of Langerhans are three types of
cells: alpha cells, beta cells and delta cells, and a
few cells is not clear that granular (Permata,
2006).
CONCLUSION
Ethanol extract and chloroform extract of
leaves of soursop (Annona muricata) various
doses have not been able to lower blood glucose
levels as well as the glibenclamide group.
Decrease in blood glucose levels can
decrease and consisten tly better than the other
treatment groups was 200mg/Kg BW ethanol
extract dose with a significant value compared
Proceeding of International Safety Management of Central Cytotoxic Reconstitution May 25th 2013 189
ISBN : 978-979-18458-6-1
Group Beta pankreas
Normal 29,00±7,09
Glibenklamid 17,25±6,95
Aloksan 11,78±3,34
Ethanol Extract 200 mg/Kg BW 18,75±6,27
Table II. Histology test of beta cell pancreas with Gomori Chrome Alum Hematoxylin-Phloxine staining method
Picture II. Histopathology Graphic of Beta Cell Pancreas
with the normal group of post-induction, the first
week and the second week in a row is 0.009;
0,020; 0,014. Repair of pancreatic beta cells by
ethanol extract doses 200mg/KgBW comparable
with glibenclamide administration.
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Abstract
Background. Instrumental analysis method give a difference measurement results in
determination of content level of active substance in medicinal herb.
Objective. The aim of this study is to campare the level content of phytomelatonin in green
algae extract determinated by spectrophotometry and TLC-densitometry technique.
Methods. The phytomelatonin was extracted from green algae using 96% aethanol. The
qualitative Alkaloid screening were done by using Mayer and Dragendorff test. The quantitative
determination of phytomelatonin were done spectrophotometrically at 277nm wavelength and using
TLC densitometry technique with silica gel GF 254 plate and eluated by BAW ( n-buthanol: acetic
acid: water=12:3:5 v/v). The spots were scanned at 254nm wavelength
Outcome measured. Phytomelatonin level in aethanolic extract of green algae
Results. The results showed that the content phytomelonin content of green algae level by
spectrophotometric technique was 0.22±0.01 % and 0.88±0.04 % was assayed by TLC-densitometric.
Conclusion. The TLC-densitometry technique gave the higher phytomelatonin of green algae
level than specthrophotometry technique (p<0.05)
Keywords : Phytomelatonin, green algae, aethanolic extract, spectrophotometry,
TLC-densitometry
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INTRODUCTION
Green algae contains melatonin called as
phytomelatonin, a substance that wide used for
cancer prevention, antioxidant (Veronique et al,
2005), surpassing the myocardial damage due to
nicotine (Baykan et al., 2008), anti-mouthcancer
(Varvares, 2008), prevention of bleeding in the
brain (Koh, 2008 ), inhibited the neurotoxic than
arsenic (Lin et al., 2008), prevent kidney damage
due to smoking (Ozan et al, 2007) and
antihypertensive (Xia et al, 2008).
Based on it's chemical structure, the
phytomelatonin can dissolve in ethanol.
Phytomelatonin can be determinated by
spectrophotometry and TLC-densitometry
technique.
This study aims to campare the
phytomelatonin level in ethanolic extract of
green algae determinated by spectrophotometry
and TLC-densitometry thechnique
MATERIAL AND METHOD
Material
The main material was geen algae
(Spyrogyra sp). Chemical material : absolute
ethanol p.a., petroleum ether, ether, acetic acid
p.a, HCl , n-butanol p.a.. purcashed from Merck,
Dragendrof dan Meyer reagents, aquadest dan
Silica gel GF-254 plate.
Methods
1. Plant identification
Plant identification was done at
Laboratorium Ilmu Alam Fakultas MIPA
Universitas Ahmad Dahlan..
2. Sample collecting
Green algaes were collected from Rowo
Jombor , District Bayat, Klaten regency, Central
Java in March of 2012.
3. Aethanolic Exctract preparation
Phytomelatonin was extracted from green
algae by Soxhlet apparatus with aethanol then
evapotated with rotary evaporator to obtaine
thick extract. The water content and the ash
content of the aethanolic extract were
determinated by gravimetric thecnique.
4. The aethanolic extract Purification
About 15 mL 15% acetic acid was added
into the thick aethanolic extract, then filtered
using Buchner funnel. Wash the filtrate with
petroleum ether. The acetic acid layer were
separated and added NH4OH until the pH value
was 10. Pour 50 ml of ether into the basic
solution. Remove the water layer. Evapoporate
the ether layer to obtain the residue. Dissolve the
residue using aethanol. The absorbance of the
solution were measured at 277nm wavelength.
5. The screening of alkaloid and
identification of phytomelatonin in
aethanolic extract
The alkaloid screening were done using
Dragendorf and Mayer test. The formation of
sediment after the addition of the dragendorf or
mayer reagent into the acidic sample indicated
the presence of alkaloid in the sample.
The qualitative analysis of
phytomelatonin in the aethanolic extract was
done with TLC thecnique. The similarity Rf
value beetween the phytomelatonin standart spot
and sample spot indicated the presence of
phytomelatonin in the sample.
6. The quantitative analysis of
phytomelatonin
a. Spectrophotometry thecnique
The phytomelatonin standart solutions in
many various level were prepared. The interval
level were between 0.1-0.3mg/ml. The
absorbance of various level of phytomelatonin
standart solution and the purified aethanolic
extract were measured at 277nm wavelength
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using Pharmaspec UV 1700 (SHIMADZU)
spechtophotometer
The linear regression equation between
the level of standart phytomelatonin vs
absorbance was determinated. This equation was
used to calculated the level of phytomelatonin in
aethanolic extract.
b. TLC-densitometry thecnique
The silica F254 was used as stationary
phase. The phytomelatonin standart
(0.2-2.0/mg/ml) and the aethanolic extract were
eluated with BAW (12:3:5)v/v. The AUC (area
under the curve ) values were determinated by
scanning the dried spot with TLC scanner 3
(CAMAG) at 284nm wavelength. The linear
regreesion equation between the level of
phytomelatonin standart vs AUC was
determinated. This equation was used to
calculated the level of phytomeltonin in the
aethanolic extract.
RESULT AND DISCUSSION
The plant identification result showed that
the plant used int his study was green algae
(Spirogyra sp.) .
About 24.3399 grams aethanolic extract
(rendemen 9.74%) was produced from 250
grams green algae The water content of the
extract was 8.34% dan 3.06% of ash content
The alkaloid screening, both of
Dragendorf and Mayer tests indicated that the
aethanolic extract of green algae consist of
phytomelatonin.
The qualitative analysis of
phytomelatonin in aetaholic extract by TLC
thecnique showed the presence of
phytomelatonin in both of the purified
aethanolic extract and aethanolic extract. (fig.1)
The quntitative analysis of
phytomelatonin
a. Spectrrophotometry technique
The spectrophotometry technique was
based on the ability of the phytomelatonin
content in the aethanolic solution to absorb the
electromagnetic radiation in Ultra Violet region.
The maximum wavelength of the
phytomelatonin standart was 277nm. The spectra
of purified aethanolic extract showed the
mximum wavelength at 275.8nm and the spectra
profile showed the similarity between
phytomelatonin standart and the purification
aethanolic extrct spectra. It's showed that the
purified aethanolic extract consit of
phytomelatonin.
The absorbance of phytomelatonin
standart soution in many various level was
available in table I. The graphic fig. 2 showed the
corelation between the phytomelatonin standart
level Vs the absorbance.(p<0.05).
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A B C
8 cm
Figure 1. Chromatogram of phytomelatonin strandart (A),
purified aethanolic extract (B) and aethanolic extract(C)
Table I. The absorbanceof the phytomelatonin
standart solution
C (mg/10ml) Absorbance
0.10 0.286
0.15 0.412
0.20 0.543
0.25 0.688
0.30 0.715
b. The TLC-densitometry technique
The chromatogram result from the TLC
technique was desribed at figure3.
The qualitative parameter of the
chromatogram were the Rf value. The Rf value
of the phytomelatonin standart was 0.75 and the
Rf value of the aethanolic extract was 0.76 . It's
indicated that the aethanolic extract consist of
phytomelatonin. The quantitative parameter of
the TLC-densitometry technique were The AUC
values. The AUC values of the phytomeltonin
standart were described in table III.
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Figure 2. The graphic corelation between phytomelatonin
level vs the absorbance
Sample
weight
(mg)
Abs
Phytomelato
nin level (%)
x
(%)
SD CV (%)
x  Le
(%)
998.6 0.469 0.22
.22 5.48 x10-3 2.74 0.22  0.01
998.8 0.482 0.22
998.8 0.489 0.23
999.1 0.494 0.23
998.8 0.475 0.22
Table II. The phytomelatonin level in aethanolic extract of green algae determinated by spectrophotometry
technique
Figure 3. The chromatogram of phytomelatonnin standart
(1-6) and aethanolic extract of green algae (a-e) on silica
F254 plate after eluated by BAW (12:3:5)v/v under UV
detector
According to The data in the table I
showed that the TLC-densitometry technique
gave the higher value of the phytomelatonin
level in the aethanolic extract of green
algae.(p<0.05) It indicated that the
TLC-densitometry technique more sensitive
than spectrophotometry technique. Another
advantage of TLC-densitometry technique was
the selectivity. The TLC-densitometry technique
was more selective than spectrophotometry.
CONCLUSION
The TLC-densitometry technique gave the
higher phytomelatonin of green algae level than
specthrophotometry technique (p<0.05)
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No
Phytomelatonin level
(mg/ml)
AUC
(mV)
Linear regression R value
1 0.2 9.1528
Y = 12.48 x + 10.63 0.94*
2 0.6 19.5458
3 1.0 27.2703
4 1.4 29.7615
5 1.8 32.9887
6 2.0 32.3886
Table. III. The AUC values of the phytomelatonin standart
Figure 4. The graphic corelation between the
phytomelatonin level Vs AUC
Sample
weight
(mg)
AUC (mV) Phytomelato
nin level (%)
x
(%)
SD CV (%) x  Le (%)
997.8 31.8568 0.85
995.5 31.6834 0.85
0.88 0.04
4.5
0.88

0.04
1000.2 32.6445 0.88
999.1 32.1614 0.86
895.9 31.8769 095
Tabel IV. The phytomelatonin level in aethanolic extract of green algae determinated by spectrophotometry
technique
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